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CHAPTER I 
 
INTRODUCTION 
 
Overview 
 Heart disease represents one of the most prevalent conditions in modern health 
care, impacting the morbidity and mortality of patients at every stage of life.  Congenital 
heart disease (CHD), as the most common birth defect, affects 1 out of every 100 live 
births worldwide (Hoffman and Kaplan, 2002).  Increasingly, subtle cardiac 
developmental anomalies and unfavorable genetic predispositions are being regarded as 
potent risk factors for adult onset heart disease.  Despite improvements in the surgical 
and pharmacological management of these afflictions, there has been a concerted effect 
to discover new treatment modalities.  Recently, embryonic and adult stem cells have 
been touted as potential tools for regenerative medicine, with the hope that they might be 
used to repair and regenerate lost and damaged tissues (Murry and Keller, 2008).  
Understanding the specification of cardiac lineages from progenitor populations and how 
these different components interact to achieve proper organogenesis is an essential first 
step to harness stem cells for the treatment of both congenital and adult heart disease. 
While factors influencing cardiomyocyte specification and differentiation have 
been well documented, little is known regarding the origin of the endocardium, the 
endothelial component of heart chambers.  Examination of endocardiogenesis, the 
process of endocardial endothelium arising from mesodermal precursors, has proven 
difficult without markers to distinguish endocardium from endothelium.  The 
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transcription factor Nuclear Factor of Activated T-Cells calcineurin-dependent-1 
(NFATc1) has been identified one of the few specific markers of this endothelial 
subpopulation.  Our laboratory has previously focused on the transcriptional regulation of 
NFATc1 in endocardial cells lining the presumptive valve cushions, where NFATc1 
functions in the maintenance of the endocardial cell layer during epithelial-to-
mesenchymal transformation (EMT).  However, NFATc1 is also expressed in 
endocardial cells as they first emerge from the cardiac mesoderm.  Characterization of the 
regulatory domains controlling expression of NFATc1 could potentially be used as a 
genetic tool to label early endocardial precursors, allowing for in depth study of 
endocardiogenesis and the origin of the endocardium.  Taking into account the unique 
role endocardium plays in cardiogenesis, we hypothesized that the endocardium is a 
distinct subpopulation of endothelium derived from a common cardiovascular precursor 
in the anterior cardiac mesodermal also responsible for generating the myocardium, and 
is essential for proper cardiac morphogenesis. 
The primary focus of my research has been to identify and monitor 
endocardiogenesis in vivo and in vitro using an NFATc1 reporter transgene.  Chapter I 
will describe heart development and detail the contributions made by various cell 
lineages to the assembling heart.  It will go on to discuss proposed models of endocardial 
differentiation, the role of endocardium in cardiac morphogenesis, and the role of 
NFATc1 in heart development.  Finally, Chapter I will provide background on embryonic 
stem cell (ESC) differentiation, specifically how it has furthered our understanding of 
cardiovascular specification and differentiation.  Chapter II documents the generation of 
NFATc1-nuc-LacZ BAC transgenic mice, which by faithfully recapitulating endogenous 
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NFATc1 expression identifies the endocardium at the earliest stage of cardiac 
development.  Chapter III focuses on the establishment of ESC differentiation as an in 
vitro model of endocardial differentiation demonstrating spatial-temporal coordination of 
endocardial and myocardial differentiation that mirrors the pattern seen during 
embryogenesis.  Chapter IV extends these observations by documenting that 
endocardium is a cardiac cell lineage distinct from the hematopoietic lineage and 
systemic vasculature.  Furthermore, the isolation and characterization of Flk1+ 
multipotent cardiovascular progenitors (MCPs) provides evidence that endocardium and 
myocardium are derived from a common precursor.  In Chapter V, I conclude by 
discussing the significance of a multipotent cardiovascular progenitor focusing on 
endocardial-myocardial interactions and highlight future experiments to explore the 
differences between endocardium and other endothelium, as well as characterize the role 
of endocardium in heart development. 
 
Heart development 
 The heart is the first organ to function in vertebrate organisms, and the cessation 
of its function is used as the defining characteristic of clinical death.  Cardiac 
development in the mouse begins at embryonic day 7.5 (E7.5) in the splanchnic layer of 
the anterior lateral plate mesoderm between the anterior visceral endoderm (AVE) and 
ectoderm (reviewed in Harvey, 2002; Srivastava, 2006). The cardiac mesoderm consists 
of two bilaterally symmetrical fields of precursors that extend cranially towards the 
extraembryonic mesoderm (Fig. 1.1A).  This pattern, which is conserved across diverse 
species, was adopted as an alternative term for this region, the cardiac crescent.  With 
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lateral folding of the embryo, occurring from E7.5 to E8.5, these precursors coalescence 
along the ventral midline to form a primitive heart tube with an outer myocardium and 
inner endocardium separated by an extracellular matrix (ECM) termed the cardiac jelly 
(Fig. 1.1B).  This linear tube serves as the structural basis for subsequent morphogenesis, 
as the heart initiates a conserved program of patterned growth and dextrorotation.  
Cardiac looping forces the atria and venous system dorsally, while the primitive ventricle 
bulges towards the anterior aspect of the embryo.  
 In addition, looping establishes borders of the atrioventricular canal (AVC) and 
the conotrunus or outflow flow tract (OFT), where swelling of the cardiac jelly marks the 
location of future valve formation (Fig. 1.1C).  By E10.5, endocardial cells of the AVC 
and OFT delaminate and invade the cardiac jelly to form the endocardial cushions (ECC) 
(reviewed in Armstrong and Bischoff, 2004; Barnett and Desgrosellier, 2003).  Through a 
process of cell differentiation, apoptosis, and ECM remodeling, ECCs are modified into 
thin leaflets of endothelium over a core of collagen, elastin, and glycosaminoglycans 
(GAGs) (Schroeder et al., 2003).  Cushion formation is the first step in a process known 
as septation, the division of atria and ventricles into right and left sides to generate the 
four-chambered heart necessary for parallel circulation in warm-blooded animals.  
Septation also marks the formation of trabecular and compact myocardial layers in the 
ventricles (Fig. 1.1D).  The rapidly proliferating outer compact layer of the myocardium 
is responsible for the majority of ventricular growth seen between E11.5 and E14.5.  The 
inner trabecular layer generates myocardial outgrowths into the ventricular chambers that 
increase myocardial perfusion and aid in contraction (Ben-Shachar et al., 1985). 
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Figure 1.1. Morphogenic events in early cardiac development. Structural changes 
during the initial formation and remodeling of the murine heart. Figure modified from 
Harvey (2002). 
 
Cranial, Cr; caudal, Ca; cardiac crescent, cc; neuroectoderm, ne; anterior visceral 
endoderm, ave; heart tube, ht; dorsal mesocardium, dmc; myocardium, m; endocardium, 
e; conotrunus, ct; bulboventricular fold, bvf; atria, a; atrioventricular canal, avc; aortic 
sac, as; common ventricle, v; endocardial cushions, ecc; left atria, la; left ventricle, lv; 
right ventricle, rv; right atria, ra; trabecular zone, tz; compact zone, cz; atrioventricular 
septum, avs; interventricular septum, ivs 
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In addition to the endocardium and myocardium, “extra-cardiac” lineages, 
populations not originating in the cardiac crescent, are crucial for complete formation of a 
functional heart, the two most notable being the Proepicardium (PE) and the Cardiac 
Neural Crest (CNC) cells.  The PE originates at the septum transversum, migrating over 
the myocardium to form a single layer of cells by E10.5, at which it is becomes the 
epicardium (Mikawa and Gourdie, 1996).  Epicardial cells undergo EMT and delaminate 
into the myocardium where they form endothelial cells, smooth muscle cells, and 
myofibroblasts.  Formation of a functional coronary vascular plexus is essential for 
myocardial growth.  CNC cells, as the other predominant extra-cardiac lineage, 
contributes to the OFT and parasympathetic innervation of the heart.  Migrating CNC 
from somites 1-3 pass through pharyngeal arches 3, 4, and 6, where they play a role in 
remodeling the originally paired pharyngeal arch arteries into the aortic arch and its 
tributaries (Waldo et al., 1998; Waldo et al., 1999).  Continuing on to the heart, cells of 
the CNC enter the distal OFT between the endocardium and myocardium to participate in 
OFT septation, becoming incorporated into the semilunar valves, and through 
myocardialization, generate myocardium and smooth muscle in the aortic and pulmonary 
arteries (reviewed in Brown and Baldwin, 2006).  
  
Mesodermal origin of cardiac lineages 
 Heart development is dependent on the coordination of several distinct cell 
lineages.  These interactions occur during specific developmental windows, at precise 
spatial locations, deviation from which can result in numerous development 
abnormalities.  To understand how these lineages interact, it is necessary to examine their 
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developmental origins and how they are specified.  Gastrulation transforms uncommitted 
embryonic epiblast into three germ cell layers: ectoderm, which forms skin and neural 
tissue; mesoderm that generates blood, bone, and muscle; and endoderm, the source of 
the respiratory and gastrointestinal systems (Tam and Behringer, 1997).  Precursors of the 
cardiac mesoderm are derived from epiblast cells that reside lateral to the brachyury 
positive primitive streak (PS) (Fig 1.2Ai).  These cells, which will come to populate the 
cardiac crescent, pass through the primitive streak during mid-gastrulation (Kinder et al., 
1999).  As this population leaves the PS to form the anterior and lateral plate mesoderm, 
it transiently upregulates the basic helix-loop-helix (bHLH) transcription factor Mesp1 
(mesoderm posterior 1); fate mapping of Mesp1+ cells indicate they localize to the 
cardiac and paraxial mesoderm to generate the heart and skeletal muscle of the head and 
neck (Fig 1.2Ai).  Loss of Mesp1, does not impact mesodermal formation or migration, or 
cardiac induction, but inhibits linear heart formation (Saga et al., 1999).  However, a 
double knockout of Mesp1 and the closely related bHLH transcription factor Mesp2 
results in failure of mesodermal cells to migrate away from the PS, indicating functional 
redundancy between the two transcription factors (Kitajima et al., 2000).  Recent studies 
in embryonic stem cell models suggest that Mesp1 is essential for the initial commitment 
of mesoderm towards a cardiac fate (Bondue et al., 2008; Lindsley et al., 2008). 
Cardiogenic progenitors express neither Mesp1 nor Mesp2 upon reaching the 
anterio, though the cell surface receptor Flk1 is ubiquitously present in the cardiac 
mesoderm (Fig. 1.2Ai).  Flk-1 (fetal liver kinase1, also known as Vascular Endothelial 
Growth Factor Receptor 2, VEGFR-2; or kinase domain region, KDR) was originally 
classified as one of the four Vascular Endothelial Growth Factor (VEGF) receptors 
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(Ferrara et al., 2003).  Targeted disruption of Flk1 was embryonic lethal at E8.5-9.5 
caused by a lack of vasculogenesis, de novo creation of blood vessels from mesodermal 
precursors (angioblasts), and impaired blood/vascular lineage development (Shalaby et 
al., 1997; Shalaby et al., 1995).  Initially, Flk1 was viewed as an endothelial-specific 
receptor functioning in vascular formation and maintenance, in part due to the 
endothelial-restricted expression pattern of an Flk1 transgenic reporter targeted with the 
Beta-galactosidase (β-gal) gene LacZ.   
However, subsequent lineage tracing with a transgenic mouse expressing Cre 
recombinase under the Flk1 promoter suggested cell populations other than just 
endothelium expressed Flk1.  When crossed with the Rosa26 LacZ reporter (R26R) 
mouse that activates β-gal in cells where Cre is actively being produced, as well as their 
progeny, expression was observed in skeletal and cardiac muscle, populations not 
previously associated with Flk1 expression (Motoike et al., 2003; Soriano, 1999).  At 
first met with skepticism, further examination indicated that Flk1 was expressed much 
earlier and in a broader pattern than previously described.  By removing the neomycin 
selection cassette from the Flk1 locus already possessing LacZ, expanded expression was 
detected in mesodermal cells departing the PS during early and mid-gastrulation (Ema et 
al., 2006).  These populations localized to blood islands in the extraembryonic 
mesoderm, the site of early vasculogenesis and hematopoiesis, and the cardiac crescent at 
E7.5 (Fig. 1.2Ai,ii).  Though present in all cardiac progenitors, Flk1 is downregulated in 
myocardial cells over the course of cardiogenesis, yet retained in endocardium.  
Interestingly, Flk1-/- mice possess no observable defects in cardiomyocyte differentiation 
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or early morphogenesis, as the primitive heart forms and initiates looping prior to 
succumbing to vasculature insufficiency (Shalaby et al., 1995).  
 
Primary and secondary heart fields 
 Until recently, segmentation of the primitive heart tube was thought to reflect 
primordial regionalization that through growth and remodeling generated all aspects of 
the mature heart (reviewed in Srivastava and Olson, 2000).  Through a combination of 
ablation studies, gene targeting, and lineage tracing it has become accepted that the adult 
heart is fashioned from two distinct heart fields (reviewed in Buckingham et al., 2005; 
Kirby, 2002).  The primary or first heart field (PHF), in the anterior lateral plate 
splanchnic mesoderm, represents the cells that generate the primitive heart tube of 
endocardium and myocardium (Fig. 1.2Aii).  This linear tube then acts as a scaffold for 
another population of heart progenitors, referred as the secondary or anterior heart field, 
to enter the arterial and venous poles (Fig 1.2Bi).  The terms anterior and secondary heart 
field are used interchangeably, but actually represent two different classifications of this 
second progenitor population.  The secondary heart field is positioned behind the OFT in 
the pharyngeal mesoderm, while the anterior heart field encompasses both the secondary 
heart field and cranial mesoderm that extends into the pharyngeal arches; for simplicity, 
secondary heart field (SHF) will be used to designate this combined population of heart 
progenitors (Fig 1.2Aii) (Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo et al., 2001; 
Zaffran et al., 2004). A retrospective clonal analysis with a α-cardiac actin laacZ reporter 
demonstrated the two lineages segregated soon after gastrulation from a common 
precursor (Meilhac et al., 2004).  How this divergence is regulated remains unknown. 
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Figure 1.2. The origin and contribution of mesodermal and extracardiac lineages to 
the developing heart. A. Migration of mesodermal cells to the cardiac mesoderm from 
the primitive streak following gastrulation with associated gene expression (i). Location 
and orientation of the PHF (green) and the SHF (blue) at the cardiac crescent stage (ii) 
through the formation of the primitive linear heart tube (iii,iv). Figure adopted from Wu 
et al. (2008). B. Contribution of the PHF (red), SHF (yellow), and CNC (blue) to 
structures of the developing and adult heart. Figure adopted from Srivastava (2006). 
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 In mice, the SHF was initially revealed by expression of an FGF10 reporter active 
in the pharyngeal mesoderm (Kelly et al., 2001).  Analysis at a later developmental time 
point in this reporter mice documented β-gal+ cells in the right ventricle and outflow tract 
of the looped heart (Fig 1.2Aiii).  This same study utilized Di-I labeling to track the 
pharyngeal mesoderm, confirming that this population did contribute to the myocardium.  
Studies of the LIM homeodomain transcription factor islet1 (isl1) further supported the 
existence of a SHF and clarified its contribution to the developing heart.  Isl1 is expressed 
at E7.5 in the pharyngeal mesoderm, and later at the poles of the E8.5 linear heart; 
however, by E10.5 isl1 is not expressed in the heart (Cai et al., 2003).  Fate mapping with 
a Cre recombinase targeted to the isl1 locus demonstrated early isl1+ populations in the 
pharyngeal mesoderm generated structures associated with the SHF.   In addition, 
deletion of isl1 resulted in embryonic lethality caused by a failure of the right side of the 
heart to form.   
Present models contend that the PHF, traditionally defined by its mesodermal 
location and expression of Nkx2.5, first identified as a homologue of the Drosophila 
tinman, generates the atria and left ventricle (Fig. 1.2Bii,iii).  The SHF, marked by its 
prototypical transcription factor isl1, is instrumental to the development of the right 
ventricle and OFT.  Asymmetrical gene expression in two sides of the heart had been 
observed prior to the discovery of the SHF.  Disruption of the T-box transcription factor 
Tbx5 or the bHLH Hand1/eHand result in left ventricle hypoplasia, while lose of Mef2c 
(myocyte enhancer factor 2) or Hand2/dHand cause right ventricular hypoplasia 
(Bruneau et al., 2001; Firulli et al., 1998; Lin et al., 1997; Srivastava et al., 1995).  But 
with the advent of the multiple heart field model, these transcriptional networks can be 
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categorized as being downstream effectors of Nkx2.5 and isl1 in the PHF and SHF, 
respectively.  
 
Cardiac induction from mesodermal progenitors 
These studies detail a stepwise process by which epiblast cells transition to 
cardiac mesoderm, but it is important to note that ingression through the PS is not 
required for cardiac specification.  Epiblast cells transplanted directly to the cardiac 
mesoderm can adopt a cardiac fate (Tam et al., 1997).  This implies that the 
environmental signals present at the cardiac crescent are the critical step for cardiac 
induction, not mesoderm progression.  Elucidating the instructive/permissive signals 
required for cardiac specification, differentiation, and proliferation has been the focus of 
extensive inquiry and considerable debate.  Early studies of cardiac specification were 
largely conducted with avian model organisms.  Both ease of access and plentiful tissue 
made the avian model an attractive system for manipulation, but also paved the way for 
future studies in mammals (Yutzey and Kirby, 2002).  Cardiac specification and terminal 
differentiation are now acknowledged to occur uniquely in the cardiac crescent because 
of the convergence of both inductive and inhibitory soluble growth factors; Wnts from 
the neural ectoderm and Bone Morphogenic Proteins (BMP) antagonists Chordin and 
Noggin from the notochord inhibit cardiogenesis, while BMPs, Fibroblast Growth 
Factors (FGF), and Wnt inhibitors Crescent and Dickkopf-1 (Dkk-1) from the endoderm 
are inductive signals (Fig. 1.3A,B) (Brand, 2003).   
Commitment of mesoderm to the cardiac fate is initiated by the release of Activin, 
a member of the Transforming Growth Factor-β (TGF-β) family, from the hypoblast in 
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chicks, and the analogous AVE in mice (Ladd et al., 1998; Yatskievych et al., 1997).  
Early TGF-β primes the cardiac mesoderm for later signaling from the AVE in mice or 
definitive endoderm in chicks (Schultheiss et al., 1995).   As the AVE is a major source 
of BMPs, BMP2, -4, and -7 were initially cited as necessary for cardiomyocyte 
differentiation (Schultheiss et al., 1997).  However, further investigation found that 
BMPs alone were insufficient to induce myocyte differentiation, and could only do so in 
concert with FGF2, and -4 (Barron et al., 2000; Lough et al., 1996).  FGFs are critical to 
cardiomyocyte differentiation; FGFR1-/- mice fail to form mesodermal structures, 
however FGFR1-/- ESCs can generate various mesodermal derivatives in teratomas and in 
embryoid body (EB) differentiation, but not cardiomyocytes (Dell'Era et al., 2003; Deng 
et al., 1994).  
The Wnt signaling pathway has an important, yet dichotomous, role in 
cardiogenesis.  Non-canonical Wnt11 originating from the mesoderm and endoderm acts 
to enhance cardiomyocyte differentiation, while canonical Wnt1, and -3A from the neural 
ectoderm inhibit cardiac differentiation along the midline and posterior aspects of the 
embryo (reviewed in Cohen et al., 2008).  A null mutation of β-catenin, the downstream 
effector of Wnt signaling, leads to additional cardiac tissue to form in endodermal layers, 
illustrating the function of canonical Wnt signaling in blocking cardiac differentiation 
(Lickert et al., 2002).  In contrast, Wnt inhibitors Crescent and Dkk-1 both act to enhance 
cardiogenesis from mesoderm progenitors.  Crescent and Dkk-1 are unique among Wnt 
inhibitors in their ability to induced cardiac differentiation.  Normally restricted to the 
AVE underlying the cardiac mesoderm, when missexpressed in other regions of the 
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Figure 1.3. Extracellular signals regulating cardiac specification from mesoderm. A. 
Extracellular growth factors and their relevant downstream effectors (white boxes) acting 
on the cardiac mesoderm to regulate cardiac gene expression.  Lines with arrowheads 
represent inductive signals.  Lines with perpendicular lines represent inhibitory signals. 
Box color denotes source of the paracrine signal. See below for color legend. B. 
Schematic depiction of E7.0-7.5 embryo displaying the origins of paracrine signals acting 
on the cardiac mesoderm (red). Inhibitory Wnts are derived from the neuroectoderm 
(blue). Inhibitory BMP inhibitors Noggin and Chordin are generated by the notochord 
(grey).  The endoderm (green) is the source of BMPs, FGFs, and Wnt inhibitors Dkk-1 
and Crescent that induce cardiac gene expression. Figure modified from Brand (2003). 
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embryo, they can convert non-cardiac posterior mesoderm to a cardiac fate (Marvin et al., 
2001; Schneider and Mercola, 2001). 
 A major caveat to the aforementioned studies is that cardiac is synonymous with 
cardiomyocyte, as few assess endocardial or endothelial differentiation from the cardiac 
mesoderm.  Only a few studies have examined what factors are necessary to induce 
endocardial differentiation from cardiac mesoderm, and all have been done with chick 
explants.  In chick cardiac mesoderm explants, endocardial cells, defined as endothelial 
cells expressing the QH-1 antigen, differentiated in the presence of lateral plate 
endoderm, either in direct contact or across a filter but not in its absence, suggesting a 
soluble factor originating from the endoderm initiates endocardial differentiation (Sugi 
and Markwald, 1996).  Further work suggested that TGF-βs, but not BMP2 or FGF2, 
were the endodermal-derived growth factors enhancing endocardial precursor formation 
(Sugi and Markwald, 2003).   Interestingly, VEGF alone had no effect on endocardial 
differentiation, but did synergize with TGF-βs.  
 
The embryonic endocardium 
 
Endocardial differentiation and development 
With its seamless integration with systemic vasculature, the endocardium has in 
the past mistakenly been categorized as a specialized continuation of vascular 
endothelium.  Advances in vascular and cardiac biology have revealed that the 
endocardium is a distinct cell population with a unique expression profile acting as a 
dynamic participant in cardiac morphogenesis.  The endocardium is also notable as one 
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of the earliest cell lineages to develop during murine embryogenesis that retains its 
identity into maturity.  Cells of the cardiac crescent are among the first mesodermal-
derived populations to express N-cadherin, an epithelial cell surface marker, after 
gastrulation.  As endocardiogenesis is initiated at E7.5, endocardial precursors 
downregulate N-cadherin expression to emerge from the ventral surface of the cardiac 
mesoderm into the fibronection-rich space between the presumptive myocardium and the 
AVE, where they can be distinguished from myocardial precursors still retaining N-
cadherin expression (Fig. 1.4A) (Linask, 1992).  Interestingly, deletion of N-cadherin 
does not hinder endocardial or myocardial differentiation in mice, but does result in cell 
adhesion defects in the myocardium (Radice et al., 1997).   
Endocardial cells first assemble into a vascular plexus, which coalesces through 
angiogenic remodeling and migration into the inner endocardial tube of the primitive 
heart (Fig. 1.4B) (reviewed in Baldwin, 1996).  During this process, endocardial cells 
establish connections with system vasculature, which is critical to establishing blood flow 
through the beating heart (Coffin and Poole, 1988; Coffin and Poole, 1991).  Endocardial 
precursors in the cardiac crescent express several vascular makers, including Flk1, Tal1, 
and CD31/Pecam-1 (Baldwin et al., 1994; Kallianpur et al., 1994).  As the endocardium 
is consolidated into an intact endothelial vessel and incorporated into the forming linear 
heart at E8.5, Tal1 expression is lost, while other vascular markers, VE-cadherin and Tie2 
(Tek) are upregulated (Drake et al., 1997; Lampugnani et al., 1992).   
The inherent problem of utilizing these genes to monitor endocardiogenesis is that 
they fail to distinguish endocardium from other endothelial populations.  However, 
certain genes have been identified as being restricted to the embryonic endocardium, 
             16
 
 
 
 
 
 
Figure 1.4.  Models of endocardial specification and differentiation. A. Endocardial 
precursors (green) delaminate from the cardiac mesoderm (red) into the fibronection-rich 
space between the presumptive myocardium and the AVE. B.  With lateral folding of the 
embryo from E7.5 to E8.5, cardiac precursors coalescence along the ventral midline to 
form the primitive heart tube consisting of an outer myocardium (red) and inner 
endocardium (green).  C. Proposed models depicting the origin of the endocardium. The 
first states that endocardium and myocardium are derived a common multipotent 
progenitor present in the cardiac mesoderm. The second asserts that endocardium and 
myocardium are two spatially sequestered populations within the cardiac mesoderm that 
develop in parallel. Figure adapted from Harvey and Rosenthal (1999). 
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indicating that endocardial cells are a distinct subpopulation of endothelium subject to its 
own unique transcriptional regulation at the earliest stages of development.  In avian 
systems, all embryonic endothelial cells are positive for the QH1 antigen, but endocardial 
cells are the only endothelium to express cytotactin and the fibrillum-like protein JB3 
(Sugi and Markwald, 1995; Sugi and Markwald, 1996; Wunsch et al., 1994).   TGF-βRIII 
is also restricted in the endocardial endothelium of avian embryos, a reversed pattern 
from what had been observed with TGF-βRII (Brown et al., 1999).  This pattern is not 
conserved in mice, as TGF-βRIII expression is detected throughout the endocardium, 
myocardium, and epicardium, as well as in the developing liver (Stenvers et al., 2003).  
In the mouse, several genes with embryonic endocardial expression patterns have been 
observed.  Irx5 and Irx6, Iriquious family related proteins, are expressed in atrial and 
ventricular endocardium at E9.5, but not cushion endocardium (Christoffels et al., 2000; 
Houweling et al., 2001).  Members of the Inhibitors of differentiation (Id) family of 
transcription factors Id1 and Id3 are present throughout the endocardium, but are also 
expressed in the epicardium and in other endothelial populations (Fraidenraich et al., 
2004).  The only gene expressed in endocardial cells at the earliest stage of their 
development not present in other vascular population, is NFATc1.  Following sections 
will discuss the expression and function of NFATc1 in detail. 
 
Genes implicated in endocardiogenesis 
 Accumulating evidence indicates that the endocardium is molecularly distinct 
from other endothelium.  The most striking examples come from zebrafish (Danio rerio) 
models, where cloche and faust mutants generate normal body vasculature, but fail to 
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form endocardium. Cloche mutants lack endocardium and hematopoietic lineages, but 
form a myocardial heart tube and have only minor abnormalities in systemic vasculature 
(Stainier et al., 1995).  While no mammalian homologues for cloche have been identified, 
cloche has been determined to function cell autonomously early in vascular signaling, 
upstream of Flk1 and Scl/Tal1 (Liao et al., 1997; Parker and Stainier, 1999).  The faust 
zebrafish mutant also fails to generate endocardial cells in spite of normal vascular 
differentiation.  However unlike the cloche mutant, faust mutants do not possess a 
midline heart tube as cardiomyocyte precursors fail to migrate resulting in two 
nonfunctional bifid heart tubes (Reiter et al., 1999).  Faust has been mapped to the 
GATA5 locus, which in mice is expressed in the early endoderm and endocardium.  It 
remains unclear whether the lack of endocardial cells in the faust mutant is due to cell 
autonomous defects in endocardial differentiation, or more likely, non-cell autonomous 
deficits in endoderm patterning.   
 No genetic mutations in mice have been found to result in a complete lack of 
endocardium as seen in these zebrafish mutants.  Nemer & Nemer demonstrated that 
inactivation of both GATA5 and NFATc1 could block endocardial differentiation from an 
immortalized mesodermal cell line treated with retinoic acid (Nemer and Nemer, 2002).  
However, as GATA5-/- and NFATc1-/- mice have no defects in endocardial differentiation, 
and double knockouts have never been generated, the in vivo relevance of this work is 
subject to question.  While no mutants with endocardial ablation in concert with normal 
myocardial and systemic endothelial development have been documented, several genes 
that are crucial for endocardial development have been detailed.  Global deletion of the 
Ets transcription factor Er71, which functions downstream of BMP, Notch, and Wnt 
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signaling in Flk1+ mesoderm and vasculature, disrupts all hematopoietic and vascular 
formation, including endocardial differentiation (Lee et al., 2008).  The severity of this 
phenotype, in terms of vascular development, exceeds even the Flk1 knockout, in which 
endocardial and endothelial cells differentiate but fail to undergo proper vasculogenesis 
to form lumenized vessels and remain as aggregates of immature endothelial cells.  The 
receptor tyrosine kinase (RTK) Tie2 (TEK), while not involved with the initial 
specification of endocardium and endothelium, does transduce a proliferative and 
organizing signal to the endocardium; deletion of Tie2 in the endocardium greatly 
reduces the number and cohesion of endocardial cells, causing circulatory collapse and 
embryonic death (Puri et al., 1999).  Proper endocardial development is dependent not 
just on growth factor transduction, but also on a permissive environmental structure.  
Loss of the ECM protein, fibronectin, indicates it is essential for formation and/or 
maintenance of the lumen of the endocardial tube (George et al., 1997). 
 
The role of endocardium in cardiac morphogenesis 
 
Endocardial-myocardial interactions in early heart development 
 Examination of endocardial-myocardial interactions in mammalian models has 
been limited.  The majority of what is known about the role of the endocardium in early 
cardiac organogenesis has been generated from studies of zebrafish development.  As 
discussed in the previous section, cloche mutants fails to form endocardium and 
hematopoietic lineages, but normal endothelial cells line body trunk vessels.  Early 
cardiac morphogenesis is relatively normal; the heart tube forms without the 
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endocardium, undergoes septation and looping, though does have reduced atrial and 
ventricular thickness (Stainier et al., 1995).  Detailed analysis of myocardial migration in 
the cloche mutant indicated that the fusing bilateral heart fields lacked angular motion in 
the most cranial and caudal regions compared to wild types (Holtzman et al., 2007).  
Direct medial motion was not impaired, thus a single heart tube formed.  Another 
zebrafish mutant miles apart (mil) was found to be deficit in medial motion resulting in a 
bifid heart phenotype with two independent heart tubes of myocardium and endocardium. 
Cloche and mil double mutants lacked both angular and medial migration, resulting in 
complete inhibition of migration of the bilateral heart fields and heart tube formation.  
While these analyses suggest the endocardium is responsible for inducing angular 
motion of the migrating heart fields, the cardiac phenotype of the cloche phenotype 
suggests endocardium is not necessary for proper specification and growth of 
cardiomyocytes.  However, another zebrafish mutant, heart of glass (heg), which encodes 
an endocardial transmembrane protein, suggests the endocardium is vital for patterned 
growth of the heart. In heg mutant embryos, the endocardium is present but myocardial 
cells fail to proliferate in the normal concentric direction, resulting in dilated chambers 
consisting of a single myocardial layer with negligible cardiac jelly (Mably et al., 2003).  
It is not known whether heg is sufficient to drive myocardial growth, or is it represents a 
link in early reciprocal endocardial-myocardial signaling.  Taken together, these studies 
of cardiac development in zebrafish suggest that the endocardium is an active participant 
in early cardiac moprphogenesis, serving as a reciprocal, and not passive, signaling 
partner with cardiomyocytes (Colvin et al., 2001; Lavine et al., 2005). 
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Patterned growth and differentiation of the myocardium 
Targeted gene disruptions in mice underscore the critical role of endocardium in 
later cardiac morphogenesis, where endocardial-myocardial interactions appear critical 
for normal patterned growth of the myocardium, trabeculation, and valvulogenesis.  FGFs 
and FGFRs not only act to induce myocardial specification, but also regulate 
cardiomyocyte proliferation and terminal differentiation during later stages of heart 
development.  Lavine et al. described how FGF9, -16, and -20, induced by retinoic acid, 
are secreted from the endocardium, and transmit a proliferative stimulus through 
alternatively spliced FGFR1c and FGFR2c isoforms expressed in the myocardium.  
While it was previously demonstrated that FGF9-/- mice die at birth with hypoplastic 
lungs and thin, dilated hearts, this work clarified that it was specifically the loss of 
endocardial-derived FGF9 that caused premature terminal differentiation of myocardium, 
most dramatically at the ventricular apex (Colvin et al., 2001; Lavine et al., 2005).  In 
addition to FGFs, other endocardial signaling molecules transmit patterning signals to 
various cardiac lineages.  Endothelins (ET) are small peptides that act as paracrine signals 
for G-protein coupled receptors, ETA and ETB.  ETs and endothelin-converting enzymes 
(ECE), which are responsible for converting ETs into an their active form, are widely 
expressed in endocardial cells and the mesenchyme of endocardial cushions and brachial 
arches (Yanagisawa et al., 1998a).  Mutations in ET1 or ECE-1 result in aberrant 
patterning of brachial arch derivatives, defective conotruncal septation, and ventricular 
septal defects (Yanagisawa et al., 2000; Yanagisawa et al., 1998b).  Since ET receptors 
are expressed in migrating CNC, as well as in the myocardium, it suggests that 
endocardial-derived ETs act on CNC and myocardium to regulate septation. 
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Trabeculation 
The development of trabecula is a defining characteristic of ventricular chamber 
morphogenesis.  In this process, myocardial cells proliferate and migrate into ECM-rich 
pockets covered by endocardium (Sedmera et al., 2000).  The formation of these highly 
muscularized radiations increase surface area for blood flow and enhance the force that 
can be generated with ventricle contraction. In addition, trabecula are incorporated into 
the interventricular septum, the papillary muscles of the mitral and tricuspid valves, and 
contribute to the conduction system.    
The first indication that endocardial-myocardial signaling plays an essential role 
in this process came with deletion of the epidermal growth factor receptor (EGFR) ligand 
neuregulin-1 (Nrg1) and the EGFR receptors ErbB2/ErbB4.  Nrg1 is normally expressed 
by ventricular, but not atrial, endocardium, while ErbB2/ErbB4 is restricted to the 
underlying myocardium.  A null mutation in any one of these three genes resulted in 
embryonic lethality at E10.5 with an absence of ventricular trabeculation and decreased 
myocyte proliferation (Gassmann et al., 1995; Lee et al., 1995; Meyer and Birchmeier, 
1995).  Nrg1 released from endocardial cells induces heterodimerization of ErbB2 and 
ErbB4, which in concert with insulin-like growth factor-1 (IGF-1) also from the 
endocardium, controls trabecular myocardial growth and differentiation (Hertig et al., 
1999).  Acting at an earlier developmental time point, endocardial Notch1 has been 
demonstrated to be required for trabeculation, modulating gene expression in both the 
endocardium and myocardium.  The Notch1 intracellular domain (NICD) regulates 
EphrinB2/EphB4 signaling within endocardial cells, which in turn modulates Nrg1 
expression (Grego-Bessa et al., 2007).  NICD signaling through RBPJk in the 
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endocardium also activates BMP10 expression in the trabecular myocardium through an 
unknown pathway to stimulate proliferation. 
Regulating developmental growth depends on converging signaling pathways that 
stimulate growth, but also halt expansion at a certain threshold.  While Notch1 and Nrg1 
induce growth of trabecular myocardium, Platelet-derived growth factor-B (PDGF-B) 
restricts proliferation.  PDGF is most commonly associated with vasculogenesis where it 
functions to recruit pericytes and vascular smooth muscle cells (VSMC) that expression 
the PDGFR-β to the endothelium (Hoch and Soriano, 2003).  Global deletion of PDGF-B 
is perinatally lethal, due in part to microvascular dysfunction (Leveen et al., 1994).  
Endothelial-specific deletion of PDGF-B is not fatal, but does highlight the role of 
endocardial-derived PDGF-B in cardiac morphogenesis as its loss results in myocardial 
thinning, chamber dilation, hypertrabeculation, and septal defects (Bjarnegard et al., 
2004).  Collectively, these analyses of endocardial-derived signals demonstrate the 
critical role of the endocardial cell lineage plays in coordinating proper septation and 
trabeculation. 
 
Valve Development 
 Valve formation is initiated when endocardial cells undergo EMT, delaminating 
into the cardiac jelly after downregulating vascular genes such as CD31/Pecam-1 and 
VE-cadherin and activating mesenchymal genes like Snail1 and Twist.  Although this 
process was documented by developmental biologists decades ago, only recently has 
empirical proof been provided that demonstrates cushion mesenchymal cells are derived 
from endocardium.  Lineage tracing with a Cre recombinase driven by the Tie2 promoter 
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breed to the R26R LacZ reporter established that all mesenchymal cells of the AVC 
cushion and the proximal cells of the OFT cushion were derived from endocardium 
(Kisanuki et al., 2001).  The entire process of valve construction, from EMT to 
remodeling, relies on signals produced and received by the endocardium, myocardium, 
and cushion mesechyme (Armstrong and Bischoff, 2004; Barnett and Desgrosellier, 
2003).  Whereas EMT is induced by BMPs and TGF-βs from underlying myocardium, 
Notch signaling must be activated in the endocardium for cells to be receptive to those 
instructions (Timmerman et al., 2004).   
Accordingly, failure to undergo EMT or disruption of signals from the 
endocardium to cushion cells results in a variety of valve defects. Under normal 
physiologic conditions, heparin-binding EGF-like growth factor (HB-EGF), an EGF 
ligand secreted by the endocardium, activates the ErbB1/B2 complex to inhibit 
proliferation of cushion mesenchymal cells, but does not affect the ErbB2/3 complex 
conveying a parallel mitogenic signal (Iwamoto et al., 2003).  Loss of HB-EGF signaling 
through ErbB1/B2 in null mice results in prolonged Smad1, -5, -8 phosphorylation, the 
downstream effectors of BMP signaling, and increased proliferation of cushion 
mesenchymal cells that leads to the development of enlarged hyperplastic valve cushions 
(Jackson et al., 2003).   
Neurofibromin1 (Nf1) is transcription factor that has been implicated in valve 
development and remodeling. In humans, mutations in Nf1 are responsible for von 
Recklinghausen neurofibromatosis, a genetic disorder causing café au-lait spots, 
neurofibromas, and potentially neural crest cell-derived malignancies.  Global deletion of 
Nf1 in mice results in a phenotype similar to neural crest ablation, consisting of valve 
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defects, increased cushion proliferation, decreased apoptosis, and decreased remodeling, 
in addition to double outlet right ventricle (Brannan et al., 1994).  Interestingly, CNC-
specific deletion fails to recreate the observed phenotype, but endothelial-specific 
deletion of Nf1 phenocopies null embryos (Gitler et al., 2003).  These studies also 
indicate that the Nf1 phenotype might be caused by misregulation of endocardial 
NFATc1. 
 
Origin of the endocardial lineage 
Despite their reciprocal signaling and close spatial-temporal relationship during 
embryogenesis, the question of whether endocardium and myocardium share a common 
progenitor in the cardiac mesoderm remains controversial.  Drawing from observations 
made in different organisms, two models have been generated; one proposes that the 
endocardium and myocardium represent two spatially sequestered populations within the 
cardiac mesoderm that develop in parallel, while the second states that endocardium and 
myocardium are derived a common multipotent progenitor in the cardiac mesoderm (Fig 
1.4C). 
Evidence for the assertion that the cardiac mesoderm contains two distinct 
subpopulations of endocardial and myocardial precursors already committed to their fate 
comes from avian lineage tracing and zebrafish studies.  Retroviral tracking of single 
cells in the cardiac mesoderm of chick embryos demonstrated that individual mesodermal 
cells in the heart field were capable of generating either myocardial cells (95.1% of 
clones) or endocardial cells (4.9% of clones), but never both cell types (Cohen-Gould and 
Mikawa, 1996).  A following study that conducted retroviral lineage tracing of pre-
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gastrulation PS cells also labeled only myocardial or endocardial cells (Wei and Mikawa, 
2000).  Pre-gastrulation blastomere transplantation in zebrafish also indicated that the two 
lineages were distinct prior to gastrulation (Lee et al., 1994).  This data is in agreement 
with a recent description of zebrafish with a mutation in the Scl/Tal1 gene (talt21384).  
Bussmann et al. demonstrated that endocardial cells originate from a region in the lateral 
plate mesoderm that also generates cells of the primitive myeloid lineage (Bussmann et 
al., 2007).  Endocardial precursors then migrate to the bilateral heart fields where they 
invest the fusing primitive heart tube.  In these Scl/Tal1 mutants, endocardial precursors 
are specified, remain as aggregates at the ventricular pole of the heart, failing to properly 
migrate.  These studies indicate that endocardial progenitors are derived from a small 
number of spatially sequestered precursors within a larger field of myocardial progenitors 
distinct not only in the cardiac mesoderm, but also identifiable prior to gastrulation. 
Despites these findings, growing evidence suggests a common multipotent 
progenitor responsible for generating the endocardial and myocardial lineages does exist 
in the cardiac mesoderm.  In the avian embryos, Linask & Lash identified a 
subpopulation in the cardiac mesoderm that co-expressed myocardial N-cadherin and 
endothelial QH-1 antigen (Linask and Lash, 1993).  In addition, the QCE-6 cardiac 
mesoderm cell line, established from Quail cardiogenic mesoderm, was shown to be 
capable of differentiating into both endocardial and myocardial cells under certain 
treatment conditions (Eisenberg and Bader, 1996).  The most compelling support for a 
common endocardial-myocardial precursor comes from lineage tracing in mice.  Cre-
mediated fate mapping of Mesp1+ cells, which is expressed in mesodermal cells exiting 
the PS to contribute to the lateral plate mesoderm, at first supported a model of two 
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separate progenitors of endocardium and myocardium.  The initial characterization of the 
Mesp1-Cre crossed with the R26R LacZ reporter mouse indicated that only the 
myocardium was derived from Mesp1+ cells, while the endocardium was not (Saga et al., 
1999).  Further analysis demonstrated this not to be the case and Mesp1-expressing 
mesoderm was shown to contribute to both endocardium and myocardium (Saga et al., 
2000).  This study only demonstrated that endocardium and myocardium were generated 
by post-gastrulation mesoderm, and failed to address the question of whether a common 
progenitor resided in the cardiac mesoderm.  With the discovery that Flk1 is expressed 
throughout the cardiac mesoderm during early development, lineage tracing demonstrated 
that myocardium and endocardium were both derived from an Flk1+ mesodermal 
population (Ema et al., 2006; Motoike et al., 2003).  Further expression-based and 
lineage tracing analyses of Nkx2.5+ and isl1+ cardiac populations suggest that as late as 
the cardiac crescent, subsets of myocardium, endocardium, vascular endothelium, and 
smooth muscle were derived a common precursor (Cai et al., 2003; Stanley et al., 2002).  
These studies also indicated that the embryonic endocardium has two distinct 
developmental origins, with the endocardium of the atria, AVC, and left ventricle derived 
from the PHF, and the endocardium of the right ventricle/ OFT arising from the anterior 
SHF.  These findings indicate that endocardium and myocardium share a common 
mesodermal precursor, but detailed examination has proven difficult due to the 
limitations of in vivo mouse models and the lack of specific markers for early endocardial 
cells. 
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NFATc1  
 
The NFAT family of transcription factors 
The Nuclear Factor of Activated T-cells (NFAT) family of transcription factors 
was initially described as activators of cytokine gene expression in the immune system, 
but have since been found to function in various tissues as an inducible transcriptional 
regulator (Crabtree and Olson, 2002; Hogan et al., 2003; Macian, 2005; Rao et al., 1997).  
The NFAT family consists of five members: NFATc1 (NFATc/NFAT2), NFATc2 
(NFATp/NFAT1), NFATc3 (NFATx/NFAT4), NFATc4 (NFAT3) and NFAT5 (Fig. 
1.5A).  The structure of NFAT family members is highly conserved with each containing 
a NFAT homology region (NHR) and a REL homology region (RHR) (Fig. 1.5B).  The 
NHR contains a transactivation domain with binding sites for calcineurin, NFAT kinases, 
and glycogen-synthase kinase 3 (GSK3β), as well as serine residues that can be 
phosphorylated to regulate its activity.  The RHR consists of a DNA binding region with 
homology to the REL-family of transcription factors, also known as the nuclear factor-κβ 
(NF-κβ) family of transcription factors. 
Calcium signaling (Ca2+) regulates the transcriptional activity of all NFAT 
proteins, save for NFAT5.  NFATc transcription factors are normally maintained in an 
inactive, phosphorylated state in the cytoplasm awaiting a cascade of Ca2+ release from 
intracellular stores and calcium-release-activated calcium channels (CRAC) in the plasma 
membrane (Fig. 1.5C).  Activation of phospholipase C-γ (PLC-γ) downstream of receptor 
binding hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to inositol-1,4,5-
trisphosphate (IP3), which in turn initiates Ca2+ release via IP3 receptors.  Ca2+ binding 
             29
 
 
 
 
 
 
Figure 1.5.  The structure and regulation of NFAT transcription factors. A. NFATc 
family members. B. Schematic representation of the transactivation, regulatory, DNA-
binding and C-terminal domains of NFATc proteins. A and B adapted from Macian et al. 
(2005). C. Following an increase in intracellular calcium, the active calcium-calmodulin-
calcineurin complex dephosphorylates NFAT, allowing nuclear localization and 
subsequent transcriptional activity. C adapted from Steinbach et al. (2007). 
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induces the formation of a phosphatase complex consisting of calmodulin and calcineurin 
A & B, which dephosphorylates NFATc, exposing a nuclear localization sequence (NLS) 
(Beals et al., 1997).  NFATc is shuttled into the nucleus and facilitates transcription by 
binding to 9-bp NFAT consensus elements ((A/T)GGAAA(A/N)(A/T/C)N) located in 
promoter regions (Rao et al., 1997).  The duration of NFATc transcriptional activity in 
the nucleus is ultimately controlled by GSK3β, which phosphorylates certain serine 
residues of the NHR, masking the NLS, resulting in nuclear export. 
 
The role of NFATc1 in heart development 
 NFATc1 possesses three distinct transcriptional isoforms; NFATc1-A is the 
shortest isoform and is controlled from the strong P1 promoter 5’ to Exon1 and the weak 
polyadenylation site pA1, while NFATc1-B and -C are expressed from either the P1 or 
P2 promoter and uses the strong polyadenylation site pA2 (Chuvpilo et al., 1999a; 
Chuvpilo et al., 1999b).  While the B and C isoforms represent basal transcription, 
NFATc1-A can be induced in an autoregulatory loop where NFATc1 or NFATc2 binds 
to NFAT recognition sites in the P1 promoter yielding persistent NFATc1 transcriptional 
activation (Chuvpilo et al., 2002; Zhou et al., 2002). 
In the developing heart, NFATc1 is expressed exclusively in endocardial 
precursors as they differentiate from the cardiac mesoderm, and throughout the 
endocardium of the E7.5-8.5 endocardial tube.  Expression is subsequently restricted to 
the endocardium of the AVC and OFT by E10.5, and is undetectable after E14.5.  Two 
separate groups concurrently generated null mutations in NFATc1, one mutating the 
RHR and other the NHR, both resulting in defects of the semilunar valves and 
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atrioventricular valves without obvious defects in the initial formation of endocardium. 
(de la Pompa et al., 1998; Ranger et al., 1998).    
The function of NFATc1 in valve development is subject to debate.  Early in 
valvulogenesis, it has been suggested that NFATc1 regulates EMT at sites of prospective 
valve development (Chang et al., 2004).  Chimeric analysis with NFATc1-/- ESCs 
suggests NFATc1 functions cell autonomously to maintain an endocardial phenotype 
during cushion formation, as chimeric valves lack NFATc1-/- endocardial cells and have 
an increased number of NFATc1-/- mesenchymal cells (unpublished observations).  With 
ingression into the endocardial cushion, NFATc1 is rapidly downregulated, in agreement 
with this purported function.  In Foxp1-/- and Sox9-/- mice, residual NFATc1 is present in 
mesenchymal cells, indirectly suggesting that NFATc1+ cells contribute to the cushions 
and expression silencing is aberrant in these genes’ absence (Akiyama et al., 2004; Wang 
et al., 2004).  EMT is not affected in NFATc1-/- mice, rather it is a failure to remodel the 
valve that causes embryonic lethality.  This phenotype highlights the essential role of 
endocardial-to-mesenchymal signaling in valve development.  NFATc1 is required as a 
transcriptional regulator of RANKL signaling, which activates tartrate-resistant acid 
phosphatase (TRAP) and the cysteine protease cathepsin K (Ctsk) to remodel ECM 
proteins in the cushion (Lange and Yutzey, 2006). 
Previous promoter analysis of NFATc1 transcriptional regulation conducted in 
our laboratory identified a 250-bp region upstream of the p2 promoter in intron 2 
responsible for autoregulation of NFATc1 (Zhou et al., 2005).  In addition to multiple 
NFATc1 sites, putative consensus elements for GATA, HOX, and SMAD transcription 
factors are present in this conserved region.  Mutatagenesis of these elements, followed 
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by transient transgenic analysis, indicted only the HOX site influences transcriptional 
activity from this element in the valvular endocardium.  When this regulatory domain 
was inserted in front of a heat shock promoter (HSP), it was capable of driving reporter 
gene expression in the valvular endocardium beginning at E9.5 and persisting until 
E13.5, but failed to recapitulate endogenous NFATc1 expression in the entire 
endocardium.  Lineage analysis with this valvular enhancer driving Cre crossed to the 
R26R LacZ reporter suggests that this NFATc1+ cell population does not undergo EMT 
(unpublished observations).  Nonetheless, as one of the few endocardial-specific gene 
transcripts, NFATc1 provides molecular evidence that the endocardium is a unique 
subpopulation of cells distinct from other endothelium and presents itself as an invaluable 
marker for tracking endocardial differentiation. 
 
Embryonic stem cell differentiation 
 Murine embryonic stem cells (ESCs) were isolated from the inner cell mass 
(ICM) of E3.5 blastocyst stage mouse embryos (Evans and Kaufman, 1981; Martin, 
1981).  Cultured on primary mouse embryonic fibroblast feeders (PMEFs), these cells 
remain undifferentiated and exhibit self-renewal when maintained in growth media 
containing fetal bovine/calf serum (FBS/FCS) and leukemia inhibitory factor (LIF) 
(Smith et al., 1988; Williams et al., 1988).  LIF functions by activating STAT3 through 
gp130, whereas FBS, or its substitute BMP4, mediates Smad activation and expression of 
the Id family of transcription factor (Ying et al., 2003).  Besides STAT3 and Id 
transcription factors, the OU domain class 5 transcription factor 1 (Oct-4), SRY-box 
containing gene 2 (Sox2), proto-oncogene c-Myc, and Kruppel-like factor 4 (Klf4), and 
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Figure 1.6. Potential of differentiating ESCs to generate ectoderm, mesoderm, and 
endoderm. A. Relationship of early embryonic cell populations to the primary germ cell 
layers and their derivatives, with respect to the differentiation potential of embryonic 
stem cells (ESCs) isolated from the ICM. Figure adopted from Keller (2005). B. A 
comparison of cardiac induction in the E7.5 mouse embryo and in embryoid bodies 
generated from ESCs illustrating that the extracellular cues required for the stepwise 
process of lineage specification and differentiation in vivo are conserved in vitro. Figure 
adopted from Foley and Mercola (2004).  
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Nanog have all been implicated in stem cell self-renewal and pluripotency (reviewed in 
Jaenisch and Young, 2008). 
 When injected in a donor blastocyst, ESCs are capable of contributing to all 
tissues of the adult mouse, including germ cells, allowing germline transmission of ESC-
derived genetic material from aggregation chimeras (Bradley et al., 1984).  In vivo 
pluripotency extends to in vitro culture, as demonstrated when ESCs were found to 
generate visceral yolk sac, blood islands, and myocardium when cultured in the absence 
of LIF under specific culture conditions (Doetschman et al., 1985).  ESC differentiation 
has since been documented to produced tissues derived from ectoderm, mesoderm and 
endoderm components (Fig. 1.6A).  Most approaches to ESC differentiation involve one 
of three methods: either cell aggregation into three-dimensional colonies known as 
embryoid bodies (EBs), co-culture with stromal cells, or in a monolayer on ECM 
proteins.  The system has come to represent a faithful in vitro model of lineage 
specification, where tissues develop in a sequential pattern mirroring embryonic 
development (reviewed in Keller, 2005).  As noted, ESC differentiation generates cells 
from all three germ cell lineages, but for the purpose of the studies presented here only 
mesodermal-derivatives that comprise the cardiovascular system will be reviewed.  
 
Hematopoietic and vascular differentiation 
 Hematopoiesis and vasculogenesis have been among the most extensively studied 
developmental programs in ESC differentiation.  Genes that are required for the 
establishment of the hematopoietic lineages in the embryo, both primitive erythroid and 
definitive, serve similar functions in EBs.  Utilizing ESCs with targeted mutations, the 
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particular roles of Scl/Tal1, Runx1, GATA1, and other transcription factors involved in 
hematopoiesis have been examined in detail.  These studies highlight the strength of ESC 
differentiation to analyze lethal mutations in vitro, as well as identify new molecular 
targets and regulators.  An additional beneficial feature of ESC differentiation in 
modeling hematopoietic and vascular commitment is that the system accurately 
recapitulates the temporal kinetics of lineage specification found in the yolk sac and 
embryo, as these lineages pass through the same stepwise pathway of specification in 
vitro that is observed in vivo (Keller et al., 1993).  Endothelial cells efficiently form non-
lumenized vascular plexus in EBs grown in serum-containing media, moving through 
successive and routine stages of maturity (Vittet et al., 1996).  Differentiating ESCs thus 
are a valuable model of vasculogenesis; examination of targeted disruptions in VEGF and 
its receptors Flk1 and Flt1 has illuminated how these different components of the VEGF 
signaling pathway interact (Kearney et al., 2002; Kearney et al., 2004).  Endothelial cell 
lines have isolated with the intent of studying endothelial cells at various stages of 
development (Balconi et al., 2000).  While vasculogenesis in EBs is generally accepted 
as a faithfully model, studies focusing on mature endothelium have been questioned as 
there is evidence that ESC-derived endothelial cells fail to achieve an equivalent level of 
functionality compared to their in vivo counterparts (McCloskey et al., 2006). 
 This ability of the ESC model to assess early developmental stages that are 
difficult to access in the embryo led to characterization of the hemangioblast population, 
a common progenitor for both the hematopoietic and vascular lineages.  The concept of 
the hemangioblast was indirectly supported by studies demonstrating that immature 
hematopoietic and vascular cells shared the expression of certain genes during 
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embryogenesis, but the actual proof and isolation of this common progenitor came from 
studies conducted using ESC differentiation.  From EBs precisely dispersed after 3-3.5 
days of differentiation, a population of cells termed blast colony-forming cells (BL-CFC) 
were characterized to generate hematopoietic, endothelial, and vascular smooth muscle 
cells in methylcellulose cultures upon exposure to VEGF (Choi et al., 1998; Kennedy et 
al., 1997).  Using progressive cell sorting and culturing, lineage analysis further 
characterized the hemangioblast population by defining the point of divergence between 
endothelial and hematopoietic lineages (Nishikawa et al., 1998).  Bulk differentiation and 
dispersion EBs later was replaced with more accurate methods of isolating the 
hemangioblast population using Flk1 in conjunction with GFP expressed by the 
mesodermal genes brachyury and Mixl1 (Fehling et al., 2003; Ng et al., 2005). 
 With these markers it became possible to not only isolate hemangioblasts from 
EBs to determine their lineage potential, but also to elucidate the mechanisms behind 
their specification from pluripotent ESCs and undetermined mesoderm.  BMP4, Activin, 
Wnt, FGF, and VEGF have all been demonstrated to play specific roles at precise times 
in the stepwise specification of ESCs to a hematopoietic fate (Nostro et al., 2008; Park et 
al., 2004; Pearson et al., 2008).  These studies not only have advanced the understanding 
of the stages of hematopoietic and vascular development, in terms of the induction 
signals at play and the required sequence of transcriptional regulation, but have also 
established a framework in which to investigate the lineage specification of other 
populations.   
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Cardiomyocyte specification and lineage analysis using the ESC differentiation model 
 Since the original description by Doetschman et al. demonstrated contracting 
myocytes in EBs, ESC differentiation has emerged as the preferred in vitro model of 
cardiomyocyte specification and differentiation (Doetschman et al., 1985).  By 
understanding the basic processes of cardiac developmental biology in this system, it has 
been argued these cells might be used to repair and/or replace cardiac tissue damaged by 
coronary artery disease (CAD), myocardial infarction (MI), and congestive heart failure 
(CHF).  Cardiomyocytes generated from EBs are both structurally and functionally 
mature, in terms of their expression of sarcomeric proteins and their electrophysiological 
attributes.  Initially small and round with disorganized bundles of myofibrils, ESC-
derived cardiomyocytes become elongated with well-developed myofibrils and 
sarcomeres.  With this structural change, mononucleated cells begin to contract, and 
exhibit cell-cell junctions with neighboring cells consistent with those in myocardium in 
vivo (Westfall et al., 1997).  Expression of cardiac gene transcripts proceeds in a 
developmental controlled manner where genes encoding early markers of the cardiac 
mesoderm such as the transcription factors GATA4 and Nkx2.5 appear prior to the 
markers of cardiomyocyte maturation, including atrial natriuretic factor (ANF), myosin 
light chain ventricular isoform 2 (MLC-2v), α-myosin heavy chain (αMHC), and β-
myosin heavy chain (βMHC) (reviewed in Boheler et al., 2002).  The appearance of these 
cardiac transcripts also indicates that myocardial chamber specification occurs in EBs 
(Miller-Hance et al., 1993).  Activation of chamber-specific genes transcripts without the 
positional cues that normally control patterning of the heart tube suggests that regional 
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specification of cardiomyocytes is a process inherent to cardiac cells, not entirely 
dependent on induction from extracellular signals. 
 The accessibility of early stages of development, which are difficult to visualize 
and manipulate in the embryo, makes the ESC differentiation model an attractive system 
to examine conditions that enhance or alter cardiac specification (Fig. 1.6B).  Many of 
the same signaling molecules that specify mesoderm towards a cardiac fate in vivo have 
been demonstrated to induce cardiomyocyte differentiation in EBs.  Temporally regulated 
administration of TGF-β2, FGF2, and BMP2 has been shown to enhance differentiation 
of cardiomyocytes, as has the inhibition of Notch signaling (Kawai et al., 2004; Kumar 
and Sun, 2005; Nemir et al., 2006).  Constitutive overexpression of certain transcription 
factors in ESCs and EBs can influence the fate of undifferentiated cells.  Oct-3/4, a stem 
cell transcription factor not previously associated with heart development enhances 
cardiac specification in a dose dependent manner by regulating the expression of 
mesodermal genes (Zeineddine et al., 2006).  These findings indicate early transcriptional 
regulation can influence the susceptibility of cells to inductive signaling, responding to 
certain cues and not others.  In differentiating ESCs, the mesodermal transcription factor 
Mesp1 activities genes associated with cardiac specification, controlling mesodermal and 
endodermal cell fates (Bondue et al., 2008; Lindsley et al., 2008).  One of genes Mesp1 
regulates in EBs is Dkk-1, which also has been demonstrated to be an extracellular signal 
enhancing cardiomyocytes specification in EBs and during embryogenesis (David et al., 
2008; Naito et al., 2006).  It is yet to be determined how these finding relate to the 
observed phenotype of double Mesp1 and -2 knockout embryos. 
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Cardiac lineage analysis of multipotent cardiovascular progenitors 
 To fully delineate the mechanisms involved in cardiac specification, it is essential 
to elucidate the stepwise commitment of precursor populations to the cardiac fate.  
Mirroring approaches taken to define the hemangioblast as a progenitor of hematopoietic 
and endothelial cells, recent studies have utilized various genetically modified ESCs and 
cell surface markers in the attempt to identify multipotent cardiovascular progenitor 
(MCP) populations.  As previously described, the VEGF receptor Flk1 is expressed in 
mesodermal progenitors of hematopoietic, endothelial, cardiomyocyte, and endocardial 
lineages.  Using a GFP reporter under control of the brachyury locus with cell surface 
Flk1 to isolate Flk1+ mesoderm, only hematopoietic/vascular lineages, not 
cardiomyocytes, were generated from GFP-Bry+ Flk1+ cells at 3.5 days of differentiation 
(Kouskoff et al., 2005).  Further analysis using this methodological approach resorted the 
GFP-Bry+ Flk1- population after reaggregation to identify Flk1+ MCPs (Kattman et al., 
2006).  When isolated after the equivalent of 4.5 days of differentiation, Flk1+ MCPs did 
not express cardiac markers, but after a short time in culture began to express Nkx2.5, 
isl1, Tbx5, and Mef2c.  Clonal analysis of these Flk1+ MCPs indicated this second wave 
of Flk1+ mesoderm represented a cardiovascular progenitor capable of generating 
cardiomyocyte, smooth muscle, and endothelial cells.  Another study utilizing Flk1 as a 
marker of cardiac progenitors found that Flk1+ in conjunction with CXCR4, but not c-kit, 
Sca-1, CD44, or CD90, could isolate cardiomyocyte-restricted precursors (Yamashita et 
al., 2005).  Though these studies were conducted in murine ESCs, Flk1+ MCPs have 
been isolated from human ESCs as well, based on differential levels of Flk1 and the stem 
cell marker c-kit (Yang et al., 2008). 
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Figure 1.7. Hierarchical model of cardiac lineage diversification from mesodermal 
multipotent cardiovascular progenitors (MCPs). Schematic of cardiovascular 
progenitors and their progeny based on previous studies in murine ESCs, as well as in 
vivo fate mapping. Hematopoietic and vascular lineages diverge early from other 
cardiovascular lineages, which are generated from a common progenitor (yellow box). 
The separation of the PHF and SHF establishes two distinct pools of multipotent 
progenitors that undergo further diversification to bipotential progenitors. These 
progenitors pass through yet undefined transitional states to produced the terminally 
differentiated cell populations of the cardiovascular system. Denote the absence of 
NFATc1+ endocardium from this model. Figure adopted from Martin-Puig et al. (2008). 
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 MCP populations have also been characterized using genetically modified ESCs 
with GFP reporters controlled by the early cardiac genes Nkx2.5 or isl1.  Using the SHF 
transcription factor isl1 as a marker, MCPs were isolated from EBs and developing 
embryos capable of giving rise to cardiomyocytes, smooth muscle, and endothelial cells 
(Moretti et al., 2006).  Clonal expansion of these isl1+ MCPs found all three lineages 
were formed in only 12% of colonies, with the majority containing one or two cell types, 
suggesting that these isl1+ MCPs were more restricted in their lineage commitment 
compared to Flk1+ MCPs.  The use of a GFP reporter driven by the PHF marker Nkx2.5 
instead of isl1 also was capable of successfully identifying a MCP population from 
differentiating ESC with cardiomyocyte, smooth muscle, and endothelial cells potential 
(Christoforou et al., 2008).  Yet in another study, when Nkx2.5-GFP+ cells were sorted 
with c-kit, a bipotential myogenic precursor capable of giving rise to cardiomyocytes and 
smooth muscle cells, but not endothelium was obtained (Wu et al., 2006).  Collectively, 
these studies has allowed for the assembly of a working model of cardiac lineage 
diversification, in which any mention of the endocardial cell lineage is noticeably absent. 
 
Aims of dissertation 
 The studies presented in this dissertation were initiated by a broad question; how 
is the endocardium different from other endothelial populations during development?  To 
specifically identify the endocardium at the earliest stage of cardiac development, we 
generated a novel NFATc1-nuc-LacZ BAC transgene to faithfully recapitulate 
endogenous NFATc1 expression.  This work is summarized in Chapter II.  To better 
characterize endocardiogenesis, in vitro ESC differentiation was developed as a model of 
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endocardial differentiation.  We demonstrate that endocardial and myocardial 
differentiation is spatial-temporal coordinated in EBs, an association that mirrors 
cardiogenesis in the developing embryo.  This work is detailed in Chapter III.  Given our 
observations of endocardial-myocardial interactions in differentiating ESCs, in 
conjugation with an emerging model of cardiac lineage specification that failed to address 
the endocardial lineage, we investigated the specification of endocardial cells from 
mesodermal precursors.  Endocardial cells are distinct from the hematopoietic lineage 
and systemic vasculature, derived from an Flk1+ MCP population that also generates the 
myocardial lineage.  This work is covered in Chapter IV.  Taken together, this work 
clarifies endocardium is a unique cardiac lineage and provides further evidence that 
endocardium and myocardium are derived from a common precursor.  
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CHAPTER II 
 
AN NFATC1-NUC-LACZ TRANSGENE IDENTIFIES ENDOCARDIUM AS A 
UNIQUE ENDOTHELIAL SUBPOPULATION DURING EARLY EMBYROGENESIS 
 
 
 
Introduction 
Many of the outstanding questions regarding the lineage classification and origin 
of the endocardium in murine heart development have been stymied by a dearth of 
specific endocardial markers in the face of an abundance of pan-vascular markers.  
NFATc1 is one of the few endocardial-specific gene transcripts, and its unique expression 
pattern makes it an attractive target to study endocardial differentiation.  As discussed, 
our previous efforts to analyze the transcriptional regulation of NFATc1 characterized a 
250 bp conserved region of intron 1 responsible for autoregulation of NFATc1 in only the 
endocardium of valve forming region, (Zhou et al., 2005).  These experiments indicate 
that different regulatory mechanisms are involved in activating NFATc1 expression in 
endocardial precursors prior to heart tube formation in the cardiac crescent from those 
that direct transcription in endocardium lining the valve cushions. 
Transcriptional cis-regulatory elements typically reside outside the core promoter 
region, and have been identified within introns and in distant untranslated segments of 
genomic DNA (reviewed in Kleinjan and van Heyningen, 2005).  Prominent examples of 
this latter phenomenon include Sox9, Pax6, and Sonic hedgehog (Shh), as they possess 
distant cis-regulatory elements required for proper regulation of gene transcription.  
Identification of these regulatory elements has largely been accomplished through 
chromosomal analysis of human disease states and mouse mutants.  Disruption of Pax6 
             44
expression can result in aniridia, or an absence of the iris, which has been attributed not 
to mutations in the transcriptional unit, but rather chromosomal rearrangements 
downstream of Pax6 (Griffin et al., 2002; Kleinjan et al., 2001).  Using the mouse mutant 
Small eye as a model, rescue experiments and expression studies indicate the cis-
regulatory domain required for Pax6 expression in the developing iris is over 200 kb 
downstream of the transcriptional start site.  As another example of distant transcriptional 
regulation, Sox9 has been linked to autosomal sex reversal, even though Sox9-/- mice do 
not display this phenotype.  The Odsex mouse mutant, displaying ocular degeneration 
and sex reversal, demonstrates how dysregulation of Sox9 expression results in sex 
reversal (Bishop et al., 2000).  In this mouse model, the insertion of a random transgene 
980 kb away consequently creates a 134 kb deletion that removes a long-range activator 
of the Sox9 promoter (Qin et al., 2004).  In addition, the random insertion of a reporter 
transgene ~1 Mb upstream of the Shh gene generated a mouse mutant termed Sasquatch 
that displays mirror image duplication of the hands and feet (Sharpe et al., 1999).  This 
particular phenotype is associated with preaxial polydactyl, a defect linked to Shh 
function in the zone of polarizing activity (ZPA) of developing limbs.  These findings 
indicate long-range regulation of Shh expression is necessary for the critical processes of 
limb patterning and development. 
To recapitulate NFATc1’s endocardial expression pattern, but without having to 
define the required regulatory region, we utilized in vitro bacterial artificial chromosome 
(BAC) recombination.  BAC recombination relies on expression of the exo, bet, and gam 
proteins of a defective λ prophage from the λPL promoter inserted into the bacterial 
genome repressed by the temperature-sensitive repressor cI857 at 32°C and derepressed 
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at 42°C.  These proteins function to direct homologous recombination for the purpose of 
either retrieving DNA fragments from BACs or inserting exogenous DNA elements, in 
this case a reporter gene, into BACs containing approximately 200 kb of genomic 
sequence (reviewed in Copeland et al., 2001; Court et al., 2002; Liu et al., 2003).  For 
our purposes, this approach will generate a reporter transgene regulated by the NFATc1 
promoter that also incorporates a sizeable amount of surrounding genomic information, 
all of which can be accomplished without affecting endogenous gene expression required 
for proper cardiac development. 
 With this system, we generated an NFATc1 BAC transgene with a nuclear 
localized beta-galactosidase (β-gal), encoded by the LacZ gene, inserted behind the P1 
promoter (Fig. 2.2).  By creating transient and stable transgenic mice carrying the 
NFATc1-nuc-LacZ BAC transgene, we demonstrate that this BAC possesses the 
regulatory elements necessary to distinguish endocardium from other endothelium during 
early embryogenesis by faithfully recapitulating endogenous NFATc1 expression. 
 
Experimental Procedures 
 
Construction of NFATc1 BAC targeting vector 
 A 300 bp SmaI/SacII fragment 5’ of the translational start site of NFATc1 (N5’) 
incorporating promoter elements and the 5’ untranslated region (UTR) was blunt end 
filled with T7 DNA polymerase (NEB) and ligated with the Mighty Mix DNA ligation kit 
(Takara) into the KpnI site of a pBluescript KS+ (pBSKSa) vector with modified AscI 
sites flanking the multiple clone site (MCS).  A 440 bp ScaI/PstI fragment from introns 
             46
1-2 distal to the exon1 splice acceptor (N3’) was blunt end filled and ligated in the NotI 
site of pBSKSa-N5’.  The nuclear β-gal cassette (nuc-LacZ) with its polyA sequence was 
excised with XhoI/PstI from pWhere (Invivogen) and subcloned into XhoI/PstI of 
pBSKSa-N5’-N3’.  Finally, the FRT flanked tetracycline resistance cassette (TetR) from 
pGFP-IBG-tetR (a gift from the Mortlock Lab, Vanderbilt) was removed with 
BamHI/SpeI and ligated into the same sites to generate the NFATc1 BAC targeting vector 
pBSKSa-N5’-nuc-LacZ-TetR-N3’. 
 
BAC recombination 
 BAC recombination was performed as previously described (Lee et al., 2001).  
Bacterial containing BAC DNA was cultured in Luria Brooth (LB) with 12.5 µg/ml of 
chloramphenical (CAM) at either 37˚C (DH10B) or 32˚C (EL250).  Glycerol stocks were 
made by mixing 200 µl of a bacterial culture with 800 µl glycerol and placed at -80˚C. 
Small-scale preparation of BAC DNA was carried out using standard alkaline lysis 
techniques.  For BAC “fingerprinting,” DNA was digested overnight (O/N) with 
restriction enzyme(s) and analyzed by pulse field gel electrophoresis (PFGE) on a CHEF-
DR III System (Bio-Rad) in 0.5 % TBE, run for >12 hours.  A BAC (RP23-189J14, 
mouse C57Bl/6J; Invitrogen) covering the entire NFATc1 locus, as well as 50 kb 5’ and 
75 kb 3’ surrounding genomic sequence, was electroporated into a specialized E. coli 
strain (EL250) carrying the temperature sensitive λ phage Red recombination system and 
an arabinose inducible Flpe recombinase in a 0.1 cm cuvette at 1.75 V, 100 Ω 25 µF on a 
Bio-Rad Gene Pulser. 
             47
 The NFATc1 BAC targeting vector, pBSKSa-N5’-nuc-LacZ-frt/TetR-N3’, was 
linearized with AscI (5-10 µg maxi-prepped DNA) and gel purified with the Qiaex II Gel 
Extraction Kit (Qiagen).  300-500 µg were electroporated into EL250 cells containing the 
NFATc1 BAC in a .1 cm cuvette at 1.75 V, 200 Ω 25 µF on a Bio-Rad Gene Pulser after 
a 15 minute 42°C heat shock to induce transcription of the λ phage Red recombination 
genes.  Recombined clones were selected on 6.25 µg/ml CAM and 5 µg/ml Tet.  Positive 
clones were treated with arabinose to activate the inducible Flpe recombinase of the 
EL250 strain to excise the TetR cassette by recombination of the FRT sites.  Diagnostic 
tests of BAC clones with PFGE following by Southern blot confirmed BAC integrity and 
recombination.  Southern probes were generated from the N5’ homology arm or the 1.1 
kb XhoI/EcoRV N-terminal fragment of nuc-LacZ and performed as previously described 
(Nagy, 2003b). 
 To establish transgenic mouse lines, NFATc1-nuc-LacZ BAC DNA was prepared 
by cesium chloride gradient purification after alkaline lysis.  The lower band containing 
intact BAC DNA was pulled with a 21-gauge needle.  Ethidium bromide was extracted 
with TE/NaCl-saturated n-butanol, then dialyzed into BAC microinjection buffer (10 mM 
Tris, 15 µM EDTA pH 7.4) using Centriprep size exclusion columns (Millipore).  
Dilutions of purified BAC DNA were cut with Not1 and analyzed by PFGE against 
Lambda DNA/HindIII standards to estimate concentration.  BAC DNA was diluted to 2 
ng/µl in BAC microinjection buffer with 100 nM spermine/spermidine and 100 nM NaCl 
for pronuclear injection FVB oocytes (Vintersten et al., 2004).         
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Generation of transgenic mice 
To generate fertilized oocytes for BAC DNA microinjection, female FVB donor 
mice were superovulated with the hormones Pregnant Mare Serum Gonadotropin 
(PMSG) and Human Chorionic Gonadotropin (hCG) and bred to stud FVB males (Nagy, 
2003b).  Oocytes were injected and cultured overnight in M2 media at 37˚C before being 
transferred into the oviducts of pseudopregnant foster mothers at the 2-cell stage.  
Vasectomized males were used to sham-fertilize recipient females to induce 
pseudopregnancy, thereby making them receptive to receiving injected embryos and 
allowing implantation and normal development to occur. 
 
Genotyping 
At three weeks of age, tail samples from offspring were digested in 100 mM Tris 
pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, 100 µg/ml of Proteinase K overnight at 
55˚C; DNA was purified by isopranol precipitation with an ethanol wash, and dried DNA 
pellets were resuspended in TE (10 mM Tris pH 7.5, 1 mM EDTA).  Mice were 
genotyped by PCR with DNA MasterMix TAQ polymerase (NEB) using the following 
primers: 5’ GCA GCA GGC AGG GTC ACA GAG A 3’ and   5’ ACC CCA GGC TGC 
AAG GAG GAT T.  Animals were maintained in accordance with protocols approved by 
the Vanderbilt University Institutional Animal Care and Use Committee (IACUC). 
 
Beta-galactosidase (β-gal) staining 
 For whole mount β-gal staining, embryos were dissected in cold PBS and fixed in 
0.2% glutaraldehyde, 2 mM MgCl2, and 5 mM EGTA in PBS for E8.5 and younger 
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embryos or 10% neutral buffered formalin (NBF) for older specimens.  Fixation times 
were 15 minutes for glutaraldehyde and 30 minutes for 10% NBF.  Embryos were 
washed twice with X-gal wash buffer consisting of 2 mM MgCl2, 0.02% NP40 in PBS 
before incubation in a X-gal staining buffer of 1 mg/ml X-Gal, 5 mM potassium 
ferro/ferricyanate, 2 mM MgCl2, 0.02% NP40, 0.01% sodium deoxycholate in PBS at 
37°C for 2-6 hours to prevent overstaining.  Embryos were cleared using a glycerol 
gradient in PBS and stored at 4°C. 
To section E8.5 and younger specimens, whole mount X-gal stained embryos 
were embedded in 3% agarose plugs and processed through an alcohol-xylene-paraffin 
series and sectioned at 8 µm.  For sections of β-gal expressing transgenic embryos at 
E9.5 and older, embryos were dissected in cold PBS and fixed in glutaraldehyde, washed 
with PBS, and cryoprotected by passing them through a sucrose gradient, 15% sucrose in 
PBS for 2-4 hours, then 30% sucrose in PBS O/N.  Specimens were embedded in OCT 
and cryosectioned at 10 µm, and stained as described above.  Both paraffin and frozen 
sections were counterstained with eosin, dehydrated, and mounted.   
 
Immunostaining 
 For immunofluorescence, embryos were dissected in cold PBS and fixed in 10% 
NBF for 30 minutes at 4˚C, washed with PBS, and cryoprotected in 15% sucrose in PBS 
for 2-4 hours, then 30% sucrose in PBS O/N.  Specimens were embedded in OCT and 
cryosectioned at 10 µm and place on charged slides.  For single immunofluorescence for 
NFATc1 or for dual labeling with NFATc1 and another antibody, the Mouse on Mouse 
kit (M.O.M.) (Vector Labs) was used as per manufacturer’s instructions with the 
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following modifications.  After Avidin/Biotin blocking (Vector) and application of the 
M.O.M. Ig Blocking Reagent, primary antibody against NFATc1 was added to M.O.M. 
diluent and incubated O/N at 4˚C.  In dual labeling conditions, primary antibody to the 
second antigen was added along with the M.O.M. biotinylated anti-mouse IgG reagent 
for 30 minutes as room temperature (RT).  M.O.M. Fluorescein Avidin DCS and Alexa-
555 conjugated secondary antibodies were added and incubated at 37˚C for 15 minutes.  
For instances where NFATc1 was not used, slides were blocked in 10% goat serum 
(Jackson Labs) prior to incubation with primary antibodies overnight at 4°C, followed the 
next day by secondary antibodies for 1 hour at 37˚C.  Samples were mounted with 
Vectashield containing DAPI (Vector Labs). 
 For whole mount immunohistochemistry, embryos were dissected in cold PBS 
and fixed in Dent’s Fixative (4:1 methanol:DMSO) O/N at 4˚C.  Embryos were bleached 
in 4:1:1 methanol:DMSO:H2O2 for 5-10 hrs at RT and stored in 100% methanol at -20˚C.  
Rehydrated embryos were washed twice for 1 hour in PSB with 2% BSA and 0.5% 
Triton-X (PBSBT) before addition of the primary antibody at a concentration of 1 µg/ml 
in PBSBT and rocked O/N at 4˚C.  The next day, specimens were washed five times with 
PBSBT for 1 hour each before addition of a species-specific biotinylated secondary 
antibody.  After another O/N incubation and five hour washes with PBSBT, embryos 
were incubated with the streptavidin:peroxidase complex from the ABC kit (Vector) in 
PBSBT, followed by signal detection with Diaminobenzidine (DAB; Vector).  After 
dehydration into 100% methanol, embryos were cleared for photography in BABB (1:2 
benzyl alcohol: benzyl benzoate).  For whole mount immunohistochemistry on X-gal 
stained embryos, specimen were fixed and stained for β-gal expression as described 
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above, then washed with PBS, post-fixed with Dent’s fixative, bleached, then stored in 
100% methanol at -20˚C.  Embryos were immunostained as described above.  For signal 
detection, NovaRed peroxidase substrate (Vector) was used for color contrast with blue 
X-gal staining.  Embryos were cleared through a glycerol/PBS series, as the NovaRed 
substrate is unstable in BABB. 
 For immunohistochemistry on paraffin slides, citrate antigen retrieval was 
performed before incubation with 3% H2O2.  Slides were blocked in 10% goat serum 
prior to incubation with anti-NFATc1 antibody overnight at 4°C, followed the next day 
by the SuperPic secondary antibody (Zymed) for 1 hour at RT.  DAB was used to detect 
antibody signal, and then slides were counterstained with Harris hematoxylin and 
desaturated with lithium carbonate.  Samples were dehydrated through an alcohol-xylene 
gradient and mounted.  Images were acquired using a Nikon Elipse E800 epifluorescence 
microscope or a Zeiss Upright LSM510 Confocal Microscope. 
 
Antibodies 
NFATc1 (mouse 7A6, BD Pharmingen, 1:200) 
Cardiac troponin T (cTnT; mouse CT3, Developmental Studies Hybridoma Bank 
(DSHB) University of Iowa, 1 µg/ml) 
Sacromeric myosin heavy chain (MHC; mouse MF20, DSHB, 1 µg/ml) 
CD31/Pecam-1 (rat MEC13.3, BD Pharmingen, 1:500) 
VE-cadherin (rat 11D4.1, BD Pharmingen, 1:500) 
Von Willibrand Factor (vWF; rabbit, Dako, 1:200) 
β-Gal (chick, Abcam, 1:1,000 or rabbit, Cappel, 1:5,000) 
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In situ hybridization 
In situ hybridization for NFATc1 was performed as previously described (Hogan, 
1994).  P35 thio-UTP labeled sense and antisense probes were generated from a plasmid 
containing a 2 kb N-terminal fragment of the NFATc1 cDNA.  Tissue was treated with 
20 µg/ml Proteinase K for 8 minutes, and probes were hybridized O/N at 55°C.  After 
extensive washing, signal was checked by O/N exposure on X-ray film.  Slides were then 
developed with emulsion, washed, dried, and mounted. 
 
Culture of embryonic endothelial progenitor cells (eEPCs)  
 Embryonic endothelial progenitor cells (eEPCs) were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 20% FBS (HyClone), 25 mM 
HEPES, 2 mM L-glutamine, 100 U/ml Penicillin/Streptomycin, 100 µM non-essential 
amino acids, and 100 µM β-mercaptoethanol.  Cells were grown on 0.1% gelatinized 
plates and passaged every 2-3 days at a ratio of 1:10.  For transfection, 2-4 µg of CsCl2 
purified BAC DNA was mixed with 40 µl of Lipofectamine 2000 (Invitrogen) in 2 ml 
Optimem (Invitrogen/Gibco).  This complex was added to 2 ml of fresh eEPC media in 6-
well dishes with cells at 70% confluency.  Differentiation of eEPCs was induced with 
addition of 1 µM all-trans-retionic acid (RA; Sigma) and 0.5 mM dibutyrul cyclic AMP 
(cAMP; Sigma) (Hatzopoulos et al., 1998).  Cells were allowed to differentiate for 48 
hours before analysis. 
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Quantitative real-time PCR (qRT-PCR)  
 Samples of undifferentiated and differentiated eEPC cDNA were provided by 
Matias Lamparter (Hatzopoulos Lab, Vanderbilt).  All qRT-PCR was performed using a 
Light Cycler (Roche) with the Light Cycler DNA Master SYBR Green I Kit, 0.5 µM of 
each primer, 3-5 mM MgCl2, and 100 ng cDNA.  Gene specific primer sets were 
designed to cross intron-exon boundries when possible to ensure mRNA, not genomic 
DNA, was amplified.  The primers used for these experiments are listed as follows: 
NFATc1: 5’ GGT GGC CTC GAA CCC TAT C 3’, 5’ TCA GTC TTT GCT TCC ATC 
TCC C 3’; CD31/Pecam-1: 5’ ATC CGG AAG GTC GAC CCT AAT CTC AT 3’, 5’ 
ATA CCC AAC ATG AAC AAG GCA GCG 3’; VE-cadherin: 5’ AAC TCA CCC TCC 
TTG TGG AAT CCT 3’, 5’ ACA TCT CAT GCA CCA GGG TGA CTA 3’; GAPDH: 5’ 
CAC TGG CAT GGC CTT CCG TG 3’, 5’ AGG AAA TGA GCT TGA CAAAG 3’.  
The specificity of the amplified product was evaluated using the melting curve analysis 
and a no template control reaction.  Each sample was done in triplicate and relative 
expression was calculated as ∆2-ct with GAPDH as the internal control (Schmittgen and 
Livak, 2008). 
 
Results 
  
NFATc1 is restricted to the endocardial endothelial lineage during early embryogenesis 
 In situ hybridization with a radiolabeled probe demonstrated NFATc1 is an 
endocardial-specific transcription factor, capable of distinguishing the endocardium as a 
unique subpopulation of endothelium (Fig. 2.1A).  At E9.5, signal is detected in all 
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endocardial cells of the primitive atria and ventricle, as well as the OFT.  Signal 
dissipated at the proximal and distal ends of the looped endocardial tube, and was 
observed to be mosaic in the sinus venous and aortic sac.  Little to no NFATc1 is 
observed in the myocardium or system vasculature.  Immunofluorescence of NFATc1 
and the endothelial marker von Willibrand Factor (vWF) in an E10.5 embryo also 
documents that NFATc1 is restricted to endocardial endothelium (Fig. 2.1B).  While 
other vascular markers such as Flk1, VE-cadherin, and CD31/Pecam-1 mark the 
endocardium early in development, vWF appears unique in that it is excluded from the 
endocardium until E14.5, after the major morphogenic events of valvulogenesis and 
trabeculation (Fig. 2.1C-E).  vWF is only expressed in the peripheral vasculature and 
distal portions of the OFT at E10.5, and not does extend into the endocardium (Fig. 2.1F-
H).  These finding, similar to previous studies of early endocardial NFATc1 expression, 
indicate NFATc1 is an endocardial-specific gene transcript, providing molecular 
evidence that the endocardium is a unique subpopulation of cells distinct from other 
endothelium (Chang et al., 2004; de la Pompa et al., 1998; Ranger et al., 1998). 
 
Generation of an NFATc1 BAC reporter transgene 
 As discussed, BACs contain large segments of genomic DNA, covering entire 
gene loci and upstream and downstream regulatory elements.  The particular BAC chosen 
to serve as the basis for the NFATc1 reporter transgene (RP23-189J14) was selected 
based on the relative position of the NFATc1 locus.  In addition to containing the entirety 
of the NFATc1 genomic locus, this BAC has 50 kb upstream sequence that extends up to, 
but not including, the closet gene on chromosome 18, Atp9b, as well as 75 kb of genomic 
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Figure 2.1. Endogenous expression of NFATc1 in the embryonic endocardium. A. In 
situ hybridization depicting NFATc1 mRNA (magenta) localized to the endocardium at 
E9.5. B. Immunofluorescence of NFATc1 (green) and the endothelial marker von 
Willibrand Factor (vWF; red) in an E10.5 embryo. Nuclei were detected with DAPI 
(blue). The white arrowhead marks the forming pulmonary artery. C-E. NFATc1 (C, 
green) is present in the endocardium of the forming AVC valve cushion while vWF (D, 
red) is not expressed in this endothelial subpopulation. F-G. NFATc1 (F, green) is 
entirely restricted to the endocardial endothelium, dissipating at the aortic sac where the 
distal portion of the OFT intersects with the systematic vasculature as labeled by vWF 
(G, red).  
 
Myocardium, m; endocardium, e; outflow tract, oft; common ventricle, v; atrioventricular 
canal, avc; aortic sac, as; atria, a; dorsal aorta, da; sinus venous, sv; pulmonary bud, pb 
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downstream sequence (Fig. 2.2A).  With this coverage, there would be a high probability 
of containing the regulatory elements necessary to drive appropriate gene expression 
from the NFATc1 locus. 
 BAC DNA was purified from the parental DH10B E. coli strain and 
electroporated into the EL250 strain engineered to carry both the heat inducible λ phage 
Red recombination gene and an arabinose inducible Flpe recombinase. DNA was 
prepared from resulting CAM resistant EL250 clones and digested with BamH1 to 
compare with the original BAC to confirm stable introduction of the NFATc1 BAC into 
the EL250 strain (Fig. 2.2C, panel i).  A nuclear localized β-gal (nuc-LacZ) was chosen 
as the reporter gene for several reasons: X-gal staining yields a robust colorimetric stain 
for histology, specific antibodies exist to detect the β-gal protein for Immunostaining, 
PCR genotyping for nuc-LacZ is specific and efficient, and the nuclear stain is beneficial 
for cell counting.  For targeting, a 5’ homology arm (N5’) was designed to contained 
upstream promoter elements of the NFATc1 locus, as well as the 5’ UTR up to the 
translational start site (Fig 2.2B).  Inclusion of the FRT flanked TetR conferred 
tetracycline resistance to the construct, but also could be removed by the arabinose 
inducible Flpe recombinase in the final construct as to not interfere with reporter gene 
expression.  For BAC targeting, the targeting construct excised from the vector backbone 
with AscI and purified before electroporation into EL250-NFATc1-BAC cells heat 
shocked at 42˚C to induce expression of the recombineering genes.  Dual resistant CAM 
and Tet colonies were screened by NotI digestion analyzed by PFGE.  As rare cutter of 
the genomic region carried on the RP23-189J14 BAC, NotI sites flanking exon1 yielded a 
7.3 kb band that increased to 13.0 kb with the introduction of nuc-LacZ-TetR (Fig. 2.2C, 
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panel iii).  Following removing of the TetR cassette, this fragment was reduced in size at 
10.5 kb.  The BAC vector backbone, which possesses two NotI sites at its ends, is 
constantly visible at 8.7 kb.  Confirming these shifts represented correct targeting, 
Southern blots with probes generated from the N5’ homology arm or the 1.1 kb 
XhoI/EcoRV N-terminal fragment of nuc-LacZ localized to the expected bands (Fig. 
2.2C, panels iii’ & iii’’).   
 Prior to use, two additional modifications were made to the targeted BAC via 
homologous recombination.  The BAC vector (pBACe3.6) contains two cryptic loxP 
sites, one wild type and one loxP511 mutant.  Though these two sites rarely undergo 
recombination, BAC transgenes integrate into the host genome as concatamers, thus 
lining up similar loxP sites of different copies of the transgene that might undergo 
inappropriate excision in the presence of a Cre recombinase (Furuta and Behringer, 
2005).  The LoxP site in the pBACe3.6 vector backbone was replaced with a zeocin 
cassette flanked by 500 bp homology arms complementary to the sequence adjacent to 
the LoxP site (pLoxPOUTZeo).  Subsequently, the LoxP511 site was replaced with a 
kanamycin cassette (KAN) flanked by 50 bp homology arms complementary to the 
sequence adjacent to the LoxP511 site (pLoxP511OUTKan).  These plasmids were used 
in collaboration with the Southard-Smith lab (Vanderbilt University).  These 
modifications resulted in an increase in the size of the vector backbone, from 8.7 kb to 
9.2 kb to 10.3 kb, as observed by a band shift after NotI digestion (Fig. 2.2C, panel ii).  
These cassettes were not removed from the BAC since the distance between the BAC 
backbone and the first exon of NFATc1 was deemed sufficient enough as to not interfere 
with activity of the reporter gene.    
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Figure 2.2. Generation of an NFATc1-nuc-LacZ BAC reporter transgene. A.  Location 
of the NFATc1 locus on chromosome 18 and the coverage of RP23-189J14 NFATc1 
BAC. B. Schematic of the BAC targeting vector and its insertion into the mouse NFATc1 
BAC locus. Red bar, homology arms; E, exons; white box, 5’UTR; N, NotI; A, AscI. C. 
PFGE of BamH1 digestion (i). Lambda/HindIII ladder (1), 1 kb ladder (2), original BAC 
from DH10B (3), electroporated BAC from EL250 (4-5). PFGE of the NotI digestion 
after removal of the loxP sites (ii). The upper band represents the 8.7 kb unmodified BAC 
backbone (6), the 9.2 kb backbone after ZEO insertion (7), and the 10.3 kb band after 
KAN insertion (8). The wild type 6.6 kb band of NFATc1 remains unchanged (iii) PFGE 
of NotI digestion with the wild type 6.6 kb band of NFATc1 (9), the 13.3 kb NFATc1-
nuc-LacZ-tetR (10), and the final 11.5 kb band left after TetR removal. Southern blotting 
for LacZ (iii’) and the 5’ homology arm (iii”) confirmed insert of the targeting construct 
and the removal of the TetR cassette.  
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NFATc1-nuc-LacZ is expressed in differentiating eEPCs 
To validate whether the targeted NFATc1-nuc-LacZ BAC constituted a functional 
construct, confirmation in vitro prior to its introduction into transgenic mice was deemed 
necessary.  However, while a number of cell lines have been established to express high 
levels of NFATc1, including the Jurkat T cell line and several osteoclast cell lines, no 
embryonic endocardial endothelial cell line exist (Heymann et al., 1998; Shaw et al., 
1988).  The differentiation of embryonic endothelial progenitors cells (eEPCS) 
represented a potential model to test the NFATc1-nuc-LacZ BAC transgene.  Isolated 
from E7.5 mouse embryos, eEPCs possess self-renewal capability, but upon treatment by 
RA and cAMP, differentiate into mature endothelial cells (Hatzopoulos et al., 1998).  
Xenoplantation of these eEPCs into chick embryos demonstrate these cells preferentially 
integrate with the endocardium, suggesting eEPCs might contain endocardial precursors.  
Though differentiated eEPCs express numerous vascular gene transcripts, it had not yet 
determined whether they expressed endocardial transcripts, such as NFATc1.  
Comparison of gene transcripts by qRT-PCR from undifferentiated and differentiated 
eEPCs indicated that endothelial markers VE-cadherin and CD31/Pecam-1 increased 4-6 
fold, respectively (Fig. 2.3A).  When transfected with CsCl2 purified NFATc1-nuc-LacZ 
BAC DNA, undifferentiated eEPCs only sparsely expressed β-gal (Fig. 2.3B, panel ii).  
However after two days of RA and cAMP induction, significant β-gal expression could 
be detected (Fig. 2.3B, compare panel i vs iii).  These findings suggested that the 
NFATc1-nuc-LacZ BAC not only functioned, but also was expressed in a manner that 
reflected changes of endogenous NFATc1 expression. 
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Figure 2.3. In vitro differentiation of endocardial cells from embryonic endothelial 
progenitors (eEPCs). A. qRT-PCR of endocardial (NFATc1) and endothelial (VE-
cadherin and CD31/Pecam-1) gene transcripts in undifferentiated eEPCs compared to 
eEPCs differentiated for 48 hours with 1 µM RA and 0.5 mM dibutyrul cAMP. 
Endocardial and endothelial genes are upregulated with differentiation. B. Expression of 
the NFATc1-nuc-LacZ BAC transgene in eEPCs with no BAC DNA (I), undifferentiated 
eEPCs transfected with the BAC transgene (II), and differentiated eEPCs containing the 
BAC transgene (III,III’).  Significant expression from the NFATc1-nuc-LacZ BAC 
transgene was only detected in differentiated eEPCs 
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The NFATc1-nuc-LacZ BAC contains the necessary regulatory elements for early 
endocardial expression 
 
Expression of the NFATc1-nuc-LacZ BAC in differentiated eEPCs failed to assess 
whether the regulatory domains required for early endocardial expression are present on 
the modified RP23-189J14 BAC transgene.  To determine the expression capacity of this 
transgene in vivo, transient transgenic embryos were obtained at E9.5.  From pronuclear 
injection of ~50 zygotes, 8 embryos were recovered, 1 of which was determined by PCR 
to carry the nuc-LacZ cassette (data not shown).  Whole mount X-gal staining 
demonstrates NFATc1-nuc-LacZ BAC expression was specific to the developing heart, 
with β-gal present in the endocardium of the primitive atrium and ventricle, as well as in 
the AVC and the OFT (Fig 2.4A-C).  Sagital sections of this transient transgenic 
demonstrate β-gal is restricted to the endocardial tube, and absent from the outer 
myocardial layer, as well as from the systemic vascular endothelium (Fig 2.4D).  In 
addition, β-gal is most robustly expressed on the endocardial lining the AVC, in 
accordance with endogenous NFATc1 restriction to valvular endocardium with the 
initiation of endocardial cushion formation (Fig 2.4E).  Mesenchymal cell expression is 
also evident even though NFATc1 is normally downregulated in this population, most 
likely representing residual β-gal protein, not active transcription.  Reporter expression is 
notably absent at the proximal and distal ends in the sinus venous and aortic sac (Fig 
2.4F).  As expression from the NFATc1-nuc-LacZ BAC transgene includes the entire 
endocardial population, and is not limited to the valvular endocardium as with the 250-bp 
intron 2 enhancer, it suggests that the distal regulatory elements required for early 
endocardial expression are present in this BAC. 
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Figure 2.4. Transient transgenic analysis of early endocardial expression from the 
NFATc1-nuc-LacZ BAC transgene. A. Whole mount X-gal stained E9.5 transient 
transgenic embryo with β-gal expressed from the BAC transgene restricted to the looped 
heart.  B-C. Higher magnification images of the ventricle and OFT (B) and the inflow 
tract and AVC (C). D. Sagital sections counterstained with eosin demonstrating β-gal 
only in the endocardial tube, and not in the outer myocardial layer. E. Sagital section of 
endocardial β-gal expression the atria, ventricle, and AVC. Residual β-gal expression can 
also be detected in endocardial cells that have just undergone EMT to become 
mesenchymal cells of the ECC. F. Reporter expression is absent at the proximal and 
distal ends in the sinus venous and aortic sac. 
 
Myocardium, m; endocardium, e; outflow tract, oft; common ventricle, v; atrioventricular 
canal, avc; aortic sac, as; atria, a; sinus venous, sv; mesenchymal cells, msc  
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NFATc1-nuc-LacZ BAC expression recapitulates endogenous NFATc1 during 
cardiogenesis 
  
With confirmation that the NFATc1-nuc-LacZ BAC possessed the regulatory 
elements necessary to drive early endocardial expression, we proceeded to generate stable 
transgenic mouse lines.  Two separate attempts to generate mouse lines through 
pronuclear injection using CD1/ICR donor oocytes failed to generate any PCR positive 
pups.  CD1/ICR oocytes respond poorly to the microinjection of BAC DNA, and thus for 
further pronuclear injections, we utilized the inbred FVB/N mouse strain, characterized 
as being highly efficient for transgenic production with limited blocking at the 1-cell 
stage in response to the introduction of foreign (Auerbach et al., 2003; Giraldo and 
Montoliu, 2001).  Supercoiled BAC DNA, not linearized BAC DNA, was injected as 
supercoiled BAC DNA has been suggested to be more resistant to sheering during 
injection, as well as more likely to be introduced into the genome intact.  The addition of 
polyamines to the microinjection buffer maintained the purified BAC in a supercoiled 
form.  Pronuclear injection of ~200 zygotes resulted in 18 live births, 3 of which were 
determined by PCR to carry nuc-LacZ (data not shown).  From these animals, a line that 
demonstrated germline transmission and robust expression was propagated as the founder 
line.  Copy number analysis has not yet been conducted, but a method to do so in BAC 
transgenic mice has been described (Chandler et al., 2007). 
 β-gal produced from the NFATc1-nuc-LacZ BAC is first detectable during 
embryonic development in the anterior portion of the E7.5 embryo as individual cells 
appear in the lateral plate mesoderm (Fig. 2.5A; white arrowhead).  Further in 
development, these cells consolidate into a tightly organized band corresponding to the 
cardiac crescent extending across the midline (Fig. 2.5B; white arrowheads).  As lateral 
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folding in the embryo at E8.0 brings the cardiac precursors towards the ventral midline to 
form the primitive heart tube, robust β-gal expression is observed in the heart-forming 
region of the PHF (Fig. 2.5C).  In coronal sections of E7.5 transgenic embryos, nuclear-
localized β-gal is restricted to endocardial precursors at the cardiac crescent that are 
organized as a distinct plate of cells positioned directly between the AVE and myocardial 
precursors rather than being interspersed with primitive cardiomyocytes (Fig. 2.5D,E). 
E7.75 X-gal stained transgenic embryos whole mount immunostained for myosin heavy 
chain (MHC) further illustrate how endocardial and myocardial precursors are dispersed 
throughout the cardiac crescent as the two populations migrate towards the midline to 
generate the primitive heart tube (Fig 2.5F,G). 
By E8.25 the linear primitive heart has been completed by the merging of the 
bilateral precursors of the PHF; at this time β-gal expression is entirely localized to the 
developing heart (Fig. 2.6A,B).  No expression was evident in the systemic vasculature, 
as illustrated by the comparison of a whole mount stained E9.5 NFATc1-nuc-LacZ BAC 
transgenic embryo against a comparable embryo whole-mount in situ stained for the 
endothelial marker CD31/Pecam-1 (Fig. 2.6C).  X-gal staining in coronal section through 
the length of the linear heart demonstrates β-gal is limited to the endocardial tube and not 
in the surrounding myocardium (Fig. 2.6D). These findings indicate the NFATc1-nuc-
LacZ BAC transgene specifically identifies the entire subpopulation of endocardial 
endothelium at its earliest stage of development as they differentiate in the cardiac 
mesoderm. 
Given NFATc1’s dynamic expression in endocardial cells across the window of 
cardiac development, we assessed β-gal expression during early murine embryogenesis. 
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Figure 2.5.  In vivo expression of the NFATc1-nuc-LacZ BAC transgene in 
differentiating endocardial precursors. A. X-gal stained E7.5 NFATc1-nuc-LacZ 
embryo with β-gal expression in the cardiac crescent (white arrowhead). B. E7.75 
transgenic embryo with β-gal+ endocardial cells (white arrowheads) organized along the 
cardiac crescent C. Merging of the endocardial tubes with lateral folding at E8.0. D,E. 
Coronal section of β-gal+ endocardial cells positioned directly between the AVE and 
myocardial precursors F. Whole mount immunohistochemistry for myosin heavy chain 
(MHC; reddish-brown) marking myocardial precursors in the cardiac crescent of an 
E7.75 X-gal stained transgenic embryo. G. High magnification image demonstrating 
endocardial (white arrowheads) and myocardial precursors dispersed throughout the 
cardiac crescent. 
 
Myocardial precursors, mp; endocardial precursor, ep; neuroectoderm, ne; cardiac 
crescent, cc; anterior visceral endoderm, ave; intraembryonic coelom, iec 
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Figure 2.6. NFATc1-nuc-LacZ BAC transgenic expression in the endocardium of the 
E8.5 primitive heart tube. A. Frontal view of an E8.5 whole mount X-gal stained 
transgenic embryo. B. Lateral view of an E8.5 whole mount X-gal stained transgenic 
embryo with β-gal expression confined to the linear heart tube (white arrowhead). C. 
Whole-mount in situ for the endothelial marker CD31/Pecam-1 displaying the entirety of 
the embryonic vasculature at the E8.5 linear heart stage. D. Coronal section of E8.5 X-gal 
stained NFATc1-nuc-LacZ embryo documenting β-gal expression is present only in the 
endocardial layer, and not the myocardial layer. 
 
Myocardium, m; endocardium, e; heart tube, ht; dorsal aorta, da; cardiac crescent, yolk 
sac, ys. 
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At E9.5, whole mount X-gal staining documents β-gal in all segments of the looped heart 
(Fig. 2.7A).  Expression is present only in the heart and is absent from the other vascular 
populations as marked by whole mount immunohistochemistry for CD31/Pecam-1 and 
MHC at this developmental point (Fig. 2.7B,C).  Robust expression was observed 
throughout the entire endocardium, present in the primitive atria, ventricle, AVC, and the 
OFT (Fig. 2.7D,E).  Expression became mosaic at the proximal sinus venous and distal 
aortic sac as the endocardium meets the peripheral vasculature, where β-gal is not 
produced from by the BAC transgene (Fig. 2.7E).  Though this pattern of expression 
matches previous descriptions of NFATc1 during early cardiogenesis, co-
immunofluorescence of NFATc1 and β-gal was performed to assess their exact location 
at E9.5 (Fig. 2.7F-I).  NFATc1 colocalizes with β-gal in endocardial cells of the looping 
heart, indicating transcription of LacZ from the BAC transgene faithfully recapitulates 
endogenous regulation of NFATc1 during cardiogenesis.  
With initiation of ECC formation at E10.5, the first alteration of expression was 
observed, as β-gal was downregulated in the atrial and ventricular endocardium.  β-gal 
retained in the valvular endocardium, endothelium overlying the valve cushions that does 
not undergo EMT (Fig. 2.8A).  The expression of cardiovascular markers during this 
stage of embryogenesis illustrates the unique expression pattern of NFATc1 in the 
developing heart.  Immunofluorescence documents that NFATc1 and β-gal are 
colocalized in the AVC and OFT in the endocardium, (Fig. 2.8C-E).  Furthermore, β-gal 
from the NFATc1-nuc-LacZ BAC transgene identifies a cardiac subpopulation of 
endothelium that expresses the vascular marker VE-cadherin, which also does not overlap 
with myocardium as identified by cardiac troponin T (cTnT) (Fig. 2.8B,F-H).  
             68
  
 
 
Figure 2.7. NFATc1-nuc-LacZ BAC transgenic expression in the endocardium of the 
E9.5 looped heart. A. E9.5 whole mount X-gal stained transgenic embryo B. Whole 
mount immunohistochemistry for CD31/Pecam-1 labeling all embryonic endothelium C. 
Whole mount immunohistochemistry for cardiac MHC with the MF20 antibody D,E. 
Sagital and frontal sections of E9.5 NFATc1-nuc-LacZ embryos with β-gal expression in 
all endocardium of the looped heart tube, but in no other embryonic endothelium. F-I. 
Immunofluorescence of an E9.5 NFATc1-nuc-LacZ heart demonstrating cellular co-
localization of endogenous endocardial NFATc1 (F, green) and β-gal (G, red). Nuclei 
were detected with DAPI (H, blue).  
 
Myocardium, m; endocardium, e; outflow tract, oft; common ventricle, v; atrioventricular 
canal, avc; aortic sac, as; atria, a 
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Figure 2.8. NFATc1-nuc-LacZ BAC transgenic expression in relation to other 
cardiovascular populations during embryogenesis. A. At E10.5, β-gal was retained in 
the valvular endocardium, but largely absent in the atrial and ventricular endocardium. B.   
Dual immunofluorescence for β-gal (green) and cTnT (red) marking non-overlapping 
endocardium and cardiomyocytes at E10.5 C-E. Immunofluorescence of an E10.5 
NFATc1-nuc-LacZ heart demonstrates cellular co-localization of endogenous endocardial 
NFATc1 (C, green) and β-gal (D, red). Nuclei were detected with DAPI (blue). F-G. β-
gal+ endocardium (green) at E10.5 identifies a cardiac subpopulation of endothelium 
distinct from system vasculature marked by VE-cadherin (VECAD, red). Nuclei were 
detected with DAPI (blue). H. Higher magnification image of nuclear-localized β-gal 
(white arrowhead) of the OFT endocardium. 
 
Outflow tract, oft; common ventricle, v; atrioventricular canal, avc; aortic sac, as; atria, a; 
endocardial cushion, ecc 
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The process of restriction first observed at E10.5 was complete by E11.5, with 
expression entirely localized to the cushion endocardium in accordance with the role of 
NFATc1 in valve remodeling (Fig. 2.9A-D) (Chang et al., 2004; Lange and Yutzey, 
2006; Zhou et al., 2005).  With the onset of chamber septation, the resulting partition of 
the AVC and OFT forms four valve cushions that will comprise the mitral, tricuspid AV 
valves, and the aortic and pulmonary semilunar valves.  β-gal was expressed on all four 
valve cushions formed with the onset of chamber septation at E12.5 (Fig. 2.9E,F).  
During valve remodeling and elongation, β-gal was retained in this endocardial 
subpopulation, and was undetectable by E16.5 (data not shown).  Although expression 
from the NFATc1-nuc-LacZ BAC transgene is specific to endocardial cells during early 
development, later in development other populations are observed to activate 
transcription of β-gal (Fig. 2.10A-D).  In the limb buds, beginning with the forelimb at 
E10.5 then the hindlimb at E11.5, LacZ expression is upregulated in the cartilaginous 
condensations of endochondral ossification (Fig. 2.10E-G).  This same process is evident 
in cartilaginous condensations of prevertebral bodies and ribs (Fig. 2.10H).  
Immunoperoxidase staining of comparable sections of prevertebral bodies demonstrates 
NFATc1 expression in the same population at this stage of development (Fig. 2.10I).  In 
addition, expression is also apparent in developing whisker follicles at E13.5 (Fig. 
2.10J,K).  These dynamic developmental expression patterns in the developing heart, and 
in other embryonic populations, confirm that the NFATc1-nuc-LacZ BAC transgene 
faithfully recapitulates endogenous NFATc1 expression.   
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Figure 2.9. Expression of the NFATc1-nuc-LacZ BAC transgene during valve 
remodeling and septation. A-C. Immunofluorescence at E11.5 shows cellular co-
localization of endogenous NFATc1 (A, green) and β-gal (B, red) at the valve cushion 
endocardium. Nuclei were detected with DAPI (C, blue). D. By E11.5, β-gal is restricted 
to endocardium overlying the valve cushions, with no expression in endocardial cells 
having undergone EMT to populate the cushions. Expression is absent in the atrial and 
ventricular endocardium (white arrowhead). E-F. After septation, β-gal expression is 
only evident in the endocardium of remodeling valves, and in no other endocardial cells 
(white arrowheads). 
 
Outflow tract, oft; common ventricle, v; endocardial cushions, ecc; left atria, la; left 
ventricle, lv; mitral valve, mv; aortic valve, av; aorta, ao; pulmonary valve, pv; right 
ventricle, rv; trabeculea, t. 
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Figure 2.10. NFATc1-nuc-LacZ BAC transgenic expression in other cell populations 
during development. (A-D) Whole mount X-gal stained NFATc1-nuc-LacZ BAC 
transgenic embryos at E10.5 (A), E11.5 (B), E12.5 (C), and E13.5 (D) demonstrating the 
onset of NFATc1’s complex developmental expression pattern during mid gestation. (E-
G) X-gal stained cryosections documenting β-gal expression in cartilaginous 
condensations during the initial stages of forelimb development at E10.5 (E), E11.5 (F), 
and E12.5 (G). H,I. Comparable sections of prevertebral bodies at E11.5 showing β-gal 
expression (H) or NFATc1 expression revealed by immunoperoxidase staining (I). J,K. 
β-gal expression in developing whisker follicle epithelium (white arrowheads) at E13.5. 
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Discussion 
 Using BAC recombineering for targeted homologous recombination in bacteria, 
we generated a 220 kb transgene that allowed for maximum utilization of critical 
genomic regulatory elements of the NFATc1 genomic locus to govern LacZ expression.  
Through in vitro differentiation of eEPCs, in addition to transient and stable mouse 
transgenesis, we confirmed this BAC contained the cis-regulatory domains required for 
activating transcription in endocardial precursors as they emerged from the cardiac 
mesoderm.  Further analysis demonstrated that β-gal expression from the NFATc1-nuc-
LacZ BAC transgene faithfully recapitulated endogenous NFATc1 expression in the heart 
and other cell populations during development.  With the ability to distinguish 
endocardium from other endothelium, this NFATc1-nuc-LacZ BAC transgene represents 
a novel and invaluable tool to monitor endocardiogenesis during early embryogenesis.  In 
addition, these findings provide additional support for our hypothesis that the 
endocardium is a distinct cardiac subpopulation of endothelium with a unique molecular 
identity. 
 Since the discovery of its role in regulating valve development, NFATc1 has 
remained one of the few specific markers of this endothelial subpopulation.  The studies 
presented here build off our previous promoter analysis of NFATc1, which characterized 
a transcriptional enhancer responsible for autoregulation of NFATc1 in endocardial 
cushions (Zhou et al., 2005).  The restricted expression pattern exhibited by this enhancer 
implied that early endocardial expression of NFATc1 is controlled by regulatory 
elements that are distinctly separate from the one modulating transcription in valvular 
endocardium.  These same analyses indicated that the early endocardial enhancer did not 
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reside within 25 kb surrounding the P1 promoter and exon 1.  Thus BAC recombineering 
was selected as it represented an efficient means to harness a genes expression pattern 
without having to define individual regulatory elements.  The resulting BAC transgene 
was advantageous compared to a direct knock-in generated by homologous 
recombination in ESCs as it would not affect endogenous gene expression and was a 
discreet unit that could be used for multiple purposes.  An additional benefit of the BAC 
approach was its modularity; the NFATc1 targeting vector, pBSKSa-N5’-nuc-LacZ-TetR-
N3’, was constructed so that the different genes of interests could be rapidly inserted and 
targeted into the NFATc1 BAC.  
The NFATc1-nuc-LacZ BAC transgene demarcated differentiating endocardial 
cells in the anterior lateral plate mesoderm at the earliest stages of cardiac development 
(Fig 2.5A-C).  β-gal+ cells were not observed at earlier stages and could not be detected 
along the path cardiac progenitors take as they migrate from PS.  These observations are 
insufficient to determine whether the endocardium is derived from a shared progenitor 
with myocardium, from a distinct population, or even from an outside source that 
migrates into the cardiac mesoderm.  However, these findings indicate that activation of 
expression from the NFATc1-nuc-LacZ BAC transgene coincides with the initial 
commitment of mesodermal cells to the endocardial lineage.  In addition, the NFATc1-
nuc-LacZ BAC transgene drives expression in all endocardial cells from both the PHF 
and SHF.  At E8.5 in the linear heart the transgene identifies the entire endocardium, 
which is entirely derived from the PHF (Fig. 2.6).  Yet at E9.5, β-gal expression is also 
present in the endocardium of the OFT, which is SHF-derived (Fig. 2.7).  Whether 
extensive molecular differences exists between endocardium derived from the PHF 
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verses that derived from the SHF remains unknown.  Collectively, these observations 
demonstrate the strength of this transgene to identify all endocardial cells during early 
cardiac morphogenesis. 
 In addition to identifying endocardial cells during early cardiogenesis, the 
NFATc1-nuc-LacZ BAC transgene documents NFATc1 in other populations during 
development.  The function of NFATc1 as an early transcriptional activator of 
chondrogenesis, as well as its role in the regulation of bone mass by controlling 
osteoclast differentiation, has been well established (Koga et al., 2005; Ranger et al., 
2000; Winslow et al., 2006).  By mid-gestation (E11.5-13.5), β-gal is detected in 
cartilaginous condensations of limbs, prevertebral bodies, and ribs.  Furthermore, β-gal 
expression is also apparent in developing whisker follicles at E13.5.  Horsley et al. 
demonstrated that NFATc1 is responsible for governing hair follicle stem cell renewal 
(Horsley et al., 2008).  NFATc1, activated by BMP signaling, represses CDK4 to 
maintain stem cell quiescence, but under signals that activated hair follicle growth, 
NFATc1 is downregulated, and CDK4 repression is relieved to allow proliferation and 
differentiation.  Our observations suggest NFATc1 might function as an early marker of 
follicle development, but a more detailed analysis of this expression pattern is needed. 
 Driven by our observations that eEPCs can be induced to form endocardial cells, 
we initially explored eEPC differentiation as an in vitro model of endocardiogenesis.  
However, there were certain caveats that reduced its viability as an appropriate system for 
our purposes.  Only a small fraction of cells differentiate into endothelium, and no 
myocardial transcripts are upregulated upon differentiation, making it less then ideal to 
study endocardial-myocardial interactions.  Also, introduction of reporter transgenes to 
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monitor endocardiogenesis would be inefficient, as it is difficult to obtain a clonal 
population from these cells.  Chapter III details the characterization of in vitro 
differentiation of ESCs as a model of endocardiogenesis and endocardial-myocardial 
interactions that is not limited by these particular obstacles. 
             77
CHAPTER III 
 
ENDOCARDIAL AND MYOCARDIAL SPECIFICATION ARE TEMPORALLY AND 
SPATIALLY COORDINATED IN EMBRYONIC STEM CELL DIFFERENTIATION 
 
 
 
Introduction 
 Examination of cardiac cell lineage specification and early differentiation during 
murine embryogenesis has been complicated by limitations on the amount of tissue that 
can be obtained, as well as difficulties in accessibility.  Since the discovery that 
embryonic stem cells (ESCs) isolated from the ICM of blastocyst-stage embryos can be 
induced to form all three germ cell layers and their derivatives, ESC differentiation has 
come to represent a faithful in vitro model of early embryonic development.  Given the 
potential of ESCs to generate a broad spectrum of cell lineages in a pattern mirroring 
embryonic development, the system has provided new avenues in which to study lineage 
induction and development.  In contrast to embryos in utero, differentiating ESCs can be 
easily manipulated either genetically or through modification of culture conditions.  In 
addition, cell populations at different stages of development can be harvested for 
biochemical and functional assays in large quantities with proper markers for selection 
and isolation. 
 ESC differentiation has been particularly useful in elucidating the mechanisms 
involved in specification of the mesodermal-derived populations that comprise the 
cardiovascular system, including endothelium, hematopoietic cells, and cardiomyocytes 
(Keller, 2005).  Through ESC differentiation, early processes and inductive signals 
required for hematopoietic and vascular lineage differentiation have been defined, and in 
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vitro analysis of targeted gene disruptions have clarified the transcriptional regulation of 
lineage specification.  Modeling hematopoietic and vascular specification in ESC 
differentiation has also led to the characterization of the long hypothesized 
hemangioblast, a common mesodermal precursor to both hematopoietic and vascular 
populations (Choi et al., 1998; Nishikawa et al., 1998).  Similarly, cardiomyocyte 
differentiation has been well documented in ESC differentiation, and as described in 
Chapter I, significant effort has been expended to devise how to enhance myocardial 
specification from stem cells in the hope of utilizing them as a therapeutic tool to treat 
heart tissue damaged by myocardial infarction and other ailments.  Although these 
studies have significantly extended our understanding of cardiac lineage specification, 
they have either drawn no distinction between endocardium and endothelium or only 
obliquely addressed endocardiogenesis.  This is due in part to the aforementioned 
absence of markers of endocardial cells, but also the fact that endocardiogenesis has not 
yet been defined in ESC differentiation. 
As ESC differentiation has been widely used to study mesodermal lineage 
determination and cardiovascular cell differentiation, we investigated its ability to model 
endocardial differentiation.  In this in vitro system, we documented that endocardial 
differentiation, as identified by NFATc1 expression, occurred at the same time as other 
cardiovascular cell types.  In addition, we demonstrate that endocardial cells only appear 
at sites of myocardial cell differentiation, a finding that was validated using an ESC line 
derived from NFATc1-nuc-LacZ BAC transgenic embryos.   Taken together, our findings 
document the close temporal-spatial relationship seen between endocardium and 
myocardium in vivo is reproduced in vitro. 
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Experimental Procedures 
 
Mouse embryonic fibroblast culture 
 Neomycin resistant primary mouse embryonic fibroblasts (PMEF-N; Specialty 
Media/Millipore) were obtained at passage 3 and plated on 1000-mm Poly-D-Lysine 
treated dishes coated with 0.1% gelatin in 1x PBS for 30 minutes at RT.  Cells were 
cultured in DMEM supplemented with 10% FBS (HyClone), 2 mM L-glutamine, 100 
U/ml Penicillin/Streptomycin, 1 mM sodium pyruvate, 100 µM non-essential amino 
acids, and 100 µM β-mercaptoethanol at 37˚C, 5% CO2.  From a single vial, cells were 
plated to 3 plates, passaged the next day 1:4, then passaged two days later 1:3; from one 
vial, 36 100-mm dished could be generated.  Cells were frozen at passage 5-6, one plate 
to one cryovial, by mixing resuspended cells in MEF media 1:1 with 2x Freezing media 
(60% MEF media, 20% FBS, 20% DMSO).  Cryovials were placed in an isopropanol 
freezing container and stored at -80˚C for 1-3 days before transfer to liquid nitrogen.  For 
growth cessation before use of PMEFs as feeders for ESC culture, confluent plates were 
exposed to 6-7 minutes (10-12 Gyr) of Cesium-137 irradiation.  After irradiation, MEF 
media was changed and plates were replaced at 37˚C to be used within 2 weeks. 
 
Embryonic stem cell (ESC) culture 
 Murine ESCs (R1) were cultured on irradiated PMEFS in DMEM supplemented 
with 15% FBS (ESC qualified; HyClone), 2 mM L-glutamine, 100 U/ml Penicillin/ 
Streptomycin, 1 mM sodium pyruvate, 100 µM non-essential amino acids, 1000 U/ml 
recombinant leukemia inhibitory factor (ESGRO, Millipore) and 100 µM β-
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mercaptoethanol at 37˚C, 5% CO2.  ESC media was changed every day, with cells 
passaged every two days by 0.25% Trypsin-EDTA treatment for 2-4 minutes at 37˚C 
after a wash with PBS.  Trypsin was inactivated by resuspension in ESC media, and the 
cell number counted with a hematocytometer.  2x106 cells were replated onto fresh 100-
mm dishes of irradiated PMEFS, an approximate dilution of 1:12.  ESC were frozen at a 
density of 5x106 cells by mixing resuspended cells in ESC media 1:1 with 2x Freezing 
media (60% ESC media, 20% FBS, 20% DMSO).  Cryovials were placed in an 
isopropanol freezing container and stored at -80˚C for 1-3 days before transfer to liquid 
nitrogen.  For plating of frozen stocks, cryovials were incubated in a 37˚C water bath and 
washed in pre-warmed ESC media, pelleted by spinning at 500xg for 5 minutes then 
resuspending in ESC for plating one vial to one 100-mm dish of irradiated PMEFs.  
 
ESC differentiation 
 1-3x106 ESCs were transferred to 100-mm gelatinized plates 1-2 days prior to the 
initiation of differentiation in order to decrease PMEF contamination and maintained in 
ESC media with LIF.  ESCs were washed with PBS prior to trypsinization to yield a 
single cell suspension that was then quenched by serum-contain media.  ESC-derived 
EBs were formed by one of two methods, either by the hanging drop method or in 
suspension.  To generate EBs by hanging drop, cells were brought to a density of 2.5x104 
cells per mL in ESC differentiation media (DM) consisting of Iscove’s Modified 
Dulbecco’s Medium (IMDM) supplemented with 15% FBS, 2 mM L-glutamine, 100 
U/ml Penicillin/Streptomycin, 200 µg/m transferrin (Roche), 0.5 mM L-ascorbic acid 
(Sigma), and 4.5x10–4 M monothioglceryol.  20 µl drops (~500 cells) were deposited in 
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12-14 rows of 8 with an 8-well multichannel pipet onto 100x100-mm square Petri dishes 
(Thermo Fisher; 0875711A), and then gently inverted and returned to the at 37˚C, 5% 
CO2 tissue culture incubator.  After two days, plates were flooded with PBS, rocked back 
and forth to centralize the EBs to be picked up with a sterile pipet and transferred to a 50 
ml conical.  EBs were allowed to settle, the remaining PBS/DM was aspirated, and new 
DM was added to the EBs.  EBs were transferred to 60-mm Petri dishes (VWR; 25384-
328), approximately 3 hanging drop plates to 1 60-mm dish.   
For EBs formed by suspension, ESCs were again diluted to a density of 2.5x104 
cells per ml in DM, and 5 ml (~ 1.25x105 cells) was transferred to 60-mm Petri dishes 
(VWR).  The use of this particular 60-mm non-tissue culture dishes from VWR was 
critical as EBs either attached to the bottom of the dishes (i.e. Fisher) or aggregated at the 
center, as occurred with Ultra-low attachment plates (Corning).  Media was changed after 
2 days in suspension.  For both hanging drops and suspended EBs, after 1-2 days of 
further differentiation (3-4 days total), EBs were transferred to tissue culture plates for 
attachment; EBs collected for RNA, β-gal staining, or flow cytometry were deposited on 
6 or 24-well gelatinized dishes, while EBs for immunofluorescence were deposited on 
Lab Tek II 4-well glass chamber slides (Nunc/Thermo Fisher).  After plating, the media 
on attached EBs was changed every two days. 
 
NFATc1-nuc-LacZ ESC derivation 
 ESC lines from NFATc1-nuc-LacZ BAC transgenic mice were derived from E3.5 
blastocyst-stage embryos plated on irradiated passage 2-3 freshly isolated MEF feeders in 
RESGRO complete ES medium (Millipore) plus 50 µM MEK inhibitor (PD98059, Cell 
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Signaling Technologies) (Schoonjans et al., 2003).  Cultured blastocysts were not 
disturbed for 3-4 days to allow attachment, after which media was changed daily. After 5-
6 days in culture, the inner cell mass outgrowth was selectively removed from the 
trophectoderm with a 20 µl pipet tip, dispersed with 0.25% Trypsin-EDTA and replated. 
Once colonies were visible, ESCs were transitioned to ESC media and expanded. 
 To prepare fresh MEFs, E13.5 embryos were dissected in cold PBS with 100 
U/ml Penicillin/Streptomycin.  The head and internal organs were removed and the 
remaining carcass was minced.  Tissue was placed into a 50 ml conical, washed with 
PBS, allowing the tissue to settle not spun.  PBS was aspirated and 0.25% Trypsin-EDTA 
with DNAse was added to digest tissue for 10 minutes at 37˚C before being passed 
through an 18 gauge needle 10 times.  Cells were spun down and replated on gelatinized 
100-mm tissue cultures dishes in MEF media and allowed to grow. 
 
Generation of stable BAC transgene ESC lines 
An NFATc1 BAC driving the red fluorescent protein mCherry was constructed as 
detailed in Chapter II. For selection purposes, a dual neomycin/ kanamycin cassette under 
the control of the mammalian PGK promoter and bacterial Em7 promoter (PGK-NEO) 
was excised from the recombineering plasmid PL452 with NheI/BamHI.  This cassette 
was inserted by blunt ligation between the two 500 bp homology arms of pLoxPOUTZeo 
after removal of the zeocin cassette with SalI.  This NEO targeting vector was 
electroporated into heat induced EL250 containing the NFATc1-mCherry or the NFATc1-
nuc-LacZ construct without the loxP modifications described in Chapter II.  Recombined 
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BACs were selected with CAM and kanamcyin (KAN) and confirmed by NotI digest run 
O/N with PFGE. 
 For electroporation into ESCs, BAC DNA was prepared with the PsiClone Big 
BAC DNA kit (Princeton Separations) according to the manufacturer’s protocol, and 
resuspended into microinjection buffer, stored at 4˚C to be used with 2 days.  Low 
passaged wild type R1 were thawed and passaged two days prior to electroporation.  The 
morning before electroporation, ESCs were fed with fresh media.  To prepare cells for 
electroporation, ESCs were washed with PBS, trypinized, then resuspended in 10 ml to 
be re-plated on a fresh gelatinized 100-mm plate and incubated at 37˚C for to allow 
PMEFs to reattach.  After 15-30 minutes, the media and the ESC still in suspension were 
pulled off, washed twice in ice-cold PBS by centrifugation at 500xg for 5 minutes, then 
counted.  Approximately 30 µg of BAC DNA was electroporated into 5x106 ESCs in a 
0.4 cm cuvette at 250 V, 500 µF.  Each electroporation was plated onto two 10 cm plates 
of PMEF-N.  After two days, selection with 500 µg/ml Geneticin (Invitrogen) began, 
with the media changed every two days.  Colonies were picked after 10-14 days of 
selection, and tested for expression. 
 
Beta-galactosidase staining  
 For whole-mount β-gal staining, EBs were washed in cold PBS and fixed in 0.2% 
glutaraldehyde, 2 mM MgCl2, and 5 mM EGTA for 6 minutes.  EBs were washed twice 
with X-gal wash buffer consisting of 2 mM MgCl2, 0.02% NP40 in PBS before 
incubation in a X-gal staining buffer of 1 mg/ml X-Gal, 5 mM potassium ferro/ 
ferricyanate, 2 mM MgCl2, 0.02% NP40, 0.01% sodium deoxycholate in PBS at 37°C for 
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2-6 hours to prevent overstaining.  EBs were cleared using a glycerol gradient in PBS and 
stored at 4°C. 
 For dual β-Gal/immunoperoxidase staining, cells first stained with X-gal as 
described above.  After 3 washes with PBS, cells were treated with 3% H2O2, followed 
by Avidin/Biotin blocking.  EBs were blocked with 10% goat serum in PBS (Jackson 
Labs) for 1 hour at RT. then incubated with primary antibody O/N in 10% goat serum in 
PBS.  The following day, EBs were washed and treated with and HRP-conjugated 
secondary antibodies (BD Pharmingen; 1:100), before detection with DAB (Vector labs).  
Samples were washed and perserved in Crystal/Mount (Biomeda). 
 
Immunofluorescence 
 For whole-mount immunofluorescent staining, EBs were washed in PBS and 
fixed in ice cold Methanol:Acetone (1:1) for 6 minutes on ice, then washed again.  EBs 
were blocked with staining buffer consisting of 3% FBS and 0.1% sodium azide in PBS 
prior to incubation with primary antibodies diluted in staining buffer O/N at 4°C.  For 
immunofluorescent staining of EBs from NFATc1-mCherry/Venus-yfp ESCs, EBs were 
fixed in 10% NBF on ice for 15 minutes, washed twice with PBS, then blocked in 
staining buffer consisting of 3% FBS and 0.1% sodium azide in PBS supplemented with 
0.5% Triton-X.  Species or isotype appropriate Alexa 350, Alexa 488, Alexa 555 and 
Alexa 647-conjugated secondary antibodies (Molecular Probes, 1:200) were added for 1 
hour at 37˚C for signal detection.  Samples were washed and mounted with Vectashield 
with or without DAPI (Vector Labs).  Images were acquired using a Nikon Elipse E800 
epifluorescence microscope or Zeiss Upright LSM510 Confocal Microscope. 
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Antibodies 
NFATc1 (mouse 7A6, BD Pharmingen, 1:200) 
Sacromeric myosin heavy chain (MHC; mouse MF20, DSHB, 1 µg/ml) 
Cardiac troponin T (cTnT; mouse CT3, DSHB, 1 µg/ml) 
CD31/Pecam-1 (rat MEC13.3, BD Pharmingen, 1:500) 
β-Gal (chick, Abcam, 1:1,000 or rabbit, Cappel, 1:5,000) 
 
Flow cytometry 
EBs were dissociated using cell disassociation buffer (Gibco) for 30 minutes at 
37˚C, resuspended in ice cold FACS buffer prepared from Hanks Buffered Salt Solution 
(HBSS) with 2% FBS (HyClone), and 25 mM HEPES, and filtered through a 42 micron 
sieve to produce a single cell suspension.  Cells were resuspended 1x106 per 100 µl and 
treated with an antibody against CD16/CD32 for 10 minutes (mouse, Ebioscence, 1 
µg/ml) to block nonspecific binding prior to a 45-minute incubation at 4˚C with an 
Allophycocyanin-conjugated (APC) antibody against CD31/Pecam-1 (rat MEC13.3, BD 
Pharmingen, 0.5 µg/ml).  Cells were analyzed on a 5-laser BD LSRII (Becton Dickinson).  
 
RNA isolation 
 Total RNA from approximately 1x106 cells or (surface area 35 mm) was extracted 
using 1 ml Trizol reagent (Invitrogen) following the manufacturers instructions.  RNA 
pellets were resupended in 50 µl of nuclease-free H2O and then treated with Turbo DNA-
free (Applied Biosystems) to remove residual genomic DNA.  An additional purification 
step was performed with the RNeasy Miniprep kit (Qiagen) following the RNA cleanup 
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protocol.  RNA was collected from RNeasy columns in 20-40 µl of nuclease-free H2O 
depending on the size of the pellet.  RNA concentration and purity were analyzed on a 
NanoDrop spectrophotometer (Thermo Scientific).  Samples with a 260/280 ratio > 1.8 
(1.9-2.1 preferrably) and 260/230 ratio > 1.5 were deemed high enough quality for qRT-
PCR.  2 µg of total RNA was reverse-transcribed into cDNA using the High Capacity 
cDNA Reverse Transcription kit (Applied Biosystems) in 20 µl as per manufacturers 
instructions, then resuspended into 80 µl to yield a final conentraton of 50 ng/µl. 
 
Quantitative real-time PCR (qRT-PCR)  
All qRT-PCR was performed using a Light Cycler (Roche) with the Light Cycler 
DNA FastStart SYBR Green I Kit, 0.5 µM of each primer, and 100 ng cDNA.  Gene 
specific primer sets used for these experiments are listed as follows: Brachyury: 5’ ACA 
GAT CAT GTT AAA CTC CTT GCA T 3’, 5’ TAC ATC TTT GTG GTC GTT TCT 
TTC T 3’; NFATc1: 5’ GGT GGC CTC GAA CCC TAT C 3’, 5’ TCA GTC TTT GCT 
TCC ATC TCC C 3’; βMHC:  5’ AGC CGC GCC AGT ACT TCA TAG GTG 3’ , 5’ 
TGT TCT TTT CCA GCC AGC CCA TAA 3’; Nkx2.5: 5’ ACC TTT CTC CGA TCC 
ATC CCA CTT 3’, 5’ GCG TTA GCG CAC TCA CTT TAA TGG 3’; Flk1: 5’ GGT 
TCT CTG TCA AGT GGC GGT AAA 3’, 5’ AGC ACA CAG GCA GAA ACC AGT 
AGA 3’; VECAD: 5’ AAC TCA CCC TCC TTG TGG AAT CCT 3’, 5’ ACA TCT CAT 
GCA CCA GGG TGA CTA 3’; CD31/Pecam-1: 5’ ATC CGG AAG GTC GAC CCT 
AAT CTC AT 3’; 5’ ATA CCC AAC ATG AAC AAG GCA GCG 3’; HPRT: 5’ AGT 
CAA CGG GGG ACA TAA AA 3’ 5’ TGC ATT GTT TTA CCA GTG TCA A 3’; 
GAPDH: 5’ CAC TGG CAT GGC CTT CCG TG 3’, 5’ AGG AAA TGA GCT TGA 
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CAAAG 3’.  The specificity of the amplified product was evaluated using the melting 
curve analysis and a no template control reaction.  Each sample was done in triplicate and 
relative expression was calculated as ∆2-ct with HPRT as the internal control. 
 
Results 
 
Endocardial cells differentiate in a similar temporal pattern to other mesodermal-derived 
cardiovascular cell populations  
 
 To confirm the presence of endocardial cells in ESC differentiation, and to define 
the particular window when they first emerge, RNA was obtained from undifferentiated 
ESCs and from EBs at 2, 4, 6, 8, 10, 12 days of differentiation in order to characterize 
gene transcripts associated with mesoderm and mesodermal-derived cell populations.  In 
a preliminary study, NFATc1, as a specific endocardial transcript, was compared to Flk1, 
a marker of mesoderm early vascular development, and VE-cadherin, expressed by 
mature endothelium (Fig. 3.1A).  NFATc1 was first detected at differentiation day 6 (D6), 
peaked at D8-10, with its levels declining by D12.  This pattern was similar to those seen 
with Flk1 and VE-cadherin, suggesting that endocardial endothelium was present in EBs 
and arose during the same time period as other vasculature.   
To further investigate the temporal pattern of endocardial differentiation in 
relation to mesodermal specification and the differentiation of other components of the 
cardiovascular system, particularly myocardium, molecular expression analyses were 
performed by quantitative real-time PCR (qRT-PCR).  Supporting our earlier findings, 
NFATc1 was absent in ESC colonies and in EBs during the first few days of 
differentiation. NFATc1 expression was first observed at D6, reaching its highest 
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Figure 3.1. Temporal analysis of endocardial, myocardial, and vascular transcripts 
during ESCs differentiation. A. RT-PCR documenting the temporal expression pattern 
of NFATc1 compared to Flk1, a marker of mesoderm early vascular development, and 
VE-cadherin, expressed by mature endothelium in undifferentiated ESCs and EBs at 2, 4, 
6, 8, 10, 12 days of differentiation. NFATc1 is first observed at differentiation day 6 (D6), 
and peaks at D8-10, similar to Flk1 and VE-cadherin. GAPDH was used as loading 
control. B. Normalized expression values from qRT-PCR analysis of the temporal 
expression of genes associated with mesoderm (brachyury, Flk1) and mesodermal 
derivatives, specifically cardiac (Nkx2.5, βMHC) and vascular lineages (VE-cadherin, 
CD31, Flk1), compared to endocardial NFATc1 during ESC differentiation.  
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expression at D8-D10 (Fig. 3.1B).  In contrast, brachyury (T), a transient marker of 
nascent mesoderm, was robustly expressed at D4, but sharply reduced by D6 (Wilson et 
al., 1993; Yamada et al., 1994).  This indicates NFATc1 expression, and by association 
endocardial differentiation, occurs subsequent to mesodermal specification.  As 
endocardial differentiation is closely tied to myocardial differentiation in both time and 
space, we examined how the temporal kinetics of NFATc1 expression in differentiating 
ESCs related to the genes expressed by cardiomyocytes (Fig. 3.1B). Nkx2.5, an early 
myocardial transcript that in vivo is observed in the PHF at the crescent stage was 
upregulated at D6 (Lints et al., 1993). βMHC encoding a ventricular myocardial specific 
isoform of myosin heavy chain is first expressed at D8, coinciding with the appearance of 
contracting foci within EBs (Mahdavi et al., 1987).  In addition to cardiomyocyte 
transcripts, the pattern of NFATc1 expression coincided with the appearance of several 
vascular markers, as had been indicated by our preliminary studies.  Flk1 expression at 
D4 again preceded NFATc1, consistent with its description as a marker of 
extraembryonic and embryonic mesoderm, as well as later vascular endothelial 
populations (Ema et al., 2006).  NFATc1 expression was notably similar to VE-cadherin, 
and the late phase of CD31/Pecam-1, which is transiently expressed in the blastocyst 
ICM and therefore undifferentiated ESC colonies (Baldwin et al., 1994; Lampugnani et 
al., 1992; Robson et al., 2001).  These findings demonstrate differentiation of 
cardiovascular cell populations in ESC-derive EBs occur during the same temporally 
window, consistent with its expression during cardiogenesis in vivo. 
To corroborate the qRT-PCR findings and establish the existence of NFATc1+ 
cells in ESC differentiation cultures when NFATc1 message is detected, EBs were 
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immunostained with a monoclonal antibody raised against NFATc1.  NFATc1+ cells 
were visualized with immunofluorescence at D8, where it was present in a subset of cells 
predominantly in its nuclear localized, transcriptionally active form (Fig. 3.2A).  Positive 
cells were largely found in discrete groups and were not dispersed evenly throughout the 
attached EBs.  The majority of these NFATc1+ cells were morphologically similar, 
consisting of a large nucleus and elongated polar processes (Fig. 3.2A, inset).  Though 
NFATc1 is found exclusively in endocardial endothelium early in development, it is later 
expressed in numerous other tissues.  To determine whether the NFATc1+ cells detected 
at D8 potentially represented endocardial cells or another cell population, we conducted 
dual immunofluorescence studies with NFATc1 and the vascular endothelial cell surface 
marker CD31/Pecam-1. This staining indicated NFATc1+ cells co-expressed the 
endothelial surface marker CD31/Pecam-1 at D8, thus suggesting these cells possessed an 
endocardial identity (Fig 3.2B). 
 
Endocardiogenesis is spatially sequestered at sites of myocardial differentiation 
 While ESC-derived EBs maintain a pattern of sequential lineage progression that 
faithfully recapitulates development in vivo, EBs have generally been considered to lack 
the spatial complexity normally seen with in embryogenesis.  These traditional 
assessments have been challenged by observations of required interactions between 
distinct cell populations in differentiating EBs that mirror in vivo spatial localization.  
The most prominent examples involve cardiovascular cell types, where one such study 
demonstrated contracting cardiomyocytes in EBs are spatially associated with conduction 
system tissue, as identified by a minK-LacZ transgene (White and Claycomb, 2005).  
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Figure 3.2. Identification of NFATc1+ endocardial cells in ESC differentiation 
cultures. A. Immunofluorescence of a D8 EB with cells containing nuclear localized 
NFATc1 (green). Nuclei were detected with PI (red). The inset contains higher 
magnification images of an NFATc1+ cells with a large nucleus and elongated polar 
processes.  B. NFATc1+ cells (green) co-expressed the endothelial surface marker 
CD31/Pecam-1 (blue) at D9. NFATc1+/ CD31+ cells represent only a subset of the total 
CD31+ vascular plexus of the EB outgrowth. C. NFATc1+ cells (green) were found 
exclusively localized adjacent to developing cardiomyocyte foci as labeled by MHC (red) 
in differentiating EBs. 
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Another study characterized a sinusoid vascular-like network that integrated with 
hepatocytes to enhance the hepatic function of these layers (Ogawa et al., 2005). 
 To explore whether spatial relationships between cardiovascular cell populations 
exist in ESC differentiation, we conducted immunofluorescence studies of EBs at the 
onset of cardiac differentiation as determined by qRT-PCR.  The earliest cardiomyocyte 
contractions in attached EB cultures can be visually identified at D8-9, thus it was at this 
point we first investigated the spatial localization of myocardium and endothelium, using 
antibodies for sarcomeric myosin heavy chain (MHC) and CD31/Pecam-1.  
Cardiomyocytes at D8 are organized in contiguous groups of cells rather than being 
dispersed throughout the EB (Fig. 3.3A).  These cardiomyocyte foci are completely 
enveloped by a network of endothelial cells, and rarely are cardiomyocytes not in direct 
contact with CD31+ cells, though the reverse is not true for endothelium, which forms an 
extensive plexus even in the absence of cardiomyocytes.  This spatial relationship 
between endothelium and cardiac muscle was even maintained across time and through 
further growth and development, as at D12 juxtaposed cells could still be observed (Fig. 
3.3B).  Combined immunofluorescence of MHC, CD31/Pecam-1, and cTnT demonstrates 
this association is consistent using different cardiomyocyte markers (Fig. 3.3C-F). More 
intriguing was that the NFATc1+ cells we previously identified were located near 
cardiomyocyte foci, suggesting that the close proximity endocardium and myocardium 
shared in the developing embryo is reflected in vitro in differentiating EBs (Fig. 3.2C). 
Using antibodies to designate early myocardium (MHC), endothelium 
(CD31/Pecam-1), and endocardium (NFATc1), we examined EBs from D8-D11 to 
determine if this spatial relationship between myocardium and endocardium was 
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Figure 3.3. Spatial dynamics of differentiating cardiovascular cell populations in 
embryoid bodies. A. Cardiomyocytes at D8, labeled by MHC (red), are organized in 
contiguous groups of cells, and are morphologically small and round with disorganized 
bundles of myofibrils. Cardiomyocyte foci are completely enveloped by a network of 
CD31/Pecam-1+ endothelial cells (blue). B. By D12, ESC-derived cardiomyocytes have 
become elongated with well-developed myofibrils and sarcomeres. The spatial 
relationship between endothelium and cardiac muscle observed at earlier developmental 
time points was maintained at D12. C-F. Immunofluorescence of a D10 EB demonstrates 
that MHC (C, red) and cTnT (E, green) effectively co-labels all cardiomyocytes (F, 
Yellow) and that the association of myocardial cells with CD31/Pecam-1+ endothelial 
cells (D, blue) is consistent with various cardiomyocyte markers. 
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Figure 3.4. Spatial and temporal coordination of endocardium and myocardium in 
embryoid body outgrowths. Immunofluorescence images documenting myocardium 
(MHC, red), endothelium (CD31/Pecam-1, blue) and endocardium (NFATc1, green) in 
differentiating ESCs at D8, D9, and D11. A. At D8, NFATc1+/ CD31+ endocardial cells 
represent a subset of all endothelial cells restricted to regions adjunct to myocardial 
differentiation. B. At D9, NFATc1+/ CD31+ endocardial cells form a condensed 
epithelial-like sheet in close association with immature MHC+ cardiomyocytes. C. With 
the maturation of cardiomyocytes into elongated, contracting cells with well-developed 
myofibrils and sarcomeres at D11, NFATc1+/CD31+ endocardial cells were still detected 
at sites of myocardial differentiation. NFATc1+/ CD31+ endocardial cells were not 
detected in regions lacking cardiomyocyte differentiation at any of these time points. 
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preserved across the temporal window of cardiac differentiation.  We observed that at D8 
NFATc1+/ CD31+ cells were restricted to regions adjunct to myocardial differentiation, 
but were not in close association with one another (Fig. 3.4A).  The association between 
endocardium and myocardium was consistent from when MHC was first detectable at 
D8, through the formation of larger contacting foci at D11.  With maturation of 
cardiomyocytes, NFATc1+/ CD31+ endocardial cells transitioned from a diffuse vascular 
plexus to a condensed epithelial-like sheet, but always maintained their close association 
with MHC+ cardiomyocytes (Fig. 3.4B,C).  NFATc1+/ CD31+ endocardial cells were 
not detected in regions lacking cardiomyocyte differentiation.  These studies provide 
evidence to support the assertion that endocardium and myocardium exhibit and spatial 
coordination in ESC differentiation. 
 
The NFATc1-nuc-LacZ BAC transgene identifies endocardial cells in ESC differentiation   
  
Though antibody staining at the initiation of cardiac differentiation in EBs 
suggests endocardium and myocardium are coordinated both in time and space, these 
findings are circumstantial, using the in vivo association of these two cardiac 
subpopulations to explain our in vitro observations.  Thus, to validate these findings and 
to further evaluate the temporal and regional differentiation of endocardium in vitro, ESC 
lines were derived from E3.5 blastocysts carrying the NFATc1-nuc-LacZ BAC transgene 
(Fig. 3.5A).  E3.5 blastocysts were flushed from the uteri of wild-type FVB/N females 
breed to male NFATc1-nuc-LacZ BAC transgenics; females carrying the transgene 
produced poor number of blastocysts (Nagy, 2003a).  Successful culturing of blastocysts 
was a difficult process that went through multiple iterations.  Initially, blastocysts were 
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Figure 3.5. Derivation and differentiation of ESC lines from NFATc1-nuc-LacZ BAC 
transgenic mice. A. An ESC line from NFATc1-nuc-LacZ BAC transgenic mice was 
derived from E3.5 blastocyst-stage embryos (1) plated on irradiated passage 2-3 freshly 
isolated PMEF feeders (2). Cultured blastocysts were not disturbed for 3-4 days to allow 
attachment before changing the growth media. After 5-6 days in culture, the inner cell 
mass outgrowth was selectively removed from the trophectoderm (3), and dispersed (4), 
to generate ESCs colonies for expansion. Image modified from 
http://stemcells.nih.gov/info/scireport/appendixC.asp B-D. Low and high (insert) 
magnification images of X-gal stained EBs from NFATc1-nuc-LacZ BAC derived ESCs. 
β-gal+ endocardial cells are first detected at D6 (B), with robust β-gal expression 
consolidated in patches observable at D9 (C), but with noticeable reduction and 
dispersion by D12 (D). 
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deposited on STO feeders, a continuous line of mouse embryonic fibroblasts derived 
from the SLN/c mouse strain. The STO line, which were originally selected for 6-
thioguanine and ouabain resistance, have been transfected to express LIF and possess 
neomycin resistance (Mann, 2001).  Other groups have used STO cells to successful 
derive ESCs from blastocysts, however in our hands, once irradiated these cells produced 
excessive amounts of ECM that impaired ICM outgrowth and it subsequence removal, 
which prompted our switch to freshly prepared PMEFs.  In addition, the use of RESGRO 
complete ES medium (Millipore) greatly facilitated blastocyst outgrowth compared to 
standard ESC media.  However with this improved growth, tropohblast cell expansion 
had an adverse effect on ICM; the addition of the MEK1 inhibitor PD98059 blocked 
tropohblast growth with no discernible effect on the ICM outgrowth. 
An ESC line derived from an NFATc1-nuc-LacZ BAC transgenic embryo was 
expanded and induced to form EBs.  Upon differentiation, β-gal expression could be first 
observed at D6 (Fig. 3.5B).  By D9, β-gal+ cells had increased in number and were 
consolidated in patches of cells, similar to what was observed in earlier 
immunofluorescence studies with NFATc1+/ CD31+ cells.  After D12, β-gal+ cells were 
noticeably reduced and dispersed throughout the EB.  The temporal expression of 
NFATc1-nuc-LacZ in EBs matched NFATc1’s documented pattern from qRT-PCR 
analysis (Fig. 3.1B).  Immunohistochemisty on X-gal stained EBs confirmed β-gal+ cells 
at D9 were CD31/Pecam-1+ endothelial cells and were spatially localized to sites of 
myocardial differentiation (Fig. 3.6A,B).  To visualize multiple cells types and antigens, 
we employed an antibody against β-gal.  Immunostaining of D9 EBs detected nuclear β-
gal restricted to CD31+ endothelial cells (Fig. 3.6C).  Further combined 
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Figure 3.6. Characterization of β-gal expressing cells in embryoid bodies formed from 
NFATc1-nuc-LacZ BAC derived ESCs. A. Dual β-gal/immunoperoxidase staining of D9 
EBs from NFATc1-nuc-LacZ derived ESCs with β-gal+ adjacent to sites of myocardial 
differentiation (cTnT, brown). B. Dual β-gal/immunoperoxidase staining documenting 
nuclear β-gal restricted to CD31+ endothelial cells. C. D9 EB from NFATc1-nuc-LacZ 
derived ESC stained with a β-gal (green) and CD31 (red) with nuclear β-gal restricted to 
endothelial cells. Nuclei were detected with DAPI (blue). D. Co-immunostaining for β-
gal (green), MHC (red), and CD31 (blue) in D9 EBs from transgenic ESCs with β-
gal+/CD31+ endocardial cells present in close proximity to myocardium, and not in 
regions lacking cardiomyocytes  
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immunofluorescence for cardiomyocytes, endothelium, and endocardium, confirmed that 
β-gal+/CD31+ endocardial cells were only present in close proximity to myocardium 
(Fig. 3.6D).  Notably, cells expressing the NFATc1-nuc-LacZ were seldom detected in 
regions lacking cardiomyocytes, and non-endothelial NFATc1 expression was not 
observed over the period of differentiation investigated.  The findings from differentiated 
NFATc1-nuc-LacZ BAC derived ESCs validates our initial immunofluorescence studies 
demonstrating temporal and spatial association of endocardium and myocardium in EBs, 
and furthermore establishes that the NFATc1-nuc-LacZ BAC transgene reflects NFATc1 
expression, allowing β-gal staining to be reliably used to monitor endocardial 
specification in ESC differentiation. 
 
Electroporation of NFATc1 BAC transgenes generates stable ESC lines that faithfully 
monitor endocardiogenesis in EB differentiation cultures 
 
 As a routine method for generating new ESC lines stabling expressing BAC 
transgenes, the process of producing BAC transgenic mice via pronuclear injection 
followed by ESC deviation from transgenic blastocysts would be prohibitively difficult 
and time-consuming.  In order to introduce BAC DNA directly into ESCs by 
electroporation, we modified a previously described method for the electroporation and 
selection of BAC transgenes (Tomishima et al., 2007).   Insertion of a PGK-NEO cassette 
between the homology arms of pLoxPOUTZeo conferred antibiotic resistance to 
NFATc1-mCherry and NFATc1-nuc-LacZ BAC constructs, allowing for selection with 
Geneticin (G418) in mammalian cells (Fig 2.7A).  Given the large separation (50-75 kb) 
between the neomycin selection cassette in the BAC vector backbone from the reporter 
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Figure 3.7. Stable NFATc1 reporter ESCs lines generated by electroporation of BAC 
DNA. A. Targeting schematic for the introduction of the fluorescent protein mCherry into 
the NFATc1 BAC, and a strategy to convey neomycin resistance for selection in ESCs by 
introducing a PGK-NEO cassette into the BAC backbone (pBACe3.6). AscI, A. B. 
Comparison of β-gal expression in D9 EBs generated from ESCs derived from NFATc1-
nuc-LacZ BAC transgenic mice and from ESCs electroporated and selected for the 
neomyocin resistant NFATc1-nuc-LacZ BAC. C. Differentiated NFATc1-mCherrry BAC 
ESC line with mCherry (red) expression at D9 with immunostaining for cTnT (green), 
and CD31 (blue). mCherry+/CD31+ cells localize to regions of myocardial 
differentiation. D. Flow cytometry of D9 EBs from NFATc1-mCherrry BAC ESCs 
demonstrating mCherry (red) expression is largely restricted to endothelial cells, 
identified by CD31/Pecam-1 (blue). 
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gene inserted into exon 1, ESC colonies that survived selection and when differentiated 
expressed the reporter were assumed to contain an intact BAC transgene. 
 This process was first tested with an NFATc1-nuc-LacZ BAC transgene modified 
with the PGK-NEO cassette.  After 10-14 days of selection, approximately 48 colonies 
were picked and tested.  DNA was collected for PCR genotyping as described in Chapter 
II.  Nearly 50% were PCR positive, but upon differentiation, only 30% expressed β-gal 
with X-gal staining.  This ratio of 10-15% colonies of the total number surviving 
selection expressing the BAC transgene has proven consist for the majority of BAC 
electroporated into ESCs.  When differentiated, the pattern of expression matched ESCs 
derived from NFATc1-nuc-LacZ transgenics in timing of expression and in the spatial 
relationships (Fig 3.7B).  With these results, an ESC line containing an NFATc1-mCherry 
BAC was generated to monitor endocardiogenesis with a fluorescent reporter for live-cell 
imaging.  Differentiated NFATc1-mCherrry BAC ESCs demonstrated that mCherry 
expression at D9 was colocalized with CD31/Pecam-1 adjacent to cTnT+ 
cardiomyocytes, in agreement with previous immunostaining and differentiation of 
NFATc1-nuc-LacZ derived ESCs that endocardial cells localize to regions of myocardial 
differentiation (Fig. 3.7C).  Flow cytometry of mCherry against CD31/Pecam-1 at D9 
demonstrated NFATc1+ cells (4.7%) were CD31/Pecam-1+ endothelial cells (Fig. 3.7D).  
This confirmed our earlier observations that the NFATc1 BAC reporter uniquely 
identified endocardial cells, and was not expressed in other cell populations during this 
window of differentiation. 
 Although mCherry signal was sufficiently luminous and photostable, its 
excitation/emission spectra were not compatible with lasers available for fluorescence 
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Figure 3.8. Preliminary characterization of differentiated NFATc1-Venus-yfp BAC 
ESCs. A-C. Native fluorescence of Venus-YFP (A, green) compared to detection with a 
primary antibody against GFP and an Alexa555 red fluorescent conjugated secondary (B, 
red) in a D8 EB. Signals from both detection methods colocalize to the same cells in the 
attached EB outgrowth (C, yellow). D. Immunofluorescent images of Venus-YFP (green) 
with cTnT (red) and CD31 (blue) in a D9 EB. YFP+ cells are CD31+ endothelial cells in 
close proximity to myocardium. E. Immunofluorescent images of αGFP (green) with 
cTnT (red) and CD31 (blue) in a D9 EB. 
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activated cell sorting (FACS).  To correct this, an NFATc1 BAC was constructed driving 
the yellow fluorescent protein variant Venus (Nagai et al., 2002).  Initially, expression of 
Venus was comparable to other NFATc1 BAC reporters we had generated, displaying the 
spatial-temporal relationship to cardiomyocytes (Fig. 3.8).  However, these lines quickly 
lost the ability to express Venus.  The generation of new NFATc1-Venus ESC is 
currently in progress.   
 
Discussion 
 With the ESC differentiation system, we have characterized an efficient and 
reproducible in vitro model of endocardiogenesis.  Building off the extensive literature 
documenting mesodermal specification and subsequent differentiation of myocyte, 
endothelial, and hematopoietic populations in murine ESC-derived EBs, we provide 
evidence that endocardial differentiation occurs in a temporal pattern consistent with the 
mesodermal origin of endocardial cells, and their early emergence in mouse 
embryogenesis.  Endocardial cells represent a fraction of the total vasculature plexus 
formed in outgrowths of attached EBs, but only appear at sites of myocardial cell 
differentiation.  This spatial-temporal relationship between endocardial and myocardial 
cells as they arise from mesodermal progenitors, initially documented with 
immunofluorescence, was further validated using an ESCs derived from NFATc1-nuc-
LacZ BAC transgenic embryos, and well as stable ESC lines containing NFATc1-nuc-
LacZ, NFATc1-mCherry, and NFATc1-Venus-yfp BAC transgenes.  Collectively, our 
findings document the close temporal-spatial relationship seen between endocardium and 
myocardium in vivo is reproduced in vitro, and provides a means to elucidate the origins 
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of the endocardial lineage and how endocardial-myocardial interactions shape early 
cardiac differentiation. 
NFATc1 expression and function in ESC differentiation has been addressed in a 
select few studies, though its temporal expression pattern had never been properly 
defined.  NFATc1-/- ESCs have been used to investigate the role of NFATc1 in osteoclast 
differentiation (Takayanagi et al., 2002).  Their data indicates NFATc1 is expressed in 
osteoclasts by D8-D10, which appears to be in conflict with our flow cytometry 
experiments on D9 EBs generated from NFATc1-mCherrry BAC ESCs where the 
majority of mCherry+ cells also express the endothelial marker CD31/Pecam-1.  
However, as osteoclastogenesis is somewhat late during ESC differentiation, and was 
only achieved with the addition of macrophage colony stimulating factor (M-CSF) and 
RANKL, the difference in experimental design might represent a potential explanation of 
this discrepancy.  During the course of our studies, a report from Narumiya et al. 
maintained that NFATc1/CD31 double positive endocardial cells associated with 
GATA4-expressing myocardial cells in D8 EBs grown in suspension (Narumiya et al., 
2007).  Though these findings seemingly confirmed observations we had made prior to its 
publication, NFATc1 and CD31/Pecam-1 immunofluorescence were not of high enough 
quality to make any definitive conclusion about the spatial association of endocardium 
and myocardium in EBs from their studies. 
 Monitoring endocardial differentiation in EBs with immunofluorescence provides 
only circumstantial evidence. Colocalization of vascular markers with NFATc1 only 
suggests an endocardial identity for this population.  It is not possible to conclude they 
are in fact endocardial cells without additional validation.  Chapter V describes future 
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experiments to further characterize NFATc1+ cells generated in EB outgrowths.  ESCs 
derived from NFATc1-nuc-LacZ BAC transgenic embryos allowed for comparison 
between embryogenesis and during in vitro ESC differentiation.  It was our intention to 
isolate by FACS NFATc1+ endocardial cells generated from EBs to confirm whether 
they possess the same expression profile and functionality as their in vivo counterparts.  
Unfortunately, technical difficulties prevented the use of NFATc1-mCherrry BAC ESCs 
for FACS, and no working NFATc1-Venus-yfp BAC ESCs have been generated.  These 
experiments still remain as future experimental goals and are discussed in Chapter V. 
In spite of the commonly held belief that EBs lack structural complexity, which in 
the embryo is essential for proper organogenesis, we observed that endocardial cells were 
only present in close proximity to cardiomyocytes in 2-dimensional EB outgrowths.  
Such consistency in organization of two distinct subpopulations implies that there might 
be required cell-cell signaling or physical interaction between the endocardium and 
myocardium that governs their association.  The exchange of signals between 
endocardium and myocardium, as discussed in Chapter I, has been demonstrated during 
cardiac morphogenesis where it is essential for proper patterned growth and the 
development of structures of the mature heart.  Furthermore, interaction between 
endothelial cells and cardiomyocytes is required for survival of these cell types in vitro, 
as cultured neonatal cardiomyocytes undergo less apoptosis and show increased 
contraction when co-cultured with HUVECs (Narmoneva et al., 2004).  Other potential 
explanations for the proximity between the endocardium and myocardium in EBs are that 
each lineage might be induced from similar cues present in the microenvironment, or they 
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directly share a common precursor.  These two possibilities are explored in detail in 
Chapter IV. 
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CHAPTER IV 
 
ENDOCARDIUM AND MYOCARDIUM ARE DERIVED FROM A COMMON 
MESODERMAL CARDIOVASCULAR PRECUSOR  
 
 
Introduction 
While comparisons of cardiogenesis in different model organisms across 
evolutionary diverse phyla have been largely consistent in describing the process of 
myocardial differentiation and early heart formation, observations of endocardiogenesis 
have yielded a convoluted picture of this cardiac subpopulation.  As a result, the exact 
lineage classification of endocardium as either a cardiac or vascular cell population 
remains controversial.  Two opposing models have been put forth to explain these 
observations, one which states that endocardial and myocardial precursors represent two 
distinct populations in the cardiac crescent, and another that asserts the two cardiac 
subpopulations are formed from a common multipotent mesodermal progenitor. 
In non-mammalian systems, the endocardium appears to originate from the same 
common precursor as other vascular and hematopoietic cells, not from mesoderm 
generating the myocardium.  Early retroviral tracing in the avian embryo indicated that 
the endocardium and myocardium exist as two distinct populations in the cardiac 
mesoderm, which separated prior to gastrulation (Cohen-Gould and Mikawa, 1996; Wei 
and Mikawa, 2000).  Blastomere transplantation in zebrafish supported the hypothesis of 
two distinct lineages for the endocardium and myocardium prior to gastrulation, and 
suggested a shared origin of endocardium and other peripheral vascular components (Lee 
et al., 1994).  By examining Scl/Tal1 mutant zebrafish, Bussmann et al. confirmed that 
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endocardial precursors migrate to invest the developing myocardial tube from a region in 
the lateral plate mesoderm that also generates cells of the hematopoietic lineage 
(Bussmann et al., 2007).   
These studies suggest that within the cardiac mesoderm, endocardial progenitors 
represent a small number of spatially sequestered precursors within a larger field of 
myocardial progenitors, each with its own distinct mesodermal origin.  However, this 
viewpoint conflicts with accumulating evidence from mammalian systems suggesting 
endocardium and myocardium are derived from a common mesodermal progenitor.  Cre-
mediated lineage tracing of Nkx2.5+ and isl1+ cardiac populations suggests that 
myocardium, endocardium, vascular endothelium, and smooth muscle might be derived 
from common precursors in the cardiac mesoderm (Cai et al., 2003; Stanley et al., 2002).  
These findings insinuate a close developmental relationship, if not a common origin, 
between the endocardium and myocardium, though detailed examination has proven 
difficult due to the limitations of in vivo mouse models. 
As discussed in Chapter I, ESC differentiation models have been used extensively 
to examine cardiac specification, focusing on the stepwise commitment of precursors to 
differentiated cardiac cell types.  While few have addressed endocardiogenesis, these 
studies focusing on the cardiomyocyte lineage have revealed the potential of the ESC 
system to address the issue of endocardial origin.  This is exemplified by work utilizing 
an ESC line expressing GFP under control of the brachyury locus along with the cell 
surface receptor Flk1 to isolate cardiac and hematopoietic/vascular lineages by FACS 
(Kouskoff et al., 2005).  These mesodermal lineages possess distinct different temporal 
patterns in EBs with the cardiac lineage arising from a second wave of Flk1+ mesoderm 
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that appears subsequent to hemangioblast specification (Kattman et al., 2006).  Clonal 
analysis further indicated this second wave of Flk1+ mesoderm represented multipotent 
cardiovascular progenitors (MCPs) that generated cardiomyocyte, smooth muscle, and 
endothelial cells.  An equivalent MCP population has since been isolated from human 
ESCs using Flk1 and c-kit (Yang et al., 2008).  Interestingly, when Flk1+ MCPs from 
both mouse and human ESCs were expanded in culture and allowed to differentiate, 
endocardial transcripts NFATc1 and Nrg1 could be detected.  These findings, in addition 
to our previous observations documenting a close temporal-spatial relationship between 
endocardium and myocardium in EBs, emphasize the potential of ESC differentiation to 
clarify the origin and lineage classification of endocardial cells. 
In the following studies, we establish that endocardial cells are a specialized 
cardiac subpopulation, specified independently from hematopoietic and endothelial 
lineages.  Endocardial differentiation is inexorably linked to cardiomyocyte 
differentiation as early exposure to BMP and Wnt signals, affecting cardiac precursors, 
enhance cardiomyocyte and endocardial differentiation in at the expense of blood and 
vasculature.  Using flow cytometry to sort mesodermal populations, we isolated a 
temporally specific population of Flk1+ mesoderm capable of generating both 
endocardium and myocardium distinct from the Flk1+ mesodermal hemangioblast giving 
rise to hematopoietic and endothelial cell types.  Furthermore, clonal analysis established 
this population contains cardiovascular progenitors with cardiomyocyte, endocardial, 
endothelial, and smooth muscle potential.  Collectively, these studies provide evidence 
that endocardium and myocardium are derived from a common cardiovascular progenitor 
within the cardiac mesoderm. 
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Experimental Procedures 
 
ESC culture and differentiation 
 ESCs and PMEF feeders were maintained as described in the Experimental 
Procedures of Chapter III.  ESCs were induced to differentiate in hanging drops and 
suspension cultures as detailed in the Experimental Procedures of Chapter III.  For 
experiments with growth factor treatment, Wnt3A, Dkk-1, and Noggin/Fc were 
purchased from R&D systems.  Concentrations and timing of administration are 
discussing the Results section. 
 
Cell staining 
 Immunostaining, β-gal staining, and dual β-gal /immunoperoxidase staining was 
performed as described in Chapter III.  For area calculations, a single EB at D3-4 was 
plated into individual wells of a gelatinized 24-well dish and maintained under its 
specified conditions until D10.  The EB was fixed and stained for MHC with the MF20 
antibody, followed by single detection using a goat anti-mouse Alexa-555 secondary 
antibody.  Hoechst Dye 33342 (Molecular Probes) was used to stain nuclei and define the 
borders of the EB outgrowth.  MetaMorph v6.1 (Molecular Devices) was used to 
calculate MHC+ area per EB. 
 
Antibodies 
NFATc1 (mouse 7A6, BD Pharmingen, 1:200) 
Sacromeric myosin heavy chain (MHC; mouse MF20, DSHB, 1 µg/ml) 
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Cardiac troponin T (cTnT; mouse CT3, DSHB, 1 µg/ml) 
CD31/Pecam-1 (rat MEC13.3, BD Pharmingen, 1:500) 
β-Gal (chick, Abcam, 1:1,000 or rabbit, Cappel, 1:5,000) 
Smooth muscle myosin heavy chain (SM-MHC; rabbit, Biomedical Technologies Inc., 
1:100) 
 
Fluorescence activated cell sorting (FACS)  
D3.5 EBs were dissociated using cell disassociation buffer (Gibco) for 30 minutes 
at 37˚C, then resuspended in ice cold FACS buffer prepared from Hanks Buffered Salt 
Solution (HBSS) with 2% FBS (HyClone), and 25 mM HEPES, and filtered through a 42 
µm sieve to produce a single cell suspension.  Cell density was adjusted to 1x106 per 100 
µl before treatment with an antibody against CD16/CD32 for 10 minutes (mouse, 
Ebioscence, 1 µg/ml) to block nonspecific binding. For double staining of D3.5 EBs, 
biotinylated Flk1 (mouse Avas12.1, BD Pharmingen, 1 µg/ml) and E-cadherin (rat 
DECMA, Sigma, 1 µg/ml) were applied directly to blocked cells and incubated for 45 
minutes on ice.  Single staining of D4.5 ECDlowFlk1low cell cultured O/N for Flk1 omitted 
E-cadherin.  Cells were washed twice with FACS buffer, and then pelleted by 
centrifugation for 5 minutes at 500xg.  Cells were again resuspended at a density of 1x106 
per 100 µl before staining with goat anti-Rat Alexa-488 (Molecular Probes, 0.5 µg/ml) 
and streptavidin-conjugated APC (Molecular Probes, 0.5 µg/ml) for 30 minutes on ice.  
Samples were washed and brought to a density of 3x106 per 1ml for FACS and stained 
with propidium iodide (PI) (Molecular Probes, 1:1000).  PI, which crosses the plasma and 
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nuclear membranes, intercalates into double stranded DNA of dead cells and allows for 
their exclusion from analysis and collection. 
For each sort, an unstained control was prepared consisting of dissociated cells 
processed without primary antibodies in order to compensate for autofluorescence and for 
nonspecific binding of secondary antibodies.  Single color controls, cells treated with 
only one secondary antibody, were prepared to optimize the voltages of the photo 
multiplier tube for each fluorochrome.  In addition, a PI control was prepared from the 
unstained control to adjust for cell death. 
Cells were sorted on a FACSAria (Becton Dickinson) using FACSDiva 6.0 for 
data collection at the VMC Flow Cytometry Shared Resource.  The VMC Flow 
Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (P30 
CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404).  Gated 
cell fractions were collected into DM supplemented with additional 20% FBS and stored 
on ice. 
 
OP9 culture 
 OP9 cells were obtained from the American Types Culture Collection (ATCC) 
and plated on gelatinized 100-mm Poly-D-Lysine treated dishes in Minimum Essential 
Medium Alpha Modification (α-MEM) supplemented with 10% FBS (HyClone), 2 mM 
L-glutamine, 100 U/ml Penicillin/Streptomycin, and 100 µM β-mercaptoethanol at 37˚C, 
5% CO2.  From a single vial, cells were plated to a single dish, passaged at 90% 
confluence, and then passaged every two days 1:3 or 1:4.  Cells were frozen 1:2 by 
mixing resuspended cells in OP9 media 1:1 with 2x Freezing media (60% OP9 media, 
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20% FBS, 20% DMSO).  Cryovials were placed in an isopropanol freezing container and 
stored at -80˚C for 1-3 days before transfer to liquid nitrogen.  Prior to their use as 
feeders, OP9 cells were exposed to 6-7 minutes (10-12 Gyr) of Cesium-137 irradiation to 
inactivate cell division.  The use of irradiated cells increased the number of differentiated 
cell types from expanded mesodermal populations. 
 
Cardiac and hematopoietic/vascular colony assays 
ECDhighFlk1low, ECDlowFlk1high, and ECDlowFlk1low fractions were plated at a 
density of 5x103 cells/cm3 onto irradiated OP9 stromal cells.  Cells were cultured for 6 
days in ESC differentiation media (DM) consisting of IMDM supplemented with 15% 
FBS, 2 mM L-glutamine, 100 U/ml Penicillin/Streptomycin, 200 µg/m transferrin, 0.5 
mM L-ascorbic acid, and 4.5x10–4 M monothioglycerol.  For secondary Flk1 sorting, 
ECDlowFlk1low cells were grown for 24 hours on OP9 stromal cells in serum-free DM 
with 15% Knockout Serum replacement (Invitrogen) substituted for FBS, as well as 
bFGF (30 ng/ml) and VEGF (5 ng/ml) (R&D Systems).  Resorted Flk1 positive and 
negative cells were plated at a density of 1x103 cells/cm3 in serum-free DM 
supplemented with VEGF (5 ng/ml), bFGF (30 ng/ml), BMP4 (50 ng/ml), and Dkk-1 
(150 ng/ml).  Contracting colonies were scored after 6 days in culture.  For clonal 
expansion, single Flk1+ cells from the D4.5 ECDlowFlk1low population were distributed 
into 96-well plates seeded with OP9 stromal cells.  After 7 days in culture, the cells were 
fixed, stained, and scored. 
 
 
             114
 Reverse Transcriptase PCR (RT-PCR) 
RNA and cDNA were prepared as described in Chapter III.  Semi-quantitative 
RT-PCR was performed using REDTaq (Sigma) and 0.5 µM of each primer gene-specific 
primers, and 50 ng cDNA under the following cycling conditions: 94°C for 2 minutes, 
followed by 30 cycles of amplification (94°C denaturation for 30 seconds, 60°C 
annealing for 30 seconds, 72°C elongation for 60 seconds), then a final incubation at 
72°C for 10 minutes.  Products were run on a 1.5% agarose gel at 4˚C at 80-90V. 
 
Quantitative real-time PCR (qRT-PCR)  
All qRT-PCR was performed using a Light Cycler (Roche) with the Light Cycler 
DNA FastStart SYBR Green I Kit, 0.5 µM of each primer, and 100 ng cDNA.  Gene 
specific primer sets used for these experiments are listed in Table 4.1.  Each sample was 
done in triplicate and relative expression was calculated as ∆2-ct with HPRT as the internal 
control. 
 
Statistics 
All statistical analyses performed represent two-tailed Student’s t-test carried out 
using Graphpad Prism for Macintosh 4.0. 
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Table 4.1. Oligonucleotides for RT-PCR gene expression analysis of Flk1 and E-
cadherin populations and their derivatives. 
   
Gene Forward Primer Reverse Primer 
Rex1 5’ CGT GTA ACA TAC ACC ATC CG 3’ 
5’ GAA ATC CTC TTC CAG AAT 
GG 3’ 
Pax6 5’ GCT TCA TCC GAG TCT TCT CCG TTA G 3’ 
5’ CCA TCT TTG CTT GGG AAA 
TCC G 3’ 
Sox17 5’ TGC CCT TTG TGT ATA AGC CCG AGA 3’ 
5’ GGG TAG TTG CAA TAG 
TAG ACC GCT 3’ 
FoxA2 5’ AAG GGA AAT GAG AGG CTG AGT GGA  
5’ ATG ACA GAT GAC TGT 
GGC CCA TCT 3’ 
Brachyury 5’ ACA GAT CAT GTT AAA CTC CTT GCA T 3’ 
5’ TAC ATC TTT GTG GTC GTT 
TCT TTC T 3’ 
Runx1 5’ GCC TCT CTG CAG AAC TTT CC 3’ 
5’ GAC GGC AGA GTA GGG 
AAC TG 3’ 
Scl/Tal1 5’ GCC GGT CTG CCT ACA CCG GC 3’ 
5’ CCC CGA AGC TGG GTT TCC 
CGG 3’ 
Nkx2.5 5’ ACC TTT CTC CGA TCC ATC CCA CTT 3’  
5’ GCG TTA GCG CAC TCA CTT 
TAA TGG 3’  
Tbx5 5’ TCT CCT TCT GGT TTG GTT CTG CCT 3’  
5’ TGT CAC CCA GGG CTC TTT 
CAG TTT 3’  
cTnT 5’ CCG GCG TGA GGA GGGA GGA GAA 3’ 
5’ AGG GGG CAC AGC TTT 
GAC GAG AA 3’ 
βMHC 5’ AGC CGC GCC AGT ACT TCA TAG GTG 3’ 
5’ TGT TCT TTT CCA GCC AGC 
CCA TAA 3’ 
GATA4 5’ TTC CTT GTC CTC ATC ACC CAC AGA 3’  
5’ GAC AA TGT TAA CGG GTT 
GTG GAG G 3’  
isl1 5’ TGT CAG GAG ACT TGC CAC TTT 3’  
5’ GCC AAA CGT TTA TTA GTG 
AAA TAG TCC TG 3’  
Mef2c 5’ TGT ATA GAG GTT TGG ACA GAC CCG 3’  
5’ TGT TAG CTC TCA AAC GCC 
ACA C 3’  
NFATc1 5’ GGT GGC CTC GAA CCC TAT  C 3’  
5’ TCA GTC TTT GCT TCC ATC 
TCC C 3’ 
Nrg1 5’ CCA ATG GCC ACA TTG CCA ATA GGT 3’  
5’ AGC CTG GCC TGT AAT TCT 
TCC TGT 3’  
Flk1 5’ GGT TCT CTG TCA AGT GGC GGT AAA 3’ 
5’ AGC ACA CAG GCA GAA 
ACC AGT AGA 3’  
VECAD 5’ AAC TCA CCC TCC TTG TGG AAT CCT 3’  
5’ ACA TCT CAT GCA CCA 
GGG TGA CTA 3’  
CD31/Pecam-1 5’ ATC CGG AAG GTC GAC CCT AAT CTC AT 3’ 
5’ ATA CCC AAC ATG AAC 
AAG GCA GCG 3’  
βH1-globin 5’ CTC AAG GAG ACC TTT GCT CA 3’ 
5’ AGT CCC CAT GGA CTC 
AAA GA 3’  
GATA1 5’ CAT TGG CCC CTT GTG AGG CCA G 3’ 
5’ CGC TCC AGC CAG ATT 
CGA CCC 3’ 
HPRT 5’ AGT CAA CGG GGG ACA TAA AA 3’ 
5’ TGC ATT GTT TTA CCA GTG 
TCA A 3’ 
 
             116
Results 
 
Serum depletion during ESC differentiation reveals an inverse relationship between 
cardiac and hematopoietic/vascular populations 
 
 The spatial-temporal association between endocardium and myocardium during 
embryogenesis and in ESC differentiation is suggestive of endocardiogenesis being 
intrinsically linked to cardiomyocyte differentiation, yet the mechanisms orchestrating 
this relationship remain unclear. The generation of cardiomyocytes from EBs is 
inefficient, and it has been hypothesized that serum, while vital to hematopoietic and 
vascular development, contains factors that inhibit myocardial differentiation.  Validating 
this concept, myocardial differentiation was found to vary indirectly with the percentage 
of serum present in culture media, where reductions in serum enhanced cardiomyocyte 
differentiation (Passier et al., 2005).  To determine the effect alternations in 
cardiomyocyte differentiation had on endocardiogenesis, ESCs were differentiated under 
culture conditions that have been described to enhance myocardial specification. 
 EBs were formed in suspension with DM containing 15% serum, and at D3 were 
plated on gelatinized tissue culture dishes in DM containing either 15% serum or DM 
with only 1% serum.  EBs were taken at every two days from D0 until D10 for RNA 
isolation and qRT-PCR analysis of myocardial, endothelial, and endocardial gene 
transcripts.  Myocardial markers βMHC and cTnT were increased nearly 2-fold by D8 in 
the 1% serum condition compared to EBs differentiated in media containing 15% serum 
(Fig 4.1A).  In contrast, vascular markers such as VE-cadherin and Flk1 during its 
vascular restricted phase, are decreased with reduced serum (Fig 4.1B).  Nkx2.5, though 
not different at D6, was enhanced with reduced serum at D8.  NFATc1, as a marker of 
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Figure 4.1. Endocardial, myocardial, and endothelial differentiation in reduced serum 
conditions. EBs cultured in media containing 15% serum  (solid lines) or with reduced 
serum  (RS; 1% serum, dotted lines) were taken at every two days from D0 until D10 for 
RNA isolation and qRT-PCR analysis of myocardial, endothelial, and endocardial gene 
transcripts. A. Myocardial markers βMHC (purple) and cTnT (orange) were increased 
nearly 2-fold by D8 in reduced serum. B. Vascular genes VE-cadherin (dark red) and 
Flk1 (blue) were decreased when differentiated in media with reduced serum.  C. The 
early cardiac gene Nkx2.5 (red), though no different at D6, was enhanced with reduced 
serum at D8, while NFATc1 expression was elevated at later stages with 1% serum. 
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endocardium, was elevated at later stages in EBs cultured in media containing 1% serum 
(Fig. 4.1C).  This pattern of differentiation demonstrates that under reduced serum, 
endocardial and myocardial differentiation in increased, while vascular development is 
inhibited. 
 
Endocardial cells respond to BMP and Wnt signaling as a cardiac lineage  
To further evaluate whether endocardium is a specialized cardiac cell or a 
spatially distinct endothelial cell, differentiating EBs were treated with soluble factors 
shown to affect cardiac or hematopoietic/vascular development.  For these studies we 
focused on the BMP and Wnt signaling families, as both have been demonstrated to play 
vital roles in vivo and in vitro in cardiovascular cell specification from mesoderm.  BMP 
and Wnt signaling are also remarkable in that activators and inhibits have been found to 
affect cardiomyocyte specification and blood/vascular specification differently.  BMP 
signaling has been implicated in extraembryonic mesoderm development where it is 
essential for hematopoiesis, but also is involved in cardiac specification as a growth 
factor from the ectoderm (Snyder et al., 2004).  Noggin, a biologic inhibitor of BMP 
signaling, has been shown to have a biphasic role in cardiomyocyte specification; Noggin 
produced by the notochord inhibits cardiac differentiation at the midline, while transient 
expression of Noggin in the cardiogenic mesoderm and AVE appears to be necessary for 
myocyte differentiation (Yuasa et al., 2005).  In ESC differentiation, early Noggin 
treatment has been documented to enhance cardiomyocyte differentiation at the 
determinant of hematopoietic and vascular lineages (Lindsley et al., 2006; Yuasa et al., 
2005).  Thus while BMP signaling is critical for mesodermal formation and subsequent 
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cardiomyocyte differentiation, BMP inhibition might also play a role in priming 
mesoderm towards a cardiac lineage as well as blocking it from progressing to a 
hematopoietic and vascular lineage.  In many cellular contexts, Wnt signaling and its 
inhibition are effective modulators of gene expression.  During embryogenesis, Wnt1, -
3A, and -8 produced by the neural tube inhibit cardiogenesis at the midline, while Dkk-1 
and Crescent from the endoderm represent inductive signals.  These effects have also 
been documented in vitro with ESC differentiation where Wnt inhibition enhanced 
cardiogenesis, while Wnt receptor activation has an opposing effect, increasing non-
cardiac mesodermal derivative and neural cell differentiation. (Naito et al., 2006).   
Modifying previously described treatment regimes we dosed EBs during two 
windows of development, either early or late, and analyzed cardiomyocyte, endocardial, 
hematopoietic, and endothelial differentiation after 10 days in culture (Fig 4.2A).  Under 
the early treatment paradigm, EBs were treated with recombinant Noggin/Fc (150 ng/ml) 
in serum containing differentiation media (DM) from day 0 until plating at day 4 
(Lindsley et al., 2006).  Late treatments with either Wnt3A (100 ng/ml) or the Wnt 
inhibitor dickkopf-1 (Dkk-1; 200 ng/ml) were added to DM at day 5 until day 7 (Naito et 
al., 2006).  Early Noggin/Fc exposure significantly enhanced cardiomyocyte 
differentiation, measured by changes in MHC+ area, with an approximate 3-fold increase 
over controls (16.2%±3.2% vs. 6.0%±1.2%) consistent with previous studies.  Dkk-1 
treatment at D5 had a similar effect (11.4%±1.6%), while late Wnt activation with 
Wnt3A suppressed myocyte formation (2.6%±0.5%) (Fig. 4.2B).  Quantitative RT-PCR 
confirmed an inverse relationship between cardiac cells and the hematopoietic/vascular 
lineage.  Markers of cardiomyocyte specification and maturation, Nkx2.5 and cTnT, were 
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Figure 4.2. Effect of BMP and Wnt signals on cardiac, hematopoietic, and vascular 
specification.  A. Schematic documenting timing of BMP and Wnt treatments compared 
to EB culture conditions. NFATc1-nuc-LacZ derived ESCs were differentiated with 
recombinant Noggin/Fc (150 ng/ml) from D0 through D4, or Wnt3A (100 ng/ml) or Dkk-
1 (200 ng/ml) from D5-D7. B. Individual EBs from different treatments were plated into 
24-well dishes and subjected to morphometric analysis of MHC at D10. Values represent 
the ratio of MF20+ area to total EB area. *=p < .05 vs. control, N=8. Error bars indicate 
SEM. Early Noggin/Fc and late Dkk-1exposure significantly enhanced cardiomyocyte 
differentiation, while late Wnt activation with Wnt3A suppressed myocyte specification. 
C. Representative images from control (i), Noggin/Fc (ii), Wnt3A (iii), and Dkk-1 (iv) 
treated D10 NFATc1-nuc-LacZ derived EBs stained for β-gal (green), MHC (red), and 
CD31 (blue). β-gal+/CD31+ endocardial cells increased with early addition of Noggin/Fc 
or late Dkk-1. 
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Figure 4.3. Molecular expression analysis of cardiac, hematopoietic, and vascular 
genes in Noggin, Wnt3A, and Dkk-1 treated EBs. Fold change in mRNA transcripts by 
qRT-PCR of endocardial (NFATc1), cardiac (Nkx2.5, cTnT), vascular (CD31, VE-
cadherin) and hematopoietic (βH1-globin, GATA1) genes in D10 EBs treated with 
Noggin/Fc (green) from D0 through D4, or Wnt3A (blue) or Dkk-1 (red) from D5-D7. 
Error bars indicate SEM.  Quantitative RT-PCR confirmed an inverse relationship 
between endocardial cells and the hematopoietic/vascular lineage. With early Noggin/Fc 
treatment and late Dkk-1, endocardial specification increased with cardiomyocyte 
markers, corresponding to a reduction in hematopoietic/vascular gene expression. In 
contrast, late Wnt3A treatment enhanced gene expression from the blood and endothelial 
lineages and inhibited cardiac gene expression. 
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upregulated with early Noggin/Fc and late Dkk-1, while suppressed with Wnt3A. 
Vascular (CD31, VE-cadherin) and hematopoietic (βH1-globin, GATA1) markers were 
upregulated with late-phase addition of Wnt3A (Fig. 4.3).  
Given the relationship between cardiomyocytes and endocardial cells in EBs, we 
hypothesized that an increase in endocardium would accompany myocyte enrichment.  
NFATc1-nuc-LacZ BAC ESCs were differentiated to examine endocardiogenesis by 
immunofluorescence.  β-gal+/CD31+ endocardial cells increased with early addition of 
Noggin/Fc or late Dkk-1.  There was a noticeable decrease in vascular plexus formation, 
though β-gal+/CD31+ endocardial cells were still present (Fig. 4.2C, compare panel i vs. 
ii & iv).  This pattern was reversed with Wnt3a, where myocardium and endocardium 
were largely absent (Fig. 4.2C, panel iii).  NFATc1, as a marker of endocardium, 
increased with Noggin/Fc and Dkk-1 similar to myocytes, not with other endothelial cells 
(Fig. 4.3).  These findings indicate endocardium is specified as a cardiac lineage, not 
from the hematopoietic/vascular lineage.  Also, as the effect of growth factor treatment is 
effective prior to the emergence of cardiac cell types, it suggests that BMP and Wnt 
signaling acts on a precursor population of endocardium and myocardium, but this data 
does not clarify whether endocardial cells are derived from a common precursor as 
cardiomyocytes or develop in a parallel and dependent pathway.  
 
Endocardium is specified as a cardiac lineage distinct from vascular endothelium 
Although our data from Noggin/Fc and Dkk-1 treated EBs indicates endocardium 
is specified as a cardiac cell type distinct from peripheral vasculature, a level of 
uncertainty is introduced by conducting these studies using whole EBs.  To more 
             123
precisely define endocardiogenesis from mesodermal populations as it relates to 
cardiomyocyte and hematopoietic/vascular differentiation, we sorted EBs at D3.5 with 
the cell surface markers Flk1 and E-cadherin.  Lineage tracing studies have shown 
components of the cardiovascular system are derived from Flk1+ mesoderm (Ema et al., 
2006; Fehling et al., 2003).  In addition, Flk1 has been used successfully to isolate 
hemangioblast and cardiac populations from differentiating ESCs.  As an additional 
marker, we chose E-cadherin (ECD), primarily because exfoliating mesodermal cells 
downregulate ECD as they exit the primitive streak (Ciruna and Rossant, 2001; Huber et 
al., 1996).  The timing for disassociation of EBs to isolate populations with or without 
Flk1 and ECD expression was determined from the literature and from pilot studies.  For 
consistency in cell number and size, EBs were formed in hanging drops, and then assayed 
for Flk1 expression at D2.5, D3.5, D4.5, and D5.5.  The number of cells seeded to 
generate each hanging drop impacted Flk1 expression at these time points, with EBs 
seeded with 100 cells possessing a greater number of cell expressing Flk1 than those 
formed from 500 or 1000 cells (Table 4.2).  For these experiments, we used 500 cells to 
initiate EB formation despite exhibiting lower numbers of Flk1+ cells, as EBs formed 
from 100 cells possessed far fewer cells after 3.5 days.  Next we examined ECD 
expression in undifferentiated ESCs and EBs at D2.5, D3.5, D4.5, and D5.5.  ECD was 
expressed almost alls cells from D0 until D3, however from D2.5 to D3.5 there was a 
precipitous drop from >90% to 15-20% ECD+ cells (Table 4.3).  The timing of this drop, 
consistent with other studies of ECD in early EBs, marks the transition of mesoderm out 
of the PS streak stage of gastrulation (Ng et al., 2005).  After D3.5, the number of ECD+ 
cell plateaued at 15-20%. 
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Table 4.2. Percentage of Flk1 positive cells at early time points in embryoid body 
differentiation. EBs were formed in hanging drops with either 100, 500, or 1000 cells per 
drop.  EBs were disassociated at particular time points and analyzed by flow cytometry to 
determine the number of cells expressing Flk1. 
 
 
 
 % Flk1 Positive Cells 
EB Day 100 cells 500 cells 1000 cells 
D2.5 3.2 ± 1.5 2.7 ± 2.1 5.1 ± 0.5 
D3.5 48.2 ± 5.3 32.2 ± 3.5 11.6 ± 4.1 
D4.5 34.5 ± 4.1 17.7 ± 2.5 12.5 ± 1.9 
D5.5 19.3 ± 2.2 7.3 ± 2.2 4.2 ± 0.9 
 
 
 
 
  
Table 4.3. Changes in E-cadherin and Flk1 expression during early embryoid body 
differentiation. EBs were formed in hanging drops of 500 cells per drop.  EBs were 
disassociated at particular time points and analyzed by flow cytometry to determine the 
number of cells expressing Flk1 and E-cadherin. No dual Flk1+ and E-cadherin+ cells 
were detected. 
 
 
 
 % Positive Cells 
EB Day E-cadherin Flk1 
ESC 98.6 ± 0.4 0.8 ± 0.3 
D2.5 94.1 ± 2.3 3.1 ± 1.1 
D3.5 22.8 ± 2.9 33.6 ± 4.9 
D4.5 14.1 ± 2.5 19.3 ± 3.1 
D5.5 13.6 ± 3.0 12.4 ± 2.9 
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Three distinct populations of cells were present in D3.5 EBs: ECDhighFlk1low, 
ECDlowFlk1high, and ECDlowFlk1low; Flk1 and ECD were not co-expressed at high levels 
(Fig. 4.4A).  Isolated ECDhighFlk1low cells expressed the primitive ectoderm marker Rex1, 
the neuroectodermal gene, Pax6, and markers of endoderm/mesendoderm, Sox17 and 
FoxA2.  The ECDlowFlk1high fraction possessed markers of the early hematopoietic and 
vascular lineage (Runx1 and Scl/Tal1), and the early mesoderm gene brachyury (Fig 
4.4B).  These finding indicate this subpopulation represents the hemangioblast 
population, present in vivo in extraembryonic mesoderm.  Cells negative for both Flk1 
and ECD at D3.5 expressed brachyury and FoxA2, but not Runx1 or Scl/Tal1, suggesting 
these cells represent non-hematopoietic/vascular mesoderm. 
To determine the potential of these mesodermal populations, we deposited 
ECDlowFlk1low and ECDlowFlk1high cells onto OP9 stromal cells in ESC differentiation 
media.  Isolated from mouse calvaria, OP9 cells have been shown to support 
differentiation of hematopoietic/vascular and cardiac cell types (Nishikawa et al., 1998; 
Yamashita et al., 2005). ECDhighFlk1low cells were excluded due to the presence of 
undifferentiated cells and ectodermal/endodermal lineages.  After three days in culture, 
the ECDlowFlk1high population developed into “blast-like” groups of cells, while 
ECDlowFlk1low cells formed densely packed colonies (Fig 4.5A,B).  After 6 days, 
contracting colonies appeared from ECDlowFlk1low cells, not from ECDlowFlk1high cells 
(Fig. 4.5C,D).  In addition, X-gal staining of D3.5 ECDlowFlk1low and ECDlowFlk1high cell 
populations cultured for 6 days indicated endocardial differentiation was only detected in 
cells cultured from the D3.5 ECDlowFlk1low fraction (Fig. 4.5D).  Immunofluorescence 
confirmed that ECDlowFlk1high cells did not generate any cardiomyocytes (Fig. 4.5E,F). 
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Figure 4.4. Isolation of hematopoietic/vascular and cardiac mesodermal precursors 
from differentiating ESCs. A. Serum stimulated embryoid bodies were disassociated and 
sorted at D3.5 by flow cytometry into fractions based on expression of Flk1 and ECD. B. 
RT-PCR of isolated D3.5 populations for markers of primitive ectoderm, neuroectoderm, 
endoderm, mesoderm, the early hematopoietic/vascular lineage. Controls included D3.5 
presort EBs and H2O. C. Gene expression analysis of ECDlowFlk1high and ECDlowFlk1high 
populations after 6 days of culture on OP9 stromal cells demonstrating blood and 
vascular differentiation in the ECDlowFlk1high cells, with endocardial and myocardial gene 
expression restricted to the ECDlowFlk1low population. D3.5 presort EBs, D10 EBs 
cultured intact on gelatin, and H2O served as controls. 
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Figure 4.5. Characterization of endocardial, cardiomyocyte, and vascular derivatives 
from D3.5 ECDlowFlk1high and ECDlowFlk1low cell populations. A,B. ECDlowFlk1high and 
ECDlowFlk1low fractions were deposited onto OP9 stromal cells serum-containing 
differentiation media.  Phase contrast images of characteristic “blast-like” ECDlowFlk1high 
cells (A) and densely packed ECDlowFlk1low cells (B) after 3 days of culture. C,D. After 6 
days of culture on OP9 feeders, contracting regions (black arrowheads) appeared from 
ECDlowFlk1low cells (D), but not in ECDlowFlk1high cells (C). X-gal staining demonstrated 
endocardial differentiation was only detected in ECDlowFlk1low cultured cell fractions. 
E,F. Immunofluorescence of CD31/Pecam-1 (green) and MHC (red) expression in 
cultured D3.5 ECDlowFlk1high and ECDlowFlk1low populations after 6 days on OP9 cells. 
No cardiomyocyte differentiation was detected from the ECDlowFlk1high cell population. 
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Molecular expression analysis of D3.5 ECDlowFlk1low and ECDlowFlk1high cells 
after 6 days demonstrated that cardiac genes (Nkx2.5, βMHC, Tbx5, cTnT, GATA4, and 
Mef2c) present in ECDlowFlk1low colonies, were absent or reduced in the D3.5 presort and 
ECDlowFlk1high fraction (Fig. 4.4C).  While both sort groups displayed vascular 
differentiation, expressing Flk1, VE-cadherin, and CD31/Pecam-1, only the 
ECDlowFlk1high displayed markers of hematopoietic development (βH1-globin and 
GATA1). In contrast, NFATc1 and neuregulin1 (Nrg1), markers of the endocardium, were 
only observed in colonies generated from ECDlowFlk1low cells with myocardial 
differentiation.  These studies clarify that endocardium is not specified from the 
mesoderm that generates the hemangioblast population in contrast to zebrafish model 
where endocardium shares a common precursor with the hematopoietic lineage. 
 
Endocardium and myocardium are derived from an Flk1+ mesoderm population with 
cardiovascular potential 
 
Specification of cardiac mesoderm follows differentiation of the blood and 
vascular lineages in murine embryogenesis and EBs (Iida et al., 2005; Kattman et al., 
2006; Tam et al., 1997).  To determine whether this explained the absence of cardiac 
derivatives from the D3.5 ECDlowFlk1high subpopulation, we re-cultured this fraction in 
DM with bFGF (30 ng/ml) and VEGF (5 ng/ml) on OP9 stromal cells, and resorted for 
Flk1 expression 24 hours later (Fig. 4.6A).  Isolated cells were cultured on OP9 stromal 
cells and cultured in serum-free media supplemented with VEGF (5 ng/ml), bFGF (30 
ng/ml), BMP4 (50 ng/ml), and Dkk-1 (150 ng/ml), as previously described (Kattman et 
al., 2006).  As discussed in Chapter I, each of these growth factors has been shown to be 
essential for cardiac specification from mesoderm. 
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Figure 4.6. Isolation and characterization of Flk1+ multipotent cardiovascular 
progenitors. (A) D3.5 embryoid bodies were differentiated in serum-containing media, 
disassociated and sorted with Flk1 and ECD. ECDlowFlk1low cells were cultured for 24 
hours on OP9 cells in serum-free media with bFGF and VEGF before undergoing a 
second sort with Flk1. (B) Resorted Flk1 positive and negative cells were plated at a 
density of 1x103 cells/cm3 onto OP9 cells in a 24-well dish in serum-free media 
supplemented with VEGF, bFGF, BMP4, Dkk-1. The number of contracting colonies per 
well was scored after 6 days in culture. *=p < .05 vs. control, N=12. Error bars indicate 
SEM. (C) Dual β-gal/immunoperoxidase staining of D4.5 Flk1+ and Flk1- populations 
from NFATc1-nuc-LacZ BAC ESCs after 6 days of culture to demonstrate cardiomyocyte 
(cTnT, brown) and endocardial (β-gal; blue) differentiation.  
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The number of contracting colonies present after 6 days of culture was 
significantly higher in the D4.5 Flk1+ population compared to the D4.5 Flk1- cells (Fig. 
4.6B).  Dual β-gal/immunoperoxidase staining of D4.5 Flk1+ and Flk1- populations 
derived from NFATc1-nuc-LacZ BAC ESC demonstrated cardiomyocyte differentiation 
in D4.5 Flk1+ cells with and without endocardial differentiation; no significant 
endocardial or myocardial differentiation was seen from the D4.5 Flk1- cells (Fig. 4.6C).  
Examining D4.5 Flk+ cells after 2, 4, and 6 days in culture, we observed early cardiac 
transcription factors Nkx2.5 and isl1 were detectable by day 2 (Fig. 4.7). While Nkx2.5 
expression increased, isl1 was downregulated at later time points.  Tbx5 and Mef2c, 
markers of the primary and secondary heart fields, respectively, were readily detectable 
by day 4.  This indicated not only that D4.5 Flk1+ cells contain primary and secondary 
heart field precursors, but also that culture conditions supported their development. In 
addition, cardiac contractile proteins (βMHC and cTnT) were present, indicting functional 
maturation of cardiomyocytes.  Most importantly, genes restricted to endocardial 
endothelium, NFATc1 and Nrg1 were also present in cultures derived from D4.5 Flk1+ 
cells.  Vascular markers (Flk1, VE-cadherin, and CD31/Pecam-1) became more 
pronounced over the course of differentiation, while hematopoietic lineages (GATA1) 
were completely absent.  These findings indicate endocardium and myocardium are 
generated from an Flk1+ multipotent cardiovascular progenitor (MCP) population that 
arises from a temporally defined mesoderm population.  
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Figure 4.7. Temporal gene expression analysis of cultured Flk1+ MCPs. RT-PCR 
expression profile of D4.5 Flk1+ cells after 2, 4, and 6 days in culture examining 
endocardial, cardiac, vascular, and hematopoietic markers with D3.5 Flk1+ cultured for 6 
days, D10 EBs cultured intact on gelatin, and H2O as controls. Early cardiac transcription 
factors (Nkx2.5 and isl1) were detected at day 2. Nkx2.5 expression increased across the 
period of differentiation, while isl1 was downregulated. Markers of the primary and 
secondary heart fields (Tbx5 and Mef2c, respectively) were readily detectable by day 4.  
Cardiac contractile proteins (βMHC and cTnT) were present, indicting functional 
maturation of cardiomyocytes. Endocardial transcripts (NFATc1 and Nrg1) were also 
present in cultures derived from D4.5 Flk1+ cells.  Vascular markers (Flk1, VE-cadherin, 
and CD31/Pecam-1) became more pronounced over time, but hematopoietic lineages 
(GATA1) were not detected from Flk1+ MCPs. 
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Clonal analysis of Flk1+ MCPs indicate endocardium and myocardium share a common 
precursor 
 
As the D4.5 Flk1+ fraction could contain separate Flk1+ endocardial and 
myocardial precursors, we performed clonal analysis to determine the potential of a given 
cell.  Individual D4.5 Flk1+ cells from the NFATc1-nuc-LacZ BAC ESC line were 
deposited by flow cytometry into wells of a 96-well dish containing irradiated OP9 
feeders, and cultured in serum-free media supplemented with VEGF, bFGF, BMP4, and 
Dkk-1.  After 7 days, colonies were immunostained and scored for cardiomyocytes, 
endothelium, smooth muscle, and endocardium (MHC, CD31/Pecam-1, SM-MHC, and 
β-gal, respectively).  Nearly 50% (42 of 90) of colonies were positive for all four 
cardiovascular cell lineages (Fig. 4.8A,B). Endocardial differentiation was only detected 
in the presence of cardiomyocytes, never in their absence.  Also, not all endothelial cells 
that differentiated with cardiomyocytes were endocardial cells.  31 percent of colonies 
(28 of 90) consisted of only myogenic cell types, cardiomyocytes and smooth muscle, 
suggesting they were derived from a bipotential myogenic cell population.  Colonies of 
endothelium with or without smooth muscle represented another 15 percent.  The ability 
of individual Flk1+ cells to generate both myocardium and endocardium provides 
compelling evidence for the existence of a common mesodermal precursor. 
 
Discussion 
In these studies, we establish that endocardium and myocardium are derived from 
a common precursor in the cardiac mesoderm.  Using BMP and Wnt signaling to enhance 
myocardial specification at the expense of blood and vasculature, we demonstrated that 
endocardium is specified as a specialized cardiac subpopulation, and not spatially distinct 
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Figure 4.8.  Clonal analysis of endocardial and myocardial potential in Flk1+ 
multipotent cardiovascular progenitors (MCPs). A. Single D4.5 Flk1+ cells from 
NFATc1-nuc-LacZ BAC ESCs were deposited into 96-well plates seeded with OP9 
stromal cells in serum-free media supplemented with VEGF, bFGF, BMP4, and Dkk-1. 
After 7 days, colonies were stained and scored for the presence of endocardium (Ec), 
cardiomyocytes (Cm), endothelium (Et), smooth muscle (Sm). (B) Representative image 
of Flk1+ multipotent cardiovascular progenitor clone stained for endocardium (β-gal, 
green), cardiomyocytes (MHC), endothelium (CD31, blue), and smooth muscle (SM-
MHC, purple). 
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endothelial cell that migrates into juxtaposition with cardiomyocytes.  Endocardium is 
not specified from the Flk1+ mesodermal hemangioblast population giving rise to 
hematopoietic and endothelial lineages, but rather a temporal distinct Flk1+ mesodermal 
population capable of generating endocardium, myocardium, smooth muscle, and 
endothelium.  Most importantly, we provide evidence through clonal analysis of Flk1+ 
multipotent cardiovascular progenitors (MCPs) that endocardium and myocardium are 
derived from a common Flk1+ progenitor, confirming that in the mouse these two 
lineages do not originate as separate populations. 
The lineage classification of endocardium has remained undefined, with its 
obligatory role in cardiogenesis conflicting with its general classification as apart of the 
systemic vasculature, expressing pan-endothelial markers.  Treatment of differentiating 
ESCs with the BMP inhibitor Noggin/Fc and Wnt inhibitor Dkk-1 indicate that 
endocardial cells are specified with other cardiac cell types.  With early Noggin/Fc 
treatment and late Dkk-1, endocardial specification increased along with cardiomyocyte 
markers, corresponding to a reduction in hematopoietic/vascular gene expression. 
Conversely, late Wnt3A treatment enhanced gene expression from the blood and 
endothelial lineages and inhibited cardiac gene expression.  Recent studies have 
demonstrated reciprocal signaling between cardiac and hematopoietic/vascular lineages 
acts to restrict lineage-specific expression (Schoenebeck et al., 2007).  The Ets 
transcription factor Er71 has been identified to act on Flk1+ mesoderm to promote 
hematopoietic and vascular cell specification at the expense of cardiac differentiation 
(Lee et al., 2008).  Our results are consistent with other studies using ESC culture to 
document an inverse relationship between these two cell lineages, but extend that work 
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by examining the effect on endocardial specification (Lindsley et al., 2006; Naito et al., 
2006; Yuasa et al., 2005).  Our observation that endocardial cells are derived from a 
cardiac lineage would appear to conflict with the recent observation of Lee et al., who 
demonstrated that when Er71 expression is abolished in the mouse embryo, no 
endothelial or endocardial cells are formed, but myocardium differentiation still occurs 
(Lee et al., 2008).  However, because of Er71’s ubiquitous expression in endothelial cells 
within the embryo, the specific role of Er71 in endocardial differentiation is difficult to 
discern.  Nonetheless, these findings suggest that similar signaling pathways might 
induce endocardial and myocardial specification, and that the two lineages could be 
derived from a common progenitor. 
Flk1 identifies mesoderm that contributes to extraembryonic blood and vascular 
lineages, as well as endocardium and myocardium (Motoike et al., 2003; Shalaby et al., 
1995).  Progenitor populations of both lineages have been isolated from ESC derived EBs 
using Flk1 as a surface marker (Fehling et al., 2003; Kattman et al., 2006; Yamashita et 
al., 2005).  Flk1+ cells isolated from D3.5 EBs generated hematopoietic and vascular 
cells, but did not express endocardial or myocardial transcripts, which were enriched in 
the ECDlowFlk1low fraction.  These findings are in agreement of those made by Kouskoff 
et al., where cardiac specification was enriched in Flk1-GFP-Byr+ cells after Flk1 
depletion at D3.5, but absent when Flk1+ cells were isolated at D4-D4.5 (Kouskoff et al., 
2005).  From these observations and our RT-PCR analysis, we concluded that the 
ECDlowFlk1high population at D3.5 represented the mesodermal hemangioblast lineage 
derived from the anterior primitive streak, while the ECDlowFlk1low fraction contained 
cardiac mesodermal progenitors downregulating ECD as they migrated from the PS.   
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Given the temporal delay of cardiac progenitors exiting the PS compared to 
extraembryonic mesoderm, and that Flk1 is expressed only after exiting the PS, we 
resorted the ECDlowFlk1low population a day later (Ema et al., 2006; Kinder et al., 1999).  
This population of Flk1+ cells was enriched for cells with cardiac potential, forming 
contracting colonies 6-fold over colonies generated from D4.5 Flk1- cells.  Endocardial 
transcripts, NFATc1 and Nrg1, were detected after 5 or 6 days in culture, relatively late, 
though still following the onset of Nkx2.5 and isl1 expression.  We postulate that there is 
a critical threshold of myocardial cell differentiation necessary to induce endocardial 
differentiation.  After two days in culture expression of early myocardial markers Nkx2.5 
and isl1 could be detected, indicating both primary and secondary heart fields were 
represented, but expression of endocardial markers was minimal.  Similar to an analogous 
study of Flk1+ MCPs, isl1 was downregulated over the course of the course of 
differentiation, in a process previously attributed to inadequate culture conditions to 
support secondary heart field derivatives (Kattman et al., 2006).  However, we found that 
Mef2c, a gene expressed in secondary heart field derived myocardium, was upregulated at 
4 and 6 days of culture.  Expressed in secondary heart field progenitors, isl1 is absent in 
myocardial later in development (Cai et al., 2003).  In addition, the decline in isl1 could 
be attributed to the inclusion of Dkk-1 in the culture media, as Wnt signaling has been 
demonstrated to positive regulates isl1+ progenitor self-renewal (Qyang et al., 2007).  
Clonal populations derived from single D4.5 Flk1+ MCPs have the potential to 
form myocardium, endocardium, endothelium, and smooth muscle.  While myocardial 
and endocardial cells are both generated from these progenitors, not all observed 
endothelial cells are endocardium.  This diversity reflects the actual endothelial 
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heterogeneity seen the developing heart.  Interestingly, endocardial cells are only 
detected in the presence of cardiomyocytes.  This suggests that the endocardial cell 
lineage diverges from the cardiomyocyte lineage soon after the Flk1+ multipotent 
progenitors arrive at the cardiac mesoderm, as is supported by the early expression of 
NFATc1 at E7.5.  In addition, the lack of endocardial cells seen in the absence of 
cardiomyocytes implies that specification/survival of endocardium is dependent on 
signals from the myocardium, absent in our culture system.  While these studies indicate 
individual Flk1+ MCPs have the ability to generate multiple cell types, the mechanism(s) 
regulating the divergence of these lineages is unknown. It remains to be seen how 
endocardial cells retain activate endocardial transcripts, while myocardial cells initiate 
transcription of contractile proteins. 
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
The primary focus of this work has been to generate novel methods to specifically 
identify endocardial cells from other endothelium during early development and to 
establish new model systems to monitor endocardiogenesis in vivo and in vitro.  
Previously, the lineage classification of endocardium as either a specialized cardiac cell 
or a spatially distinct endothelial cell remained undefined, in part due to opposing models 
differing on whether endocardial cells were derived from a common multipotent 
progenitor in the cardiac mesoderm or from two distinct precursor populations.  In the 
studies presented here, we demonstrate that endocardium is specified as a cardiac cell 
lineage independent from other vascular populations.  Using a novel NFATc1-nuc-LacZ 
BAC transgenic reporter mouse line, we have specifically labeled endocardial cells as 
they emerge from the cardiac mesoderm, and tracked their participation in early cardiac 
morphogenesis.  With this reporter, in conjugation with other methods to monitor 
NFATc1 expression, we have characterized endocardiogenesis in differentiating murine 
ESCs, demonstrating that the close temporal-spatial relationship seen between 
endocardium and myocardium in the developing embryo is recapitulated in embryonic 
stem cell differentiation.  By isolating a temporally distinct populations of Flk1+ 
mesoderm, we show that endocardium is not specified with hematopoietic and 
endothelial lineages, but rather an Flk1+ mesodermal population capable of generating 
endocardium, myocardium, smooth muscle, and endothelium.  Our clonal analysis of 
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these Flk1+ multipotent cardiovascular progenitors (MCPs) indicate that endocardium 
and myocardium are derived from a common mesodermal progenitor and not from two 
separate, but parallel lineages, addressing a longstanding question in the field of 
cardiovascular development. 
 
Endocardial differentiation from multipotent cardiovascular progenitors (MCPs) 
The findings presented here build on recent work establishing a stepwise, 
hierarchical model of cardiac lineage diversification analogous to models of 
hematopoiesis in which all blood cells are derived from a single progenitor population.  
Gathering from studies of cardiac progenitors isolated from differentiating ESCs and in 
vivo fate mapping combined with our observations, we propose a working model of 
cardiac lineage specification from MCPs, where endocardial cells are a unique cardiac 
lineage (Fig. 5.1).  As discussed in Chapter I, Flk1+, Nkx2.5+, and isl1+ MCPs isolated at 
precise time points from EBs are capable of generating cardiomyocytes, endothelium, 
and smooth muscle.  Although these studies have significantly extended our 
understanding of cardiac lineage specification, they have either drawn no distinction 
between endocardium and endothelium or only obliquely addressed endocardiogenesis.  
In the analysis of expanded D4.5 GFP-Bry+ Flk1+ MCPs, Kattman et al. documented 
expression of the endocardial transcript Nrg1 in cardiac colonies grown in 
methylcellulose culture conditions, which was absent in blast colonies formed from the 
D3.5 GFP-Bry+ Flk1+ population (Kattman et al., 2006).  With this finding, the authors 
speculated that endocardial cells were derived along with cardiomyocytes from Flk1+ 
MCPs.  MCPs isolated from human ESCs with Flk1+ (KDR) and c-kit were also found to 
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Figure 5.1. Working model of endocardial differentiation from multipotent 
cardiovascular progenitors (MCPs).  See Chapter V text for further discussion. 
             141
express endocardial genes, specifically NFATc1 and Nrg1 upon further differentiation 
(Yang et al., 2008).  However, as they assessed endocardial differentiation only through 
RT-PCR analysis, it could not be definitely stated that endocardial cells were present in 
these cultures.  Our findings validate these assumptions by demonstrating that 
endocardial cells are derived from the same Flk1+ MCPs that produce the cardiomyocyte 
lineage. 
In agreement with other studies, our findings indicate that vascular and 
hematopoietic lineages are derived from an Flk1+ hemangioblast specified earlier than 
the Flk1+ MCP.  Contrary to what has been described in zebrafish and avian systems, the 
endocardial cell lineage is independent from blood cell and other vascular populations.  
Our model depicts that Flk1+ MCPs are defined prior to isl1+ and Nkx2.5+ MCPs.  
Absent at D3-4 as Flk1+ mesoderm emerges, isl1 and Nkx2.5 appear within two days in 
D4.5 Flk1+ MCP-derived colonies (Fig. 4.4).  This corresponds to the expression profiles 
of Flk1, isl1, and Nkx2.5 in vivo, where Flk1 is detected in mesoderm migrating away 
from the PS before isl1 and Nkx2.5 are upregulated in the PHF and SHF at the cardiac 
crescent stage.  Also, compared to the lineage potential of isl1+ MCPs, Flk1+ MCPs are 
less defined in terms of what type of cells they can generate; while 46% of D4.5 Flk1+ 
MCPs in our experiments formed cardiomyocytes, smooth muscle, and endothelial cells, 
only 12% of colonies generated from expansion of isl1+ MCPs possessed all three 
lineages (Moretti et al., 2006).  
As studies isolating isl1+ and Nkx2.5+ MCPs failed to distinguish endocardium 
from endothelium and examined no endocardial specific transcripts in their 
characterizations of cell lineages produced from these MCPs, it not possible to conclude 
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whether these progenitors have the potential to form endocardium (Christoforou et al., 
2008; Moretti et al., 2006).  However, fate mapping of Nkx2.5+ and isl1+ cardiac 
populations and expression analysis of the NFATc1-nuc-LacZ BAC transgenic indicates 
that both the PHF and SHF contribute to the endocardial lineage.  Accordingly, the 
endocardium is depicted in our model as being generated from an Flk1+, Nkx2.5+ and 
isl1+ MCP, but will require further analysis for confirmation of this hypothesis.   
Further specification of these MCPs establishes the endocardial, myogenic 
(smooth muscle and cardiomyocyte), and vascular lineages.  Aside from colonies 
containing all 4 lineages, the next most abundant types of colonies either consisted of 
only myogenic cell types, cardiomyocytes and smooth muscle, or endothelium with or 
without smooth muscle (Fig 4.8).  These findings are supported by work documenting 
Nkx2.5+ c-kit+ bipotential precursors of the myogenic lineage, as well as Flk1+ 
progenitors that yield vascular smooth muscle and endothelium (Ema et al., 2003; Wu et 
al., 2006; Yamashita et al., 2000).  In our clonal analysis, myocytes represented the 
majority of cells in each colony, with endocardial and endothelial cells seen as only a 
small fraction of the total number of cells.  Similarly, in colonies formed from of isl1+ 
MCPs, endothelial cells were the least well represented subpopulation of the three 
lineages analyzed, and in colonies formed from Nkx2.5+ MCPs, endothelial cells made 
up only 15-20% of the total number of cells per colony with the rest being 
cardiomyocytes and smooth muscle cells (Christoforou et al., 2008; Moretti et al., 2006).  
In our model, endocardium has been designated as an independent lineage, without a 
transitional state as with endothelium and smooth muscle derived from the MCPs.  Given 
the early appearance of endocardium in the cardiac crescent, in addition to its unique 
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expression profile, and our observation that endocardium, as opposed to endothelium, is 
never seen in conjugation with smooth muscle cells alone, we hypothesize that the 
endocardium is an entirely separate cardiac subpopulation. 
 
The transcriptional regulation of early NFATc1 expression in endocardium 
 The NFATc1-nuc-LacZ BAC transgenic mouse described in Chapter II 
specifically identified endocardial precursors at the earliest stage of cardiac development 
by faithfully recapitulating endogenous NFATc1 expression.  However, NFATc1’s 
expression profile is dynamic during early cardiogenesis; over time, NFATc1 is restricted 
from the entire endocardium to the valvular endocardium, before becoming undetectable 
by late-gestation (Fig. 2.6-8).  Thus utilizing a direct transcriptional reporter of NFATc1 
has the inherent drawback of not identifying all endocardial cells across the window of 
heart development.  The most efficient approach to permanently label all endocardial 
cells, from the earliest progenitors at E7.5 to the adult endocardium, and structural 
features derived from endocardial cells entails the use of Cre recombinase and a floxed 
lineage reporter.  By crossing an NFATc1-Cre BAC transgenic mouse with the R26R 
LacZ reporter, a permanent genetic marker, in this case β-gal, would presumably be 
expressed in all endocardial cells.  It remains unknown whether the adult endocardium is 
derived from the endocardium of the primitive heart tube or from other sources that 
contribute to this subpopulation in the mature heart.  Lineage analysis as described above 
could provide a definitive answer to this question. 
 An NFATc1-Cre BAC transgenic mouse could also be employed for tissue-
specific gene knockout analyses.  Presently, the only option available to excise floxed 
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alleles to elucidate the function of a particular gene in the developing endocardium relies 
on transgenic mice with Cre driven by vascular promoters, such as Tie1 and Tie2.  
However, this approach deletes the gene not only in the endocardium, but also in 
embryonic endothelium and the yolk sac vasculature, making resulting phenotypes 
difficult to interpret as endocardial-specific gene deficits (Jiao et al., 2006).  A Cre 
recombinase driven by the NFATc1 BAC would provide specificity unique among Cre 
deleter lines, targeting a subpopulation of the embryonic vasculature at its earliest stage 
of development.  An NFATc1-Cre BAC transgene was constructed and was injected into 
mouse pronuclei with the aim of generating a stable mouse line.  No PCR+ offspring 
were born after several rounds of injections.  Recently, we have renewed our efforts to 
generate this mouse line, and if successful, it will represent a powerful new tool for 
studying the function of genes in the endocardium of the developing heart. 
 While BACs carry a sizeable amount of the genetic information, including protein 
encoding regions and a large portion of their surrounding cis-regulatory elements, they 
still are finite.  Thus, the NFATc1 BAC utilized in these experiments represents a starting 
point for deletional analysis to locate the regulatory domain necessary to govern 
expression in endocardial precursors.  Two different, but complementary approaches 
would be appropriate for these studies.  Either the galK system could be employed to 
generate large-scale deletions in the BAC, or fragments from the 5’ UTR could be 
subcloned in front of a HSP promoter and a reporter gene (Warming et al., 2005).  
Previous enhancer studies have relied on mouse transgenesis to evaluate fragments for 
proper expression, and while that is possible in this case, this approach requires 
significant time and financial commitment.  With the characterization of 
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endocardiogenesis in EBs, fragments could be efficiently evaluated in ESCs prior to final 
confirmation in mice.  Identification of the regulatory region that controls early 
endocardial expression of NFATc1 could provide valuable information regarding the 
transcriptional control of endocardial differentiation.  An analogous study utilizing the 
method described here isolated a SHF enhancer from a Mef2c BAC and demonstrated the 
mechanism by which early cardiac transcription factors, isl1 and GATA4 modulate 
Mef2c expression (Dodou et al., 2004).  As virtually nothing is known regarding the 
transcriptional control of early NFATc1 expression and endocardial differentiation, 
identification and mutational analysis of putative transcription factor binding sites within 
this regulatory element might provide new targets for study. 
 
Characterization of ESC-derived endocardial cells 
 The differentiation of ESCs obtained from NFATc1-nuc-LacZ BAC transgenic 
mice and ESCs carrying stable BAC transgenes provides evidence that the NFATc1+ 
cells seen in EBs represent endocardial cells.  However, as both cardiomyocytes and 
endothelial cells formed in EBs have been determined to maintain immature phenotypes, 
it remains unclear whether these ESC-derived endocardial cells are functional.  To 
characterize further endocardial cells generated from EBs, we had planned to utilize 
ESCs with an NFATc1 BAC fluorescent reporter to isolate cells by FACS.  Though 
technical issues have prevented significant progress at this time, several lines of 
investigation are possible in the near future.  Given an ESC line with a working NFATc1-
Venus-yfp BAC transgene, YFP+ cells also positive for CD31/Pecam-1 could be 
distinguished and isolated from cells only expressing CD31/Pecam-1, allowing direct 
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comparisons of endocardial cells from endothelium.  RNA harvested from these two 
subpopulations could then be subjected to microarray analysis to compare and contrast 
their expression profiles.  The use of polony multiplex analysis of gene expression 
(PMAGE), a strategy that combines tagged beads with serial analysis of gene expression 
(SAGE) sequencing, would be able to detect rare transcripts and avoid issues with cross-
hybridization that can lead to errors seen with microarrays (Kim et al., 2007).  
Transcriptional profiling of these endocardial cells could provide new insights into how 
the endocardium is specified and identify genes involved in that process. 
 The functional capacity of ESC-derived endocardial cells would be best examined 
with in vitro collagen gel assays (Camenisch et al., 2002).  Endocardial cells of the AVC 
and OFT are unique among endothelium in their ability to under EMT and migrate into 
the underlying ECM of the cardiac jelly.  The collagen gel assay has been used 
extensively with cushion explants from avian hearts to assess factors that affect EMT. 
Depositing YFP+/CD31+ endocardial cells isolated by FACS from differentiating 
NFATc1-Venus-yfp BAC ESCs onto collagen gels could determine their competence to 
respond to signals that induce EMT.  The addition of a marker from endocardial cushion 
cells would facilitate the identification of a mesenchymal phenotype.  Snail1, a 
transcription factor that regulates mesenchymal properties in cells, is expressed in 
cushion cells but not the overlying endocardium (Timmerman et al., 2004).  At present, a 
Snail1 reporter transgene is under construction in our laboratory to be used to label cells 
of the endocardial cushion; combined with the NFATc1 BAC reporter, this transgene will 
allow further characterization of mechanisms involved in the EMT of endocardial cells at 
the initiation of valve development.   
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While these experiments aim to test whether endocardial cells obtained from EBs 
are functionally comparable to their in vivo counterparts, it does not address the 
endocardial-myocardial interactions governing cardiac cell differentiation.  To ascertain 
how signals from endocardial cells affect myocardial differentiation and growth in EBs, 
endocardial cells could be selectively ablated as they differentiate from mesodermal 
precursors.  Differentiating ESCs containing an NFATc1 BAC transgene driving the 
pu∆tk suicide gene, a fusion of puromycin N-acetyltransferase and a truncated Herpes 
Simplex Virus thymidine kinase (HSVtk), would allow for endocardial ablation at critical 
periods of differentiation, temporally controlled by administration of the prodrug 
ganciclovir (GCV) (Chen and Bradley, 2000; Chen et al., 2004).  If the dramatic effect of 
paracrine signaling from endocardium to myocardium seen during latter development in 
vivo, as described in Chapter I, is recapitulated during early cardiac differentiation in 
EBs, the effect of endocardial ablation on myocardial differentiation would be expected 
to attenuate either early stages of differentiation and proliferation or progression to latter 
stages of myocardial maturation. 
 While murine ESCs are a robust and well-defined system for studying basic 
processes of development particularly lineage specification, they are not applicable to 
studying genetic and epigenetic origins of human disease or for use in regenerative 
treatments.  As numerous technical and ethical issues surround the use of human ESCs, a 
subject beyond the scope of this discussion, it necessitates the identification of alternative 
sources of progenitor cells.  The most radical and exciting alternative to human ESCs 
came with the recent discovery that human skin fibroblasts virally infected with 
constructs constitutively expressing Oct3/4, Sox2, Klf4, and c-Myc could be converted to 
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a human ES cell-like state (Takahashi et al., 2007; Yu et al., 2007).  Termed induced 
pluripotent stem cells (iPS), these cells are capable of generating multiple cell lineages 
upon differentiation in vitro and form teratomas in vivo similar to human ESCs.  
Originally obtained from normal human subjects, iPS cells have now also been isolated 
from human subjects with genetic diseases including adenosine deaminase deficiency-
related severe combined immunodeficiency (SCID), Duchenne and Becker muscular 
dystrophy, Parkinson disease, Huntington disease, and type 1 diabetes mellitus among 
others (Park et al., 2008).  As disease-specific iPS cells can produce genetically 
comparable tissues of actual patients in vitro, they represent a remarkable model to study 
mechanisms of cell differentiation and function under pathologic conditions.  The 
isolation of iPS cells from patients born with CHD, specifically those with valve defects, 
could serve to demonstrate how deficit endocardial function might result in this type 
congenital defect. 
 
Regulation of MCPs and lineage divergence 
 Flk1+ MCPs isolated from differentiating ESCs possess the ability to generate 
myocardium, endocardium, endothelium, and smooth muscle under the appropriate 
culture conditions.  However, the mechanism governing the divergence of endocardium 
and myocardium from these progenitors remains unknown.  The transcription factor Er71 
has recently been suggested to act as a regulator of endocardial and endothelial fate from 
cardiac progenitors (Ferdous & Garry, unpublished).  Nkx2.5 binds to an evolutionarily 
conserved homeodomain element in the Er71 promoter to activate transcription.  
Overexpression of Er71 in EBs consequently results in enhanced endothelial specification 
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with coincidentally decreases in cardiomyocyte differentiation.  Interestingly, Er71 has 
also been identified as a positive regulator of Flk1+ mesoderm in vitro and in vivo (Lee et 
al., 2008).  To confirm whether Er71 might regulate the divergence of endocardium and 
myocardium, Flk1+ MCPs could be procured from ESCs containing the Er71 coding 
region under the control of an inducible promoter to determine if Er71 might direct 
MCPs towards an endocardial/endocardial fate. 
 In the clonal analysis of the D4.5 Flk1+ MCPs, no colonies made of endocardial 
cells with or without other endothelial cells were observed.  In fact, endocardium was 
only detected in the presence of cardiomyocytes, implying that specification/survival of 
endocardium is dependent on signals from the myocardium or from other factors absent 
in our culture system.  Exposing Flk1+ MCPs to various extracellular growth factors at 
differentiation concentrations could provide insight into the signals required for 
endocardial specification.  ESCs with the NFATc1-mCherry BAC as a marker for 
endocardium and the Nkx2.5 or MHC promoter driving GFP to designate myocardium 
would be useful for high throughput analysis of these experiments.  To use a candidate 
gene approach instead a screen, TGF-βs-1/2/3 would be of most interest as they have 
previously been demonstrated to enhance endocardial specification from mesoderm 
where BMP-2, FGF-2, and VEGF did not (Sugi and Markwald, 2003).  These 
experiments, in concert with other mentioned here, could clarify the underlying 
mechanisms of endocardiogenesis and further define how interactions between the 
endocardium and myocardium shape cardiac morphogenesis. 
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 Concluding remarks 
Characterizing cardiac stem cells is foundational to understanding the 
mechanisms of cardiac lineage specification, and for development of rational therapeutic 
strategies for the treatment of cardiovascular disease.  The work we have described here 
has relevance not only to the field of cardiac developmental biology, but potentially has 
significant implications for the field of regenerative medicine.  The ability to identify the 
endocardium at the onset of differentiation and throughout subsequent stages of 
development will allow for the precise delineation of the critical mechanisms involved in 
the ontogeny of this unique population.  In addition, as an abundance of evidence has 
emphasized the role of endocardial-myocardial interactions in regulating later cardiac 
morphogenic events, the models and tools generated in these studies can be used to 
further elucidate how these two lineages interact at the earliest stages of development is 
essential.  With experimental evidence suggesting that paracrine signals from the 
endocardium to the myocardium during development can rescue genetic defects of 
myocardium that are lethal in utero, the manipulation of endocardial-myocardial 
interactions during stem cell differentiation might be a viable strategy to enhance the 
regenerative potential of stem cell based replacement therapy (Chien et al., 2004; 
Fraidenraich et al., 2004).  In conclusion, these studies provide a framework to further 
investigate the unique characteristics of endocardial specification and differentiation that 
are essential for understanding basic processes of heart development and congenital heart 
disease.  
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